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As Chairperson of the Board, I and my colleagues on the 
Board are pleased to submit the first Annual Report and 
Financial Statements prepared since the re-establishment of 
a Board for the Health Service Executive (HSE) in June 2019.
As we submit this Annual Report and Financial Statements, 
COVID-19 has changed the focus of all healthcare systems 
around the world, including our own. The scale of the current 
challenge facing the Irish health system from COVID-19 and 
the associated HSE response is unprecedented.
Our Chief Executive Officer (CEO) and everyone working 
within the HSE have redirected their focus and attention 
to managing this pandemic to ensure that lives are saved 
and overall health is protected. Colleagues are working 
hour-by-hour to continually support public health, hospitals, 
the community, nursing homes, the National Ambulance 
Service and other essential functions as we all strive to 
manage the COVID-19 pandemic. On behalf of the Board, 
I am extremely grateful for the dedication and extraordinary 
commitment of every member of staff for all that is being 
done during this unprecedented and difficult time. That 
thanks extends to General Practitioners (GPs), pharmacists 
and other community based workers as well as to everyone 
working in our partner organisations and our stakeholders. 
Healthcare workers, from the doctor or nurse in the front line 
to the procurement expert or tech support colleague, all have 
mobilised quickly to protect our country and our people from 
the virus. They are to be admired and commended.
The last 12 months have seen progressive change in a 
number of areas across the HSE, from service developments 
which are enhancing the experience of patients, to new ways 
of working which are changing the way services are delivered. 
During the year, Ireland: Country Health Profile 2019, State 
of Health in the EU reported Ireland as having the fastest 
improving life expectancy in the EU driven by survival rates 
from conditions such as heart disease, stroke and cancer. 
The same report stated that Ireland has the highest share 
of the population that reports being in good health in the 
EU. These are important measures of general population 
health and mean that with its partners the HSE is achieving 
success in helping people to maintain good health and 
access effective healthcare services when illness arises. 
Progress also continues with the reform and modernisation 
of services including work on the introduction of major trauma 
centres and trauma units, further development of clinical 
networks for specialist services, and the introduction of 
new community-based care delivery models.
Recent increases in the HSE’s annual budget allocation 
have helped the HSE to make significant improvements 
in many areas and we are grateful for those increases. 
As a Board we are pleased with the improved financial 
control within the HSE. Financial control and predictability 
are a requirement for effective planning of operational 
capacity and future investment. I again thank colleagues 
for helping us make rapid progress in this area, progress 
which will pay back in stakeholder confidence and will set 
us up well to open discussions on future funding through 
a long-term multi-year settlement.
Whilst these and many other improvements should be 
welcomed we know that we have much more to do. 
The demand for health services is exceeding available 
capacity and unmet need is accumulating, often expressed 
in significant waiting lists in both hospitals and the community 
and through increased demand for emergency care. The past 
year was also challenging for the health service as a result of 
issues which arose from the audit process in CervicalCheck 
and the publication of the MacCraith report into the delays 
in issuing cervical screening human papillomavirus (HPV) 
retest results to a large cohort of women and their GPs. 
As a Board we are determined to increase service capacity 
to reduce waiting times. We are equally determined to avoid 
failures in services we provide which cause distress to those 
who are supposed to benefit from them and to the staff 
who administer them. Both groups deserve better.












Statement from the Chairperson
With an increasing population who are living longer, it is 
crucial that the health services effectively plan for future 
healthcare needs. New ways of working and delivering 
services bring great opportunities and ensure that future 
healthcare in Ireland remains of the highest quality, with 
the patient placed at the heart of all we do. As part of the 
response to COVID-19, a range of significant and essential 
changes has been put in place by the HSE and this provides 
an opportunity to identify changes which should be retained 
in the future. Doing so will ensure that we capitalise on the 
gains that have been made during the crisis, minimising 
long-term impacts for patients and staff while maximising 
value for the taxpayer. The implementation of the long-term 
policy direction set out in Sláintecare will continue to be a 
key focus for us in 2020 and beyond.
Listening to what matters to our patients is fundamental in 
shaping the way we deliver services. During 2019, a number 
of areas were progressed to promote patient and service 
user involvement across our health service in order to hear 
the views of stakeholders who have day-to-day experiences 
of the health services and to gain an understanding of what 
they see as the priorities for the future. Service improvement 
is best achieved when the voice of the patient, the clinician 
and the service manager are simultaneously engaged in 
improving outcomes. We hope to see further progress in 
this area though the current year.
Ireland has many attributes on which to build a world-leading 
health system. In the Board’s first year, we have been hugely 
impressed by the skill, commitment and expertise of the 
clinicians, support staff and managers of the HSE. This 
is also the case for the equally dedicated staff of our 
partner organisations with whom we share the challenges 
of providing high quality care under tight financial control. 
As a Board we see significant strengths in these attributes 
which will drive a high performing health and social care service 
of which we can all be rightly proud. Through innovation, 
service development, new ways of working and thinking we 
have seen much positive change and remain committed to 
further improving the health and experience of our patients.
As the Board, I and my colleagues are in a position 
of significant trust, privilege and responsibility in working 
with staff across the HSE in improving how the organisation 
is run, how it delivers services, and how it plans for the 
future provision of health and social care services. I am very 
optimistic for the years ahead and we will collectively strive 
to provide the health service that our population deserves.
Finally, I would like to thank sincerely all the Board members 
who served during the year for their commitment and valued 
contribution. I would also like to thank the Minister for Health, 
his officials, our Board Committees, and our CEO, Paul Reid, 
his management team and all colleagues. We have had an 
eventful first year. I look forward to continued collaboration 
and to working with the new Government in 2020. The year 
ahead promises to be a year of change and challenge and 
we look forward to both.
Ciarán Devane 
Chairperson, Health Service Executive Board












It is my privilege as CEO to publish the 2019 Annual 
Report and Financial Statements for the HSE.
While we have seen many challenges in 2019, we are 
at this moment in the throes of defending our population 
against the COVID-19 global pandemic. Our services are 
facing unprecedented pressures which have necessitated 
the coming together of the whole of our health system; 
public, private and not-for-profit. Every service, every worker, 
and indeed every person and household has stepped up 
to the plate to support the national effort. Our health system 
has shown an agility and a resilience that many of us did not 
believe was possible. As CEO I hope to support our staff 
to continue to give the best of themselves, to be proud of 
their efforts and to be working for the HSE, and to sustain 
the confidence of the public, which has been so very 
important in sustaining all of us this far. Rest assured that 
I will be careful to ensure that the response of our staff, 
and of our partner organisations to this pandemic will be 
documented for the record in the 2020 Annual Report.
By the time we bring this pandemic under control many 
of us will have endured the virus or worse, the loss of family 
members and dear friends. I take this opportunity to express 
my sincere sympathies. I also want to assure the public 
that we are putting absolutely everything that we have 
into minimising the impact of this terrible disease.
This Annual Report concerns of course our activities 
in the preceding year. I came into office as CEO on 
14 May 2019. In my first few months in this role, I spent 
a significant amount of time meeting with staff in various 
locations. During my visits I have witnessed many examples 
of staff who are innovating and working determinedly 
to overcome systemic obstacles, many of which were 
unintended, in the design of our national health service. 
They have done so by relying on strong personal and 
professional relationships which they have deployed for the 
benefit of patients. Our workforce is committed, and most 
have a strong vocation to public healthcare and to the public 
service. We therefore owe it to our staff – and to the public 
– to ensure that the health system is easy to understand, 
is rationally organised, and that our substantial funding 
is always spent wisely and on the right things.
I also met with a range of stakeholders, including those 
who have occasion to use our services intermittently or 
on a daily basis. It is clear to me that trust and mutual 
respect are the defining characteristics upon which the 
required relationships for the delivery of excellent healthcare 
must be built and sustained. Frontline staff achieve this 
primarily by doing their jobs competently and with care 
and compassion. At a corporate level we must enable 
and support this environment by eliminating systemic 
obstacles to care, and by ensuring that the interests of 
our health system are fully aligned with our purpose, with 
our core values, and with our best traditions of quality care. 
Any future structural changes to the HSE at corporate or 
service delivery level will be made with the singular purpose 
of converging the whole of our system around a high quality, 
integrated model of patient care.
Despite the crisis, I do not want to lose sight of the 
significant developments and progress made within our 
health services across many areas in 2019. It is only right 
that these should be recognised. The impact of all of 
this work can be seen in the service developments and 
improvements reflected throughout this Annual Report. 
The key priority for the HSE during 2019 was to maximise 
the provision of safe services to the people we serve, and 
to finally get a grip on the health budget. At year end the 
budget is under control. However, this will be an on-going 
challenge in the context of the ever-increasing level of 
demand for our services which is influenced by factors 
such as a growing population with an ageing demographic, 
advances in technology and clinical practice, as well as an 
on-going societal and economic change. The financial 





















Introduction from the  
Chief Executive Officer
Priorities in 2019
During 2019, the new Board of the HSE came into operation 
under the Health Service Executive (Governance) Act 2019. 
In conjunction with the Board I worked to ensure that 
the patient, service user and the public are at the core 
of our thinking and planning, that we value and support all 
healthcare staff, including those who work in not-for-profit, 
that we are structured in a way which supports frontline 
services, and that our financial and operational management 
is strengthened. I set out three immediate priorities for 
the organisation:
• The delivery of quality and safe services
• Transitioning to a new model of integrated care
• Strengthening the confidence and trust in the 
organisation.
Our changing population
There is increasing pressure placed on our services as 
a result of population growth, an increasing incidence of 
chronic diseases and an ageing population. Life expectancy 
is above the EU average with women living to, on average, 
84 years and men to 80.4 years. The three most common 
chronic diseases in Ireland are cancer, cardiovascular disease 
and respiratory disease. Chronic disease increases with age. 
The population in 2019 grew by an estimated 3.8% since the 
2016 Census. This was across all age groups with the most 
significant growth seen in the older age groups. The number 
of people aged 65 years and over has increased by 35.2% 
since 2009 (considerably higher than the EU average of 
16.5%). It is projected that the number of those over 65 years 
will increase by a further 15% in 2021. This continuing growth 
is due mainly to medical innovations, enhanced treatments 
and improved lifestyles.
There are many positive trends visible within the health 
service: life expectancy is increasing, mortality rates are 
declining and survival rates from conditions such as heart 
disease, stroke and cancer are improving. The experience 
of patients receiving care is generally good, with 84% of 
patients having a good/very good inpatient experience 
as indicated by the National Patient Experience Survey. 
Progress has also been made in recent years in improving 
hospital productivity and efficiency, increasing proportion 
of appropriate procedures carried out as day case, and 
improving day of surgery admission rates. But there is still 
room for improvement, particularly in relation to the length of 
time patients are having to wait to access particular services.
The Organisation for Economic Co-operation and 
Development (OECD) report Ireland: Country Health 
Profile 2019 provides an overview of health and the health 
system in Ireland. The OECD report highlighted that our 
health expenditure per capita is above the EU average; 
public health and healthcare in Ireland are comparatively 
effective; the use of both primary care and inpatient care 
is lower in Ireland than the EU average; Ireland has a lower 
number of doctors but a relatively high number of nurses; 
health workforce planning needs to be strengthened and 
more coherent; hospitalisation rates for ambulatory 
care sensitive conditions are around the EU average; 
long waiting times remain a substantial problem in 
Ireland; eHealth solutions will be an important element 
in the future service delivery model; more efficient use of 
hospital resources can be achieved; budget management 
remains an issue at all healthcare levels; far-reaching 
changes are required to make the Irish health system 
sustainable. What is evident from the OECD Report is 
that we have no choice but to pursue ambitious reform 
plans in order to make the best use of current resources. 
These areas are being addressed in our National Service 
Plan (NSP) for 2020 linked to Sláintecare.
Strengthening management 
capacity
In 2019, the former Directorate structure within the HSE 
was replaced with an Executive Management Team (EMT) 
in July which meets fortnightly. A Senior Leadership Team, 
comprising the EMT, National Directors, Hospital Group 
CEOs and Chief Officers of Community Healthcare 
Organisations (CHOs) has also been established and 
this group meets every second month.
Prior to the establishment of the HSE Board, the 
Department of Health (DoH) exercised direct oversight 
over the HSE’s performance. However, the establishment 
of the Board necessitated a reconsideration of how 
the HSE and the DoH engage with one another around 
performance and related matters. With the direct involvement 
of the Performance and Delivery Committee of the Board, 
a new engagement model with the DoH has been agreed. 
This model recognises the DoH’s role as vote holder and 
the accountability that comes with that responsibility, while 
at the same time recognising that the Board is now the 
HSE’s governing body.
Since coming into office, I have come to appreciate just 
how essential it is that the HSE’s corporate structure and 
its administration becomes more outward looking and that 
we fully commit ourselves to supporting the people who 
staff our hospitals and provide care in the community. 
A ‘review of the centre’ is currently underway. Its initial 
focus is on the current organisation, its functions, structures 
and ways of working. This will inform the future design, 
ensuring design robustness and consideration of all 
components, as well as informing the impact assessment 
required for implementation.
Reform
I committed to working to make Sláintecare a reality and 
it has been a key focus of our service planning for 2020. 
(We have deployed many of the Sláintecare principles 
in how we have organised our response to COVID-19). 
I have engaged extensively with the DoH and with the 
Sláintecare Programme Implementation Office (SPIO) 

















regarding the Sláintecare Action Plan. Arising from these 
engagements, it has been agreed that two large projects 
will be taken forward as a matter of priority, namely:
• The putting in place of national, regional, local health 
and social care delivery structures
• Improving capacity and access.
Supporting the early implementation of Sláintecare, a 
€20m Sláintecare Integration Fund was established in 
2019 to test and scale how services can best be delivered. 
I have been working closely with the SPIO to support, 
monitor and evaluate the range of HSE projects and 
supports that have received funding.
Operational Performance
The NSP 2019 set out priorities and actions for the 
organisation by service area, together with targets against 
key performance indicators and expected levels of activity 
for 2019. It includes detailed financial and Human Resources 
(HR) data together with a schedule of intended capital 
projects for 2019. The Service Plan was supported by 
detailed business plans and operational plans identifying 
named responsible people for its delivery. The National 
Performance Oversight Group review performance 
against the NSP.
The NSP 2019 has over 125 priorities with 555 supporting 
actions across all areas of service delivery and enabling 
functions. 80% of those actions were on schedule to be 
delivered (26% completed; 54% on track to be completed 
to the timeline set out in the NSP), almost 20% delayed 
and 1% not progressed. Updates on many priorities and 
actions are included in this Annual Report. Those delayed 
or not progressed are mainly due to resourcing issues, 
capacity constraints, dependencies on external stakeholders 
or factors outside the direct control of the action owner. 
These however impact on our ability to meet our key 
performance indicator targets or planned activity levels. 
Included within the service delivery chapter of this Annual 
Report, is a high level overview on the key performance 
indicators and activity data in 2019 against 2018 across 
community healthcare and acute services. The full suite 
of data is included in Appendix 3.
During the year Professor Brian MacCraith conducted 
an independent and rapid review of delays in issuing 
cervical screening human papillomavirus (HPV) retest 
results to a large cohort of women and their GPs. 
Professor MacCraith was asked to examine the series of 
events within the CervicalCheck programme that occurred 
following the delays and this report was presented to me 
in August. While much work and many improvements have 
taken place in the CervicalCheck service, it is unacceptable 
that women should have to wait so long for important 
information about their health. The HSE accepted entirely 
the findings of the MacCraith Review and committed to a 
careful and expeditious implementation in full of each of the 
recommendations. The HSE wishes to reiterate its apology 
to all of the women impacted by the delays in issuing 
important information to them. A number of key actions are 
being progressed including strengthening the management, 
leadership and organisation of CervicalCheck; developing 
a culture of putting women first; establishing a clinical 
evaluation and assessment of the women impacted and 
establishing an audit of Quest’s IT processes and interfaces.
Improving financial management
On my first day as CEO I committed myself to improving 
financial reporting and controls. This continues to be a 
difficult message to deliver, especially when it is clear that 
many services are under pressure. However, managing the 
balance between providing access to high quality care 
and remaining within budget, is a key aspect of the role 
of health managers.
During 2019, we continued our intensive focus on financial 
management and financial planning. Senior managers 
across the organisation were actively engaged regarding 
activity and expenditure and the related challenges of 
operating within available resources. Financial management 
meetings chaired jointly by myself and the Chief Financial 
Officer, are now a regular feature of our performance 
management processes and take place on a monthly 
basis. Senior budget holders give account of their 
financial performance against service plan objectives 
and give an informed view of predicted outturn by end 
of year. A new Integrated Financial Management System 
is being progressed. Myself and the EMT are working with 
the Board to ensure good governance, including rigorous 
and meaningful risk oversight, and assurance as to the 
appropriate use of public money.
Developing our Corporate Plan
We are developing a new vision for our health services 
which will support implementation of Sláintecare and 
address our key priorities and goals for the next number 
of years. An extensive Engagement and Consultation 
Programme with almost 12,000 external and internal 
stakeholders has now been completed, the findings of 
which will inform how we plan and deliver our services 
over the coming years.
Notwithstanding the considerable work undertaken to 
date, it has not been possible to conclude the Corporate 
Plan process by the intended timeline of end of March 
2020, given the need for staff at all levels, from across the 
organisation, to focus on preparations for and responses 
to the COVID-19 emergency. The Corporate Plan will be 
finalised later in 2020.


















The United Kingdom (UK) left the EU on 31 January 2020 
and has entered a transition period until 31 December 2020. 
The HSE had already put a comprehensive package of 
measures in place in 2019 to mitigate against the risk of 
a ‘no-deal’ Brexit. These preparations are continuing into 
2020 and we will continue to work with the DoH and partner 
agencies to prepare for the end of the transition period 
and the new deadline date of end-December 2020.
Thank You
In conclusion, I would like to thank once again all staff 
working in the HSE, across community, hospital and 
national services. I would also like to acknowledge the 
support and commitment of my colleagues on the EMT 
and Senior Leadership Team.
I would like to pay tribute to the Board and to the 
Chairperson, the Board Committees, to the Minister 
for Health and to those working within the DoH. 
I am conscious that 2020 has and will yet prove to 
be an extremely difficult year; particularly for families 
who have lost loved ones due to COVID-19.
As CEO I am immensely proud of the innovation 
we have shown in response to the current crisis. 
Many of the measures we have taken as individuals 
and as an organisation clearly have the potential to 
transform the HSE permanently, and for the better.


















Our Health  
Service
Under the Health Act 2004 (as amended), the HSE is 
required to submit a Corporate Plan every three years, 
specifying the key objectives of the HSE for the period 
concerned. The last formal Corporate Plan developed 
was for the period 2015-2017. In 2018, in anticipation of 
the publication of Sláintecare and its strategic implications, 
it was agreed with the DoH to extend the 2015-2017 
Corporate Plan by refreshing it to incorporate additional 
developments arising in 2018. Recognising the establishment 
of the new HSE Board and the appointment of a new CEO 
and other governance arrangements covered in legislation, 
another refresh was completed in 2019.
Developing the Corporate Plan
A number of steps were taken to examine the evidence base, policy environment and views of key stakeholders 
in determining an initial set of corporate priorities for consultation. Initial insight and information gathering tasks 
provided an analysis of the health service from many perspectives. These tasks included:
1.  Completion of four Rapid Reviews which focused on:
  i.  Corporate Plans of relevant and comparable international health systems
  ii.  Existing strategies of the Irish health system
  iii.  Existing data relating to the views of citizens, staff and the people who use our services
  iv.  Population health and wellbeing profile of people living in Ireland
2.  A Strengths, Weaknesses, Opportunities and Threat (SWOT) analysis
3.  A Political, Economic, Social, Technological, Environmental and Legal (PESTEL) analysis.
Our Consultation Process
A critical component of the process to develop the Corporate Plan is relevant and broad consultation with a 
wide range of stakeholders and interested parties ensuring the voices of as broad a range of stakeholders as 
possible are brought to bear on the content of the Corporate Plan. This has been done through the following 
channels:
•  Face-to-Face Consultation Meetings: open and broad ranging meetings focused on individuals 
and groups with particular interest in the strategic priorities and goals of the HSE
•  Workshops: involving both internal and external stakeholders
•  Community Panel: a panel established by the HSE providing early stage feedback on the strengths 
and weaknesses of the health service
•  Written Submissions: from key stakeholder organisations across all key sectors – unions, statutory, 
government, HSE funded agencies, community and voluntary groups and professional bodies
•  On-line Open Survey: targeting both the public and staff
•  Omnibus Survey: targeting a nationally representative sample of 1,000 people
•  Regional Listening Meetings: targeting regional staff, community-based/support groups and members 
of the public.
Outputs from the each of the consultations will be analysed and key findings identified for consideration 
by the HSE Board in the preparation of the Corporate Plan.
The development of a new Corporate Plan commenced 
in quarter three of 2019 under the guidance and direction 
of the HSE’s EMT, the Performance and Delivery Committee 
of the Board and the Board itself. A Project Team was 
established and a detailed Project Plan and Consultation 
Plan were developed. It is intended that the Corporate Plan 
will be published later in 2020. It will have a five-year focus, 
be aligned with Sláintecare and will focus on providing a 
clear medium-term roadmap for staff, patients, service 
users and all stakeholders.










Over 4.9m people live in Ireland (Central Statistics Office (CSO), 2019). 
The population has increased by 64,500 from April 2018 to April 2019, 
following a similar increase in 2017/2018, and these are the largest 
annual increases since 2008.
The population in 2019 has grown by an estimated 
3.8% since the 2016 Census. The population is growing 
across all regions and age groups, with the most significant 
growth seen in the older age groups. Assuming moderate 
changes in migration and fertility rates, the total population 
is projected to reach some 5.7m by 2039 with more than 
one in five people expected to be aged 65 years or over. 
Notwithstanding this growth in the older population, 
in 2016 a quarter of our population are children aged 
0-17 years, which is high by EU comparisons.
Ageing population
The greatest change in population structure over the 
last 10 years is the growth in both the proportion and the 
number of people aged 65 years and over. The number 
of people aged 65 years and over has increased by 35.2% 
since 2009, which is considerably higher than the EU 
average of 16.5% over the same period. It is projected 
that the number of people aged 65 years and over will 
increase by a further 23,200 (14.9%) by 2021. Similarly, 
the number of adults aged 85 years and over will increase 
by some 3,600 (4.5%) by 2021. This continuing growth 
is due mainly to medical innovations, enhanced treatments 
and improved lifestyles.
Birth rates
There were 61,200 births in 2019, 184 more births 
when compared with the same period in 2018. Births 
and birth rate have reduced in recent years and are projected 
to continue to reduce in the next decade. The fertility rate 
has continued to decrease (1.75% in 2018) and is now at 
its lowest in the last decade; however, Ireland still has the 
third highest fertility rate in the EU behind France and 
Sweden.
Life expectancy and health 
of the population
Life expectancy in Ireland has increased by 3.1 years 
for males and by almost two years for females since 2007 
and is now above the EU average with women living to, 
on average, 84 years and men to 80.4 years. The greatest 
gains in life expectancy have been achieved in the older 
age groups reflecting decreasing mortality rates from major 
diseases. However life expectancy is socially patterned and 
is lower among unskilled workers compared to professional 
workers. Studies have shown that certain groups have 
lower life expectancy such as Travellers and people who 
are homeless.
Greatest gains in life 
expectancy achieved in 
older age groups, reflecting 
decreasing mortality rates 
from major diseases
Mortality rates declined over 
past decade – mortality rates 
from circulatory system diseases 
decreased by 25.1%, respiratory 
death rates by 10.5% and cancer 
death rates by 10%
Suicide rates have fallen 
by 37.8% between 2009 and 
2018 – However both self-harm 
presentations to hospital and 
suicide in the 15-19 age range 
are both above European norms










Overall, age-standardised mortality rates have declined 
over the past decade; mortality rates from circulatory 
system diseases decreased by 25.1% between 2009 
and 2018 and respiratory death rates and cancer death 
rates have decreased by 10.5% and 10% respectively 
over the same period. Transport accident mortality 
rates have also fallen by 49.7% in the past decade.
Suicide rates have fallen by 37.8% between 2009 and 
2018 and the rate in 2016 was 8.5 per 100,000, placing 
Ireland below the EU average for both men and women. 
However, both self-harm presentations to hospital and 
suicide in the 15-19 age cohort are above European norms.
The infant mortality rate in 2019 was 3.3 per 1,000 live 
births and remains low by EU comparisons. The average 
maternal age for all births registered in 2019 was 31.3 
years, with teenage births reducing to 980 births in 
2018 from 1,041 births in 2017 and 1,098 in 2016.
Lifestyle risk factors
In 2019, 14% of adults in Ireland smoked tobacco every 
day, down from 27% in 2002, and now slightly below the 
EU average. Nearly one third of adults reported regular 
heavy alcohol intake in 2014, a rate well above the EU 
average. The obesity rate increased to 18% in 2015, 
up from 15% in 2007, and is now higher than the EU 
average. (Ireland: Country Health Profile 2019, State 
of Health in the EU).
Chronic disease
The three most common chronic diseases in Ireland are 
cancer, cardiovascular disease and respiratory disease. 
These diseases give rise to three quarters of deaths in 
Ireland. It is estimated that over 1.07m people over the age 
of 18 years currently have one or more chronic diseases.
As chronic disease increases with age, the highest 
prevalence is observed in the population aged 50 years 
and over. The number of people in this age cohort, living 
with one or more chronic disease, is estimated to increase 
by 40% from 2016 levels, to 1.1m in 2030.
In recent years age-adjusted cancer incidence in Ireland 
is slowly declining for males and is stable for women. 
Given population growth and ageing, if future populations 
have the same risk of being diagnosed with cancer as 
currently, the number of cancers (excluding non-melanoma 
skin cancer) would be expected to more than double in 
men and to almost double in women by 2045 (to 43,000 
cases in total).
The burden of dementia is also projected to increase, 
from some 55,000 people in 2016 to over 150,000 
people in 2046, almost a three-fold increase 
(The Irish National Dementia Strategy 2014).
In recent years age-adjusted 
cancer incidence in Ireland is 
slowly declining for males and 
is stable for women – however 
the absolute number of cancer 
diagnoses is expected to 
approximately double to 43,000 
by 2045 due to population 
growth and ageing
The five year survival rate 
for female breast cancer 
improved by 15% between 
1994 and 2015
The most common newly 
diagnosed cancers in Ireland 
for the years 2013-2015 were 
for men: prostate, colorectal 
and lung and for women: breast, 
lung and colorectal. The next most 
common new cancer for both 
genders is melanoma










Ethnic and minority groups within our population 
include Travellers (30,987, CSO, 2016), asylum 
seekers (5,660 pending applications, Irish Refugee 
Council, 2018) and those who are homeless (6,696 
adults and 3,752 children, Department of Housing 
Planning and Local Government, November 2019). 
The estimated Roma population is between 4,000  
and 5,000.
Socially excluded groups have complex health 
needs and experience very poor health outcomes 
across a range of indicators such as chronic disease, 
morbidity, mortality and self-reported health. 
These populations require greater support across 
a range of healthcare areas.
These statistics and trends provide us with an 
understanding of the demographic change and the 
challenges we face which have implications for future 
planning and health service delivery.
The number of people 
aged 50 years and over, 
living with one or more 
chronic disease, is estimated 
to increase by 40% from 2016 
levels, to 1.1m in 2030
The burden of dementia 
is projected to increase 
from some 55,000 people in 2016 
to over 150,000 people in 2046, 
almost a three-fold increase










This Annual Report describes what was accomplished in 
2019 to meet the priorities set out in our National Service 
Plan 2019. In meeting our legislative requirements under 
the Health Act 2004 (as amended), this Annual Report also 
reports progress against our Capital Plans and provides 
detailed financial statements for the organisation.
Governance
This is the first Annual Report prepared by the HSE since 
the re-establishment of a non-executive external Board 
for the organisation under the Health Service Executive 
(Governance) Act 2019 which commenced on 28 June 2019. 
During the period 1 January to 27 June the HSE Directorate 
was the governing body of the HSE under the Health Service 
Executive (Governance) Act 2013, with the Director General 
accountable to the Minister for Health.
Since 28 June, the Board is the governing body of the 
HSE and is accountable to the Minister for Health for the 
performance of its functions. The CEO is in turn accountable 
to and reports to the Board and is responsible for managing 
and controlling generally the administration and business 
of the HSE. The HSE exercises a wide range of statutory 
functions which may have significant implications both 
for individuals and for the public generally.
Under the Health Service Executive (Governance) Act 
of 2019, the Minister for Health can issue directions to the 
HSE on the implementation of Ministerial and government 
policies and objectives, and determine priorities to which 
the HSE must have regard in preparing its Service Plan. 
The HSE must comply with directions issued by the 
Minister for Health.
In line with the implementation of the recommendations 
of Sláintecare with regard to governance, the establishment 
of an independent Board was an important step in 
modernising and strengthening governance arrangements 
and sustaining reform.
Membership of the Board [as at 31 December 2019]
Mr Ciarán Devane – Chairperson
Appointed: 28 June 2019
Tenure: 5 years
Chief Executive of the British Council. Member of Board of NHS England from 2012-2015 
and was also Chief Executive of the UK health charity, Macmillan Cancer Support.
Professor Deirdre Madden – Deputy Chairperson
Appointed: 28 June 2019
Tenure: 5 years
Professor of Law at University College Cork (UCC) specialising in healthcare law and ethics. 
Chaired the Commission on Patient Safety and Quality Assurance and has extensive experience 
of healthcare and professional regulation.
Mr Fergus Finlay
Appointed: 28 June 2019
Tenure: 5 years
Retired CEO of Barnardos. Former Government and political adviser. Chairperson of Dolphin House 
Regeneration Board and Member of the Charities Regulatory Authority. Lifelong disability activist. 
Author and columnist.














Governance and Our Organisation
Mr Tim Hynes
Appointed: 28 June 2019
Tenure: 3 years
Group Chief Information Officer for Allied Irish Bank. Holds a Masters in Executive Leadership 
from Ulster University, qualified bank director, and Fellow of the Irish Computer Society.
Mr Brendan Lenihan
Appointed: 28 June 2019
Tenure: 5 years
Managing Director of Navigo Consulting and former President of the Institute of Chartered Accountants 
in Ireland. Non-executive Director of Bus Éireann. Chairperson of Good Shepherd Cork. Trustee and 
Chairperson of Audit and Risk Committee Pieta House until January 2020. Holds a Bachelor of 
Commerce degree from UCC, a Post Graduate Diploma in Professional Accounting from University 
College Dublin (UCD), a Fellow of Chartered Accountants Ireland. Holds a Professional Diploma in 
Corporate Governance from UCD Smurfit Business School and member of the Institute of Directors.
Dr Sarah McLoughlin
Appointed: 28 June 2019
Tenure: 5 years
Patient Advocate, Science and Communication Officer at Retina International and participates 
in patient, clinical and research initiatives in cross-disease areas in Ireland. Graduate of the 
first ‘Patient Education Programme in Health Innovation’ in Ireland by Irish Platform for 
Patient Organisations, Science and Industry.
Mr Mark Molloy
Appointed: 28 June 2019
Tenure: 3 years
Quantity Surveyor by profession. Following the avoidable death of his infant son in 2012, he 
has been at the forefront of striving for improvements in patient safety, outcomes and experiences 
across all spectrums of healthcare provision in Ireland.
Mark resigned from the HSE Board on the 7 January 2020.
Mr Aogán Ó Fearghail
Appointed: 28 June 2019
Tenure: 3 Years
School Placement Tutor with Dublin City University (DCU). Gaelic Athletic Association President 
from 2015 to 2018. Former School Principal. Holds a Bachelor in Education degree from 
St Patrick’s/DCU, Diploma in Law and Education and a Masters in Education Management 
from Trinity College Dublin (TCD).
Professor Fergus O’Kelly
Appointed: 28 June 2019
Tenure: 5 Years
Retired Family Physician. Recognised as a leading figure in the development of Family Medicine in 
Ireland, working as a Trainer, then as Assistant Director of the TCD/HSE training programme, and as 
Director of the programme for 18 years. Past President of the Irish College of General Practitioners 
(ICGP) and member of the Governing Board of ICGP from 2014 to 2017. Founded the first Out of 
Hours GP co-op services in Ireland and was the recipient of the Fiona Bradley Award, recognising 
his commitment to serving Dublin’s vulnerable and deprived communities.















Appointed: 28 June 2019
Tenure: 5 years
Chairperson of Córas Iompair Éireann (CIÉ). Has served on several Boards in Ireland and the UK. 
Former Director/CEO of the National Library. Currently chairs Mental Health Ireland and lectures 
on governance at the Irish Management Institute.
Dr Yvonne Traynor
Appointed: 28 June 2019
Tenure: 3 years
Vice President of Regulatory and Scientific Affairs with Kerry Group. Chartered Director and held 
role of Chairperson of the Audit, Risk and Compliance Committee of the Irish Blood Transfusion 
Service. Holds a PhD in Chemistry from TCD, a Certified Diploma in Accounting and Finance 
and an MSc in Executive Leadership.
Role of the HSE Board
In accordance with the Health Act 2004 (as amended) 
the Board has the following key functions:
1. It is the governing body of the Executive with authority, 
in the name of the Executive, to perform the functions 
of the Executive.
2. It is required to satisfy itself that appropriate systems, 
procedures and practices are in place:
(i) to achieve the HSE’s objectives
(ii) for the internal performance and accountability 
in respect of the HSE’s:
(a) performance of its functions
(b) achieving its objectives in accordance with the 
corporate plan
(iii) to enable compliance with the policies (whether set 
out in codes, guidelines or other documents, or any 
combination thereof) of the Government or a Minister 
of the Government to the extent that those policies 
may affect or relate to the functions of the Executive.
3. It is required to establish and implement arrangements 
for the management of the performance of the CEO.
The Board is accountable to the Minister for the 
performance of its functions above and shall inform the 
Minister in writing of any matter that it considers requires 
the Minister’s attention. Under the Code of Practice for the 
Governance of State Bodies (2016), the Board is collectively 
responsible for leading and directing HSE activities within a 
framework of prudent and effective controls which enables 
risk to be assessed and managed. The Board is required to 
act on a fully informed and ethical basis, in good faith, with 
due diligence and care, and in the best interest of the State 
body, having due regard to its legal responsibilities and the 
objectives set by Government.
The Board is responsible for holding the CEO and senior 
management to account for the effective performance of 
their responsibilities. It is the responsibility of the CEO and 
his senior management team to ensure that the Board is 
provided with all the necessary information to enable it to 
perform its functions. The CEO must also provide assurance 
to the Board that the functions which it has delegated to 
him are being appropriately discharged.
Delegation of Functions
The legislation recognises that neither the Board nor the CEO 
could exercise all of these functions personally and provides 
for a formal system of delegation under sections 16C and 
16H of the Health Act 2004 (as amended). This Delegations 
Policy Framework sets out the framework and supporting 
policy guidelines that underpin good governance regarding 
the system of delegation of statutory functions throughout 
the HSE. This allows these functions to be undertaken on 
an operational basis through the Executive Management 
Team and Senior Leadership Team and their supporting 
structures within the organisation.
Committees
The Board has established four Committees in order 
to provide it with assistance and advice in relation to 
the performance of its functions. Three of the Board’s 
Committees act in an advisory capacity and have no 
executive function. The Audit and Risk Committee has 
a number of specific functions, and those pertaining to 
audit have a legislative basis.














The Health Service Executive (Governance) Act 2019 
provides for the establishment of an Audit Committee and 
any other Committees that the Board deem as necessary 
for the purpose of providing assistance and advice in 
relation to the performance of the Board’s functions.
The Board’s Committees are:
• Audit and Risk Committee
• People and Culture Committee
• Performance and Delivery Committee
• Safety and Quality Committee.
Functions of the Committees
Audit and Risk Committee
The Audit and Risk Committee is established and 
maintained in accordance with section 40H of the Health 
Act 2004 (as amended) by section 23 of the Health Service 
Executive (Governance) Act 2019. The legislation recognises 
that the Audit Committee has a role to provide oversight and 
advice on risk management. Therefore, its title has been 
expanded to the ‘Audit and Risk Committee’ to reflect 
the full nature of its remit.
Legislation obliges membership of the Committee to 
comprise no fewer than three Board members and not 
fewer than four other persons who, in the opinion of the 
Board, have the relevant skills and experience to perform 
the functions of the committee, at least one of whom shall 
hold a professional qualification in accountancy or auditing.
Under current legislation the Committee is required to:
• Advise the Board and the CEO on financial matters 
relating to its function
• Report in writing at least once in every year to the Board 
and CEO on those matters and on the activities of the 
Committee in the previous year and provide a copy of 
that report to the Minister.
The functions of the Audit and Risk Committee include a 
range of financial, statutory, compliance and governance 
matters as set out in legislation.
People and Culture Committee
The role of the People and Culture Committee is to 
enhance the environment that supports and values the 
staff of the health service in order to engage the talent and 
nurture the leadership capability of individuals and teams 
working together to drive the desired culture throughout 
the health service to deliver safer better healthcare.
In pursuit of its role, the Committee will provide strategic 
oversight of and advice on matters to support the ambition 
of the People Strategy 2019-2024 to have the right people, 
with the right skills, in the right place and at the right time.
The Committee is not responsible for any executive functions 
and is not vested with any executive powers. In relation to 
its duties and functions, it fulfils an advisory and support 
role only.
Performance and Delivery Committee
The role of the Performance and Delivery Committee is 
to advise the Board on all matters relating to performance 
within the health service to ensure that such performance is 
optimised across all relevant domains of the agreed balanced 
scorecard to ensure better experience for patients and 
service users.
In pursuit of its role, the Committee provides strategic 
oversight of and advice on matters relating to planning for, 
developing and monitoring of relevant plans to ensure that 
they are delivering on the Board’s objectives.
Attention is focused on the key areas of performance 
achievement, improvement and learning in the context of 
an appropriate accountability framework and an incremental 
approach to developing a comprehensive scorecard.
Safety and Quality Committee
Given the profile and nature of services provided by the 
HSE, the Board decided on the establishment of a specific 
Committee to focus on the clinical aspects of the provision 
of health and personal social care. Accordingly, it established 
a Safety and Quality Committee.
The scope of the Committee’s authority extends to all 
aspects of safety and quality within the public health service. 
The role of the Committee is to provide strategic oversight 
of and advice on:
• The Patient and Service User Safety Framework
• The Quality Assurance Framework
• The Quality Improvement Framework of the HSE.
The Committee is not responsible for any executive functions 
and is not vested with any executive powers. In relation to 
its duties and functions, it fulfils an advisory and support role 
only. The Chairperson of the National Independent Review 
Panel reports to the Committee Chairperson.
Under the Health Act 2004 (as amended), the HSE is 
required to develop a Code of Governance to set out the 
principles and practices associated with good governance. 
The current Code was issued in 2015 and during the year 
work commenced on a revised Code of Governance to be 
finalised in 2020. The Statement on Internal Control in Part II 
Financial Governance of this Annual Report reflects our 
compliance with the requirements of the Code of Practice 
for the Governance of State Bodies (2016).
The Health Service Executive (Governance) Act 2019 
strengthens independent oversight and performance of the 
HSE. The establishment of the Board is an important step 
in improving governance arrangements and is a priority in 
the implementation of Sláintecare. The Chairperson and the 
Board are working closely with the CEO and EMT to ensure 
the organisation works effectively as well as responding 
efficiently and productively to a range of new governance 
requirements stemming from these new arrangements.














Membership of the Executive Management Team [as at 31 December 2019]
Mr Paul Reid
Chief Executive Officer
Paul Reid was appointed Chief Executive Officer of the HSE on 14 May 2019. He was CEO of Fingal 
County Council immediately prior to his appointment and, in previous roles has led large organisations 
in the private, not-for-profit, central and local government sectors. He has held senior executive roles 
previously in the Department of Public Expenditure and Reform, Trócaire and eir. He holds a Masters 
Degree in Business Administration from Trinity College Dublin and a BA in Human Resources and 
Industrial Relations from the National College of Ireland.
Ms Anne O’Connor
Chief Operations Officer
Anne O’Connor is the Chief Operations Officer of the HSE. She leads in excess of 100,000 
staff members who deliver health services across community and hospital settings in Ireland. 
She has led health services in Ireland at local and national level. She is trained as and has worked 
as an Occupational Therapist.
Mr Stephen Mulvany
Chief Financial Officer
Stephen Mulvany is the Chief Financial Officer of the HSE with extensive experience in financial 
planning, operational planning and service delivery. He is a Chartered Accountant (FCCA) with 
a Post Graduate Diploma in Information Technology for Managers and in 2018 completed the 
MSc in Management Practice. He has also completed the Institute of Directors Certificate and 
Diploma in Company Direction.
Dr Colm Henry
Chief Clinical Officer
Dr Colm Henry is the Chief Clinical Officer (CCO) of the HSE with responsibility for ensuring that 
clinical leadership is represented at the most senior level of the HSE. Prior to his appointment as 
CCO, he was National Clinical Advisor and Group Lead for Acute Hospitals in the HSE and, before 
this, was the National Lead for the Clinical Director Programme in the HSE. He was appointed as 
consultant geriatrician to the Mercy University Hospital in Cork in 2002 and was the hospital’s 
Clinical Director from 2009 to 2012.
Mr Dean Sullivan
Chief Strategy Officer
Dean Sullivan is the Chief Strategy Officer of the HSE, leading the HSE’s strategy development, 
planning and reform process across the health and social care system. He has 30 years’ experience 
in the public and private sectors, including senior roles in the Northern Ireland Health and Social Care 
Board and DoH, and with PA Consulting and Price Waterhouse. He is a qualified accountant (CIPFA) 
and has also completed the Institute of Directors Certificate and Diploma in Company Direction.
Ms Anne Marie Hoey
National Director, Human Resources
Anne Marie Hoey is the National Director of Human Resources for the HSE. She has over 30 years’ 
experience in the Irish health service, holding a number of senior management roles, including 
leading a change programme across a number of units within the Primary Care Reimbursement 
Service. Her focus includes strategic and operational management, change management 
and people management.
















Fran Thompson is Chief Information Officer of the HSE and CEO of eHealth Ireland enabling 
the digital transformation of Ireland’s health service. With over 25 years’ health ICT leadership 
experience, through both roles, he is particularly focussed on maximising digital transformation 
within the health sector.
Dr Paul Connors
National Director, Communications
Dr Paul Connors is National Director of Communications for the HSE. He leads a team of 
approximately 60 communications professionals who co-ordinate and manage a wide range 
of communications output for the organisation. He completed a primary degree in Business in 
University College, Galway. This was followed by a Masters in Communications from Dublin City 
University. He completed a PhD in Strategic Major Emergency Communications in 2009 and has 
also been called to the Bar.
Dr Geraldine Smith
National Director, Internal Audit
Dr Geraldine Smith is National Director of Internal Audit for the HSE. She also chairs the Audit 
Committee of a central government department. Her experience includes working as Assistant 
National Director of Internal Audit with the HSE, Director of Audit with the Eastern Regional Health 
Authority and Senior Auditor with the Office of the Comptroller and Auditor General. She is a Fellow 
of the Association of Chartered Certified Accountants and a Chartered Internal Auditor and has a 
PhD in Governance and a Masters in Public Management. She also has a Professional Diploma 
in Corporate Governance from UCD Smurfit Business School.
Mr John Kelly
Head of Corporate Affairs
John Kelly is Head of Corporate Affairs for the HSE. He is a qualified solicitor and has worked 
for one of the largest law firms in the country where he specialised in public administrative law, 
employment law, and healthcare law. Prior to training as a solicitor he worked as a senior 
healthcare manager.
Risk Management
Delivering quality and safe services for patients, service 
users and the public, is our overriding priority. Real and 
meaningful partnerships between patients and those working 
at all levels of the health service generate a shared vision for 
a compassionate health service, one that learns when things 
go wrong, responds accordingly and reduces harm to those 
who entrust their lives and care to us.
Risks to the delivery of healthcare will ultimately impact on 
patients and those who use our services and it is this that 
guides our overall approach to the management of risk 
described below.
1. Risk Management in the HSE
The HSE is the largest public sector organisation in Ireland 
accounting for approximately one-third of all public expenditure, 
employing one-third of the public sector workforce and with 
one-third of the population accessing its services each year. 
Effective risk management is an essential element of good 
corporate governance as it assists in determining priorities 
and setting objectives, analysing uncertainties within 
decision-making arrangements, clarifying accountabilities 
and demonstrating that the public interest is best served.
It is the policy of the HSE to manage risk on an integrated 
basis. This means it is inclusive of all risk whether to do 
with management or service delivery processes. It involves 
anticipating risks that threaten the achievement of objectives 
and putting in place actions that, as far as possible, reduce 
risks to an acceptable level.














2.  Risk Management Roles 
and Responsibilities
Board
The Board has collective responsibility for leading and 
directing the HSE’s activities including the oversight of the 
Integrated Risk Management Policy, the approval of the risk 
management framework and monitoring of its effectiveness.
Audit and Risk Committee and other Committees 
of the Board
The Audit and Risk Committee on behalf of the Board 
provides overall oversight and advice on the operation 
of the HSE’s Risk Management Policy and related activities 
within the function of risk management. The Audit and Risk 
Committee works closely with other Board Committees 
in fulfilling this oversight function.
Executive Responsibilities
Whereas every staff member is responsible for identifying, 
notifying and managing risk within the context of their 
work, risk management is a line management responsibility. 
The HSE’s Integrated Risk Management Policy outlines the 
roles and responsibilities for managing risk. The Policy and 
its associated processes apply throughout the HSE and 
HSE-funded agencies.
The Policy requires each national team to clearly outline the 
governance arrangements for risk management, including 
the process for the notification of risk and the escalation 
of actions to the next level in the accountability structure. 
National community and acute operations teams have 
arrangements in place to oversee how risk is managed 
and monitored across CHOs, Hospital Groups, and in 
the National Ambulance Service. Other national functions 
have arrangements in place to oversee how risk is 
managed and monitored within their areas of responsibility 
(e.g. Chief Financial Officer, National Human Resources, 
Chief Information Officer, Health Business Services (HBS), 
Internal Audit, National Screening Service, etc). For HSE 
funded services, requirements for managing and monitoring 
risk are set out in the relevant service agreements between 
the HSE and individual agencies.
3.  Review of Organisational Approach 
to Risk Management
Changes in 2019 to the HSE’s organisational structure at 
a corporate level together with the appointment of the HSE 
Board were key drivers in relation to the decision by the 
HSE to conduct a review of risk management. This decision 
also coincided with the publication of the Scoping Inquiry 
into the CervicalCheck Screening Programme 2018 which 
recommended that ‘the implementation of new governance 
arrangements for the HSE should include a substantial 
revision to the organisational approach to risk management 
and its reporting’.
The review of the HSE’s approach to risk management 
recognised that while significant progress had been 
achieved, challenges remained in implementing and 
embedding risk management in a manner that integrates 
both corporate and clinical governance across the health 
service. The review report and its recommendations were 
accepted by the HSE Board at its September 2019 meeting. 
The recommendations of the review included the need for 
the HSE to:
• Adopt an Enterprise Risk Management (ERM) approach
• Establish an ERM Programme
• Appoint a dedicated Chief Risk Officer.
The introduction of an ERM approach represents a significant 
change, and a properly resourced and structured change 
process will be required to ensure its success. The Board has 
ensured budget provision for the establishment of these new 
arrangements as part of the NSP 2020.
Implementation of the review recommendations has 
commenced with:
(i) A comprehensive review of the risks on the Corporate 
Risk Register by the CEO and EMT in October 2019 
(see below),
 and
(ii) The initiation of the process to recruit a Chief Risk Officer.
The implementation of the other recommendations set out 
in the review report will be progressed during 2020.
4.  Corporate Risks
The Corporate Risk Register is a key organisational 
document that allows the Board and the EMT to review 
and assess the HSE’s response to risk. As noted above, 
each of the risks on the Corporate Risk Register is assigned 
to one of the four committees of the Board. It is these 
committees, with the relevant members of the Executive, 
which scrutinise the risks and associated action plans. 
During 2019 the organisation took a number of actions 
to mitigate identified corporate risks. In October 2019 the 
CEO commenced a process with the EMT to undertake a 
comprehensive review of all the risks on the Corporate Risk 
Register to ensure that the Register identified all of the most 
significant risks facing the organisation, together with 
associated mitigating actions. For each risk, an assessment 
was made of both impact and likelihood to give an overall 
‘risk score’. This review process was substantially completed 
in 2019 and identified the following as the highest risks facing 
the organisation at that time:














Healthcare associated infections and antimicrobial resistance
What is the risk? What drives the risk? How are we managing the risk?
Healthcare associated 
infections (HCAIs) and 
antimicrobial resistance (AMR) 
can result in patients becoming 
sicker, placing additional 
demands on health service 
capacity in the case of AMR 
the longer term risks to the 
sustainability of healthcare 
services.
The ease with which micro-
organisms spread in healthcare 
settings both hospital and 
community.
• Enhanced surveillance
• Implementation of Ireland’s National Action Plan 
on Antimicrobial Resistance 2017-2020 (iNAP) 
and 2019-2020 HSE Implementation Plan on 
Antimicrobial Resistance and Infection Control
• National oversight of HCAI AMR Programme
• Investment in additional infection prevention 
and control, surveillance and antimicrobial 
stewardship staff and communications
• Increased screening for Carbapenemase-
Producing Enterobacterales (CPE) enhanced 
surveillance.
Capacity and access demand
What is the risk? What drives the risk? How are we managing the risk?
Demographic pressures, high 
occupancy rates in acute hospital 
services and insufficient capacity 
across community and acute 
services can lead to a reduction 
in the quality of patient care 
and repeated failure to achieve 
standards of care.
Any sustained or exceptional level 
of demand for services, such as 
during the winter period can 
reduce the availability of services.
• Providing additional acute hospital beds and 
homecare services as part of the Winter Plan
• Recruitment of additional staff in community 
and hospital settings
• Strengthening chronic disease management 
in the community
• Working with the National Treatment Purchase 
Fund (NTPF) to provide additional capacity for 
planned and unplanned care in acute hospitals.
Medical and clinical workforce
What is the risk? What drives the risk? How are we managing the risk?
Not having a sufficient number 
of critical staff in particular clinical 
staff, who have the required skills 
and professional qualifications, 
can impact on our ability to 
ensure safe and effective 
services.
A high reliance on agency staff 
and challenges recruiting and 
retaining medical, clinical and 
other critical workforce grades 
including the employment of 
consultants not on the specialist 
division register (SDR).
• Establishment of Workforce Planning Unit
• Developing new models of care
• Review of current recruitment process
• Workforce planning strategy and draft strategy 
Demand for Medical Consultants and Specialists 
to 2028
• Additional HR support for key strategic 
workforce planning priorities
• Clinical governance arrangements for non-SDR 
consultants.















What is the risk? What drives the risk? How are we managing the risk?
The way services for people 
with disabilities are currently 
organised and resourced can 
impact on our ability to ensure 
appropriate, safe and quality 
care.
Delays in moving to new models 
required to address increasing 
and changing need.
• Residential placement committees now operate 
in each CHO to triage, and manage waiting 
lists and new referrals based on risk
• The single assessment of need process was 
introduced to enable the residential placement 
process operate more efficiently and 
transparently
• Commencing the operation of Children’s 
Disability Networks.
Capital infrastructure and critical equipment
What is the risk? What drives the risk? How are we managing the risk?
Access to and the quality of 
health services is dependent 
on its built infrastructure 
and specialist equipment.
Inadequate built infrastructure 
and ageing critical clinical 
equipment, including 
ambulances.
• Available capital funding has been prioritised 
to address infrastructural and clinical risk
• Planned preventive maintenance programmes 
are in place for all critical infrastructure and 
equipment.
Brexit
What is the risk? What drives the risk? How are we managing the risk?
Brexit may result in threats to 
the continuity for critical goods 
and services which ultimately 
could have an impact on patients 
and service users.
Uncertainty in relation to the final 
agreement between the UK and 
the EU.
• HSE Brexit oversight group and steering 
group in place and meeting regularly
• Risk assessments complete for each priority 
area and Brexit work plan in place
• Service Provision Agreements signed with 
21 UK Hospitals as a contingency measure 
for the current provision of services to Irish 
patients post Brexit
• Additional warehouse storage capacity.
Other risks on the Corporate Risk Register are set out below:
• Current configuration of hospitals
• Cyber security




• Policy and legislation development and implementation
• Safety, health and wellbeing of staff
• Individual performance management and accountability
• Information and Communication Technology (ICT) 
systems and infrastructure
• System of internal controls, including management 
and prioritisation of resource allocation




All of the HSE’s corporate risks and associated actions will 
be subject to on-going monitoring and review during 2020.
5.  COVID-19
In January 2020, the EMT added COVID-19 to the 
list of principal risks of the HSE as part of the risk 
management process and brought it to the attention 
of the Board. Mitigating actions were commenced at that 
time. On 11 March 2020, the World Health Organisation 
declared COVID-19 a pandemic and noted its alarming 
levels of spread and severity. The emergence of this 
pandemic and its material impact on the health system 
and on citizens underlines how quickly new risks emerge 
and existing risks change.
Notwithstanding the HSE’s timely recognition and response 
to this risk, it also underlines for the EMT and the Board the 
importance of continuing to prioritise and seek to improve 
risk surveillance and risk management processes.














COVID-19 has had a huge impact on the HSE, the 
services we provide, our staff, and the populations we 
serve. It is inevitable that new risks will emerge and existing 
risks will change. We will ensure, both during and following 
the immediate crisis, a continued focus on the risks within 
the Corporate Risk Register and other emerging risks.
Our Workforce
We are committed to delivering on the ambition set out 
in Sláintecare, putting patients and service users at the 
centre of everything we do. Recognising the essential 
role of our workforce in meeting this, we are committed 
to delivering an exceptional employee experience that 
engages the talent and nurtures the leadership capability 
of all individuals and teams. In this regard, a new People 
Strategy was developed in 2019.
Staff Engagement
Staff engagement is and will continue to be an organisational 
priority as we progress to implement Sláintecare and address 
the public sector reform agenda. It is widely recognised that 
staff who are fully engaged at work are better able to give 
their best to patients and service users.
• Engaging Health Staff Action Plan 2019-2021 was 
developed in response to the results of the 2018 Your 
Opinion Counts staff survey findings. The plan defines 
staff engagement and highlights the benefits for staff 
and patients of having an engaged workforce in the 
health service, emphasising that staff engagement is 
a core component in developing policies and strategies.
• As a response to feedback received from the staff 
survey Your Opinion Counts, an organisational wide 
Anti-Bullying Task Force has been established with the 
inaugural awareness day held in February. A number 
of initiatives are being rolled out across the organisation 
to assist those experiencing or witnessing bullying at 
work, including a helpline with dedicated support and a 
social media campaign supporting the theme #cutitout.
• The National Staff Engagement Forum continued 
throughout the year, providing valuable information 
and feedback for on-going service developments and 
initiatives. The unique structure of the forum, which is 
based on proportional representation of staff across 
the health services, is a key element to the success 
of the forum.
• A practical toolkit – Leadership Skills for Engaging 
Staff in Improving Quality was launched at an event 
hosted by the National Staff Engagement Forum. 
At the event, delegates had an opportunity to explore 
practical examples of successful engagement to 
improve operational performance, service user 
experience and improved outcomes.
Training and Development
• The implementation of People’s Needs Defining Change 
– Health Services Change Guide progressed with a 
particular focus on practice development. Three Change 
and Improvement Practice Programmes were held in 
Tullamore, Portrane and Sligo, where 70 participants from 
a wide range of services presented key challenges and 
used the Change Guide to inform their action plans.
• 291 blended management development programmes, 
including Coaching Skills for Managers, First Time 
Managers and People Management the Legal 
Framework, were delivered locally to nearly 5,000 
multi-disciplinary staff.
• Other training and development highlights included:
– 140 Team Development/Team Intervention 
programmes were delivered around the country, 
facilitating some 1,500 participants.
– 619 one-to-one business coaching sessions were 
delivered internally to staff across the organisation.
– Graduates on the 2018/2019 Gradlink programme 
completed their final continuous professional 
development module as part of the programme.
• HSELanD (the HSE’s on-line learning portal) won two 
awards during the year:
– The award for Best Use of Technology in People 
Management at the Chartered Institute for Personnel 
Development Ireland HR Awards. HSELanD received 
this award in recognition of its use of technology to 
drive a change in culture through learning.
– HSELanD also won the Brandon Hall Group 
Excellence Bronze Award for the Best Unique or 
Innovative Learning and Development programme for 
An Introduction to Children First. 128,715 individual 
health service users have completed at least one 
learning programme on HSELanD during 2019.
Recruitment and Retention
• The Annual Medical Careers Day took place in 
October, a joint initiative between the HSE, the Forum 
of Postgraduate Medical Training Bodies and the Irish 
Medical Council. The event highlights the range of 
training and broad spectrum of career opportunities 
open to medical graduates in Ireland.
• A review of the existing Recruitment Model was carried 
out. Initial work has commenced on this model and is 
expected to be completed in 2020.
• A multi-stakeholder forum has been established 
to examine and develop recruitment and retention 
strategies for medical consultants.
Diversity, Equality and Inclusion
• A Diversity, Equality and Inclusion event for International 
Women’s Day in March was held for 200 colleagues in 
the Royal College of Physicians, as well as eight Women 
in Leadership events throughout the country.
• A number of HSE staff joined the LGBTI+ Allies Network 
and proudly participated in the Dublin LGBTQ Pride Parade.
• Dr Steevens’ Hospital participated in Culture Night, 
which commenced with the launch of the book The 
Patient is Paramount, comprised of entries for the 
HSE Nurses and Midwives Short Stories competition 
held earlier in the year. The remainder of the night’s 
entertainment included singing, dancing and theatrics 
performed by the Dublin Theatre of the Deaf, Deaf Folk 
Dance Ireland and Dublin Deaf Choir together with, for 
one night only, the Culture Night Choir, a collaboration 
of several HSE staff members.














• To mark International Day for Persons with Disability, 
a special inaugural forum was hosted to engage staff of all 
ranks and abilities on how we can embrace, promote and 
embed principles of diversity, equality and inclusion for our 
colleagues with disabilities. The forum included a staff panel 
who spoke honestly and openly of their own disability, 
the challenges they face and their experience as a HSE 
employee with a disability. As part of our commitment to 
equality, diversity and cultural awareness, an introductory 
training module is being delivered on an on-going basis.
Employment Levels
The health service is the largest employer in the state 
with just under 120,000 whole time equivalents (WTEs) 
employed by the HSE and section 38 agencies, as at 
31 December 2019. Since 2018, overall staffing levels 
have increased by 1.7% or 1,960 WTEs. All staff categories, 
except general support (-0.4%/38 WTEs) showed growth 
in 2019 compared with 2018. The largest growth was seen 
in nursing and midwifery (+561 WTEs) followed by patient 
and client care (+427 WTEs). Medical and dental staffing 
was the third highest staff category showing an increase, 
with an additional 390 WTEs, of which 154 WTEs were 
consultants.
Table 1: WTEs by staff category
Staff Category WTE WTE
Dec 2018 Dec 2019
Medical and dental 10,467 10,857
Nursing and midwifery 37,644 38,205




General support 9,454 9,416
Patient and client care 25,292 25,719
Total health service 117,857 119,817
Data source: Health Service Personnel Census.
European Working Time Directive
A key focus for the health service continues to be improving 
compliance with the European Working Time Directive 
(EWTD) amongst Non-Consultant Hospital Doctors (NCHDs) 
and social care workers. As of end December 2019:
• Compliance with the 24-hour shift
– 97.1% NCHDs, acute
– 98.3% NCHDs, mental health
– 80% disability services, social care workers.
• Compliance with the 48-hour average working week
– 83.6% NCHDs, acute
– 93.3% NCHDs, mental health
– 88% disability services, social care workers.
• 98% received 11-hour daily rest breaks or equivalent 
compensatory rest
• 99% compliance with 30-minute breaks
• 99% compliance with weekly/fortnightly rest or equivalent 
compensatory rest.
Pay and Staffing Strategy
The 2019 Pay and Staffing Strategy reflected the key 
learning from 2018, and began with a central high-level 
affordability assessment of the level of staff, on an average 
cost per WTE basis, that the budget for 2019 could support. 
This approach, designed to enable more realistic and 
affordable forecasting, followed on from the WTE limits 
process implemented in late 2018. Key stakeholders and 
budget holders then operationalised the WTE limits taking 
account of service priorities and maintenance of existing 
services, while identifying the opportunities for optimisation 
and efficiencies.
Significant progress was made on aligning our workforce 
with the associated funding in 2019 with further key learning 
from this first full year of implementation being used to 
further strengthen and inform the process for 2020.
Finance
The total HSE expenditure in 2019 was €17.2bn for the 
delivery and contracting of health and personal social 
services.
Total capital expenditure in 2019 was €688 million (m) 
including €603m for capital projects and €85m for ICT 
capital projects. This included capital grants to voluntary 
agencies of €325m.
Payroll
The overall pay bill of the health service, excluding 
voluntary service providers and superannuation, increased 
by €364m (7.4%) in 2019 to a total of €5.3bn. Basic pay 
increased by €179m (4.9%) and other allowances increased 
by €61.1m (9.9%).
Governance Arrangements with the 
Non-Statutory Sector
The HSE provided funding of €4.7bn to non-statutory 
agencies to deliver health and personal social services:
• Acute voluntary hospitals €2.5bn (53%)
• Non-acute agencies €2.2bn (47%).
Over 2,300 agencies were funded, with over 5,500 separate 
funding arrangements in place. Eight agencies accounted 
for over 50% of the funding.
Work continued to enhance governance arrangements 
with section 38 and section 39 funded agencies. In particular:
• Governance documentation for 2019 was again made 
available to the operational system from the beginning 
of the previous November, with a substantial number 
of Service Arrangements and Grant Aid Agreements 
being completed and signed by agencies before the 
end of March.














• The Annual Compliance Statement process continued, 
which requires all section 38 and section 39 agencies 
(which are funded by more than €3m annually) to 
submit a statement annually to the HSE confirming their 
compliance with good governance practice in the previous 
year. The Annual Compliance Statement process covers 
approximately 93% of the funding released to section 38 
and section 39 agencies. These statements were reviewed 
and matters requiring further clarification were addressed 
with the agencies concerned.
• The review of governance at Board and Executive level in 
section 38 agencies continued with a further six reviews 
finalised in 2019 and 28 reviews completed to date.
• Four pilot Contract Management Support Units (CMSUs) 
were established to assist service managers in managing 
and documenting all aspects of the relationship with 
section 38 and section 39 agencies. The CMSUs will 
allow greater oversight of the delivery of services by 
agencies in a manner that will give on-going assurance 
in relation to the significant amounts of funding involved.
Preparing for Brexit
A HSE Brexit planning group has been in place since 
2017 and has worked closely with the DoH on a wide 
range of Brexit contingency planning and mitigating actions. 
The focus of the work has been on implications across the 
following key work-streams:
• Continuity of patient and client health services
• Cross-border and frontier arrangements, including 
Co-operation and Working Together (CAWT) programmes
• Emergency health services (including the NAS)
• Public health matters
• Environmental health services – food import control and 
expert certification
• Workforce issues and recognition of qualifications
• Continuity of supply of goods and services/procurement 
arrangements
• General Data Protection Regulation (GDPR) compliance
• Communications.
In 2019, the HSE worked closely with the DoH and other 
agencies on ‘no deal’ Brexit contingency planning as part 
of the whole of Government Brexit preparedness on a range 
of issues. This involved identifying, assessing and addressing 
the necessary contingency measures and actions required to 
maintain service continuity in the event of either an orderly or 
disorderly Brexit.
• Service provision agreements were signed with a number 
of UK hospitals including all transplant hospitals as a 
contingency measure to ensure the current provision 
of services to Irish patients’ post Brexit remained in place.
• A Memorandum of Understanding was updated and 
signed between the National Ambulance Service and 
the Northern Ireland Ambulance Service.
• 100 additional environmental health service posts 
were recruited in order to meet statutory obligations 
associated with food import controls.
• Additional warehouse storage capacity was provided 
to facilitate improved stock management. Recruitment 
of extra staff for medicine compounding commenced 
to ensure greater resilience in these facilities.
• New equipment and staff were provided to the 
Public Analyst Laboratory to increase capacity.
• A detailed communications plan was developed 
and regular meetings took place with stakeholders, 
and with the DoH.














In order to provide high quality care, it is essential that we continually engage 
with patients and service users to ensure their views, concerns and experiences 
are at the centre of service delivery. A number of areas were progressed during 
the year to promote patient and service user involvement across our health service.
While we have achieved good patient engagement at some levels within the 
organisation we also recognise that this is an evolving area of work. We need 
to ensure that it continues to grow right throughout the organisation as we move 
to implement Sláintecare so that people who use our services are partnered with 
every step of the way to ensure that they are at the heart of the planning, design, 
delivery, implementation and evaluation of services.
National Patient Experience 
Survey
The survey, which first launched in 2017, is part of a broader 
programme to help improve the quality and safety of 
healthcare services provided to patients in Ireland by trying to 
understand how patients interact with the healthcare system 
and how they experience this process. The 2019 survey 
contained a total of 61 questions on topics such as admission 
to hospital, care and treatment on the ward, trust in hospital 
staff, respect and dignity, and discharge from hospital.
• All patients discharged in May aged 16 years and over, 
who spent 24 hours or more in one of the 40 participating 
hospitals and had a postal address in the Republic of 
Ireland, were asked during the year to complete the 
National Patient Experience Survey, a nationwide survey 
asking people for feedback about their stay in hospital.
• In general, the findings were similar to those reported 
in 2018 with the exception of an improvement in the 
area of discharge of transfer. While the survey results 
were generally positive, a significant number of patients 
did not have a good experience. The sharing of these 
experiences helps identify areas where improvements 
are needed. A further analysis on findings can be seen 
on page [27] of this Annual Report.
• Over 12,300 people participated, a response rate 
of over 46%. Key findings included:
– 84% of respondents said they were always 
treated with respect and dignity while in hospital
– 96% of respondents said their room was clean 
or very clean
– 86% of respondents said they were always given 
enough privacy when being examined or treated.
Engaging and Partnering with 
People who use our Service
Our aim is to build engagement with patients, service users, 
families and communities to make healthcare safer through 
the insights and experience of patients and service users 
themselves. We do this by creating and facilitating 
opportunities for partnering with the people who use 
our health services through group engagement, individual 
representation and membership of steering groups, working 
groups and committees.
• National Patient Forum
– Discussion on the Assisted Decision-Making 
policy and legislation
– Consultation on the development of the new 
Corporate Plan
– Participation in a panel discussion at the State 
Claims Agency Patient Safety Conference.
• Patients for Patient Safety Ireland
– Input into development of quality improvement training
– Input into the Patient Safety Strategy 2019-2024
– Feedback provided on the revised Open Disclosure 
Policy.
• National Patient Representative Panel
– Attendance at Sláintecare workshop on integrated 
community services
– Attendance at Infection Prevention Control Ireland 
National Conference
– Consultation on National Clinical Guidelines 
including for intraoperative massive haemorrhage 
and for nutrition screening and use of oral nutrition 
support for adults.











Listening to Our Service Users
The National Inpatient Experience Survey 2019 and What We 
Have Done – Listening, Responding and Improving Services
What you told us What we have done
Admission 
to Hospital
• The average patient rating for 
the admissions stage of care was 
7.9 out of 10
• 82% of respondents said that they 
were always treated with respect 
and dignity on the ward
• 30% of people said that they 
were admitted to a ward within 
the HSE’s target of six hours, with 4% 
saying they waited 48 hours or more 
before being admitted to a ward.
• Supporting the use of microsystems 
in EDs which is designed to understand 
how every part of the patient’s journey 
can be improved
• The ED Taskforce has set out a range 
of time defined actions to reduce 
overcrowding including optimising 
capacity, develop internal capability 
and process improvement and 




• The average patient rating for care 
on the ward was 8.3 out of 10
• 96% of people said that their room 
was very clean or fairly clean
• Most patients felt that staff did everything 
they could to help control their pain
• Patients were less positive about hospital 
food with almost 28% saying it was poor 
or fair.
• To improve patient care on the ward, 
in particular, the availability of staff to 
listen to the patient’s worries or fears, 
individual hospitals will promote patient 
advice and liaison services
• The development of the HSE Food, 
Nutrition and Hydration Policy was 
launched and recommended nutritional 
screening and a patient-centred 




• The average patient rating for 
examinations, diagnosis and 
treatment was 8.2 out of 10
• 86% of patients said that they were 
always given enough privacy when 
being examined or treated
• Patients were less positive about 
communication with 39% saying they 
were not given, or were only to some 
extent given, enough time to discuss 
their care and treatment with their doctor.
• The National Healthcare Communication 
Programme was developed to improve 
communication of healthcare 
professionals. The programme is 
designed to enable staff to take a 
skilled, sensitive and person-centred 
approach to all conversations with 
patients and their families
• The HSE has also developed on-line 
citizen health guides to provide easy to 
understand health information to patients.
Discharge 
or Transfer
• The average patient rating for discharge 
or transfer was 7 out of 10
• 71% of respondents said that staff 
completely explained the purpose of 
medicines they were to take at home
• However, just 45% said that staff 
completely explained the potential 
side effects of medications.
• The HSE has established a national 
team to implement improvements for 
delayed discharges between hospital 
and community care
• The HSE Code of Practice for Integrated 
Discharge Planning outlines the 
importance of providing patients with 
information about what to do after leaving 
the hospital, danger signs, who to 
contact and medication information.











• We established in 2019 a Cancer Patient Advisory 
Committee as part of the National Cancer Strategy 
2017-2026. A selection process was undertaken by 
a group comprising representatives of the Irish Cancer 
Society, the HSE’s National Cancer Control Programme, 
the DoH and a member of the former Cancer Patient 
Forum. The Committee comprises 15 members and 
its establishment is a significant advance in developing 
health services to meet the needs of patients.
• Engage: National Men’s Health Training was developed in 
response to the growing demand from service providers for 
support to improve their engagement and interaction with 
men. The training content was based upon the partners’ 
experience, evidence from academic and evaluation 
literature, and an extensive 24-month pilot phase.
• Nurses and midwives were encouraged during the year 
to collect patient stories, which were collected into a 
book The Patient is Paramount. Great stories can offer 
us valuable feedback about our patients’ experiences 
of healthcare services, challenging us and enabling us 
to develop a deeper understanding of these experiences, 
encouraging problem solving, new learning and discovery.
• Service user input was an integral part of the process 
undertaken to develop a strategic framework for health 
and social care professions setting out a roadmap for 
them to deliver on Sláintecare. Service users were invited 
to be involved in all consultations.
• In October, 300 staff and 50 patients attended a series 
of masterclasses/briefings on Partnering with Patients.
• Work began in collaboration with the All Ireland Institute 
of Hospice and Palliative Care on the production of videos 
of personal experiences of palliative care across Ireland.
• Your Voice Matters is a project which captures the 
lived experiences of service users and their families 
by inviting them to describe a recent instance of 
engaging with health and social care service, focusing 
on what is most important to service users and allowing 
the opportunity to capture both positive and negative 
feedback. This information is then used to inform service 
improvements. To date 1,135 stories have been collected 
with the following key themes emerging:
– The need for clear communication and information
– The need for improved access to services.
• Through the experiences gathered from Your Voice 
Matters a number of service improvement initiatives 
have been undertaken including the launch of a chronic 
obstructive pulmonary disease (COPD) Peer Support 
Group in South Tipperary and COPD information leaflets 
and posters developed for use throughout the South East.
• Engagement has begun with the Independent Patient 
Advocacy Service established by the DoH. This new 
service will encourage patients to communicate with 
health services about any concerns.
• A National Consent Policy Steering Group was convened. 
Working groups have been established and have 
commenced a review of the policy and development 
of an e-learning programme.
Office of the Confidential Recipient
The Office of Confidential Recipient is a national service that 
receives concerns/complaints such as allegations of abuse, 
negligence, mistreatment or poor care practices in HSE or 
HSE funded residential care facilities in an independent 
capacity and, in good faith, from patients, service users, 
families, other concerned individuals and staff members. It 
has dealt with 896 formal concerns/complaints from across 
the country since its establishment in December 2014.
In 2019, the total number of formal concerns/complaints 
received by the Confidential Recipient was 155, a decrease 
of 51 on 2018. The type of concerns raised included funding, 
leading to inappropriate placement, and lack of services for 
people with disabilities.
Appeals Service
The National Appeals Service ensures that applicants for 
eligibility schemes (e.g. medical cards/GP visit cards, 
residential support services maintenance and 
accommodation contributions, Nursing Homes Support 
Scheme (NHSS)) are given their correct entitlement, and also 
provides governance to the HSE in relation to the correct 
application of legislation, regulations and guidelines. 2,184 
cases were processed in 2019, of which 32% were allowed 
or partially allowed. The Appeals Service shares the learning 
from appeals, including feedback from appellants, with 
scheme managers and other relevant stakeholders.











Table 2: Appeals in 2019






Medical/GP Visit Card (General Scheme) 1,160 1,225 338 122 38%
Medical/GP Visit Card (Over 70’s Scheme) 172 169 39 3 25%
16 and 25 Year Old Medical Card/
GP Visit Card (* from 1 July 2019) 104 93 51 4 59%
Nursing Homes Support Scheme 493 507 55 60 23%
Common Summary Assessment Report 48 51 4 0 8%
Homecare Package 10 12 1 1 17%
Home Help 34 39 2 0 5%
Residential Support Services Maintenance 
and Accommodation Contribution 29 35 5 2 20%
Other 55 53 3 0 6%
Total 2,105 2,184 498 192 32%
Note: Appeals received are from 01.01.2019-31.12.2019. Those processed also relate to cases carried forward from 2018.
Compliments and Complaints
Health Service Executive
(Excluding voluntary hospitals and agencies)
Many compliments go unrecorded and work is on-going 
to encourage all staff to record compliments as they provide 
important information on the positive aspects of our service 
to assist in learning from what is working well. In 2019, 
there were 9,872 compliments recorded.
There were 5,938 formal complaints recorded in 2019 
and examined by complaints officers under the Health Act 
2004 (as amended) and the Disability Act 2005, see Table 3. 
Of these, 719 were excluded from investigation under the 
Your Service Your Say complaints process or withdrawn. 
Of the remaining 5,219 complaints, 3,398 or 65% were 
resolved by a complaints officer either informally or 
through formal investigation within 30 working days.
Voluntary Hospitals and Agencies
There were 17,139 compliments recorded in 2019. 
There were also 12,160 complaints recorded and 
examined by complaints officers. Of the total number 
of complaints received 11,757 were investigated. 
The other 403 were either excluded or withdrawn. 
Of those investigated, 9,760 or 83% were resolved 
by a complaints officer either informally or through 
formal investigation within 30 working days.
Complaints under Parts 2 and 3 
of the Disability Act 2005
1,244 complaints were received in 2019 under Part 2 of 
the Disability Act 2005 in relation to a child’s assessment 
of need for disability services, an increase of 68%. 842 
complaints were received under part 2 of the Disability Act, 
68% were recorded as resolved within 30 working days. 
12 complaints were recorded as received under Part 3 of the 
Act, relating to access to buildings and services for people 
with disabilities. These figures are included in Table 4.
Table 3: HSE Formal Complaints Received 




No. and % dealt 
with within 30 
working days
2019 5,938* 3,398 (65%)*
2018 6,610* 3,695 (56%)*
2017 8,281 6,298 (76%)
2016 9,158 6,972 (76%)
2015 9,289 6,854 (74%)
Data source: HSE Quality Assurance and Verification.
*  The introduction of the HSE’s Complaints Management System 
and increased staff training have resulted in enhanced reporting 
on formal complaints. The number of complaints received now 
refers to those which are formally addressed by Complaints 
Officers only and no longer includes point of contact complaints, 
(which are reported separately) received by frontline services 
which have been immediately resolved. This is reflected in 2019 
data above in respect of both complaints received and those dealt 
with within 30 working days. This figure includes 719 complaints 
received which were either excluded or subsequently withdrawn.


















2018 2019 2018 2019
Access 2,267 2,595 3,114 3,299
Dignity and respect 684 599 1,653 2,154
Safe and effective care 2,154 1,927 4,026 4,012
Communication and information 1,413 993 3,724 3,605
Participation 56 3 164 199
Privacy 56 61 313 419
Improving health 89 69 141 239
Accountability 266 254 615 572
Clinical judgement 160 162 423 165
Vexatious complaints 9 3 128 173
Nursing homes/residential care for older people (65 and over) 33 2 10 20
Nursing homes/residential care (aged 64 and under) 12 0 84 22
Pre-school inspection services 0 0 16 65
Trust in care 1 1 68 98
Children first 0 2 67 31
Safeguarding vulnerable persons (new 2016) 1 4 267 312
Data Source: HSE Quality Assurance and Verification.
Note: Some complaints contain multiple issues and therefore fall under more than one category.
Learning from Feedback
Many people take the time to tell us about their experience of our services. This feedback, much of which 
is positive also includes complaints. Feedback, both positive and negative, can provide unique insights 
into the standards of care being provided to service users. Being in a position to capture this feedback 
and experience is therefore central to how we learn and improve the quality of our services.
In 2019, the HSE began publishing quarterly casebooks on complaints received from the public and how 
they are addressed. The complaints are anonymous and the purpose is to use it as a tool for learning and 
to facilitate the sharing of that learning. This is a positive step as it provides an opportunity to publicly 
demonstrate our commitment to learn from the feedback we receive.
The establishment of the new independent Patient Advocacy Service in November 2019 provides a free, 
confidential and independent national service to help users of public hospitals making or intending to make 
a formal complaint through the HSE complaint process Your Service Your Say. This new service will encourage 
patients to communicate with the health services first to resolve their complaint. It aims to build positive 
relationships with the health services so that good communication is nurtured, and issues can be resolved 
efficiently and learned from.
Complaints addressed by Complaints Officers in HSE statutory services are either formal complaints or 
unresolved complaints escalated from point-of-contact in a frontline service. During 2019, the HSE continued 
to support and empower staff to resolve complaints at point-of-contact through an interactive on-line module. 
5,756 staff members have completed this module to date. An additional 5,161 complaints were recorded as 
addressed by frontline staff as they occurred at point-of-contact. These figures are not represented in Table 3.












The Sláintecare Report (2017) and Sláintecare 
Implementation Strategy (2018) signal a new direction for 
the delivery of health and social care services in Ireland. 
The implementation of Sláintecare has the potential to 
create a more sustainable, equitable, cost effective system 
that delivers better care and value for patient and services 
users. At its core, the strategy focuses on establishing and 
delivering programmes of work to provide care closer to 
home at every stage of a person’s life, enabling our health 
service to be more responsive to patient and service user 
needs and to deliver better outcomes, with a strong focus 
on prevention and population health improvement.
A Sláintecare Action Plan 2019 was developed by the 
DoH and outlined the key areas of focus for the first full 
year of Sláintecare implementation. It did this under four 
work-streams:
1. Service Redesign and Supporting Infrastructure
2. Safe Care, Co-ordinated Governance and Value 
for Money
3. Teams of the Future
4. Sharing Progress.
The vast majority of 2019 actions in the Sláintecare Action 
Plan have progressed in line with expectations and the 2020 
Action Plan is in development. This will include a particular 
focus on two priority Joint HSE/DoH Action Programmes 
of Capacity and Access and Regional Health Areas.
Given the need to ensure Sláintecare becomes fully 
embedded in everything we do, five high level reform 
and transformation priorities were identified for 2019:
• Governance, leadership and corporate strategy
• Transitional funding to shift the balance of care
• Managing demand and continuing productivity 
improvement
• Delivering programmes of work aligned to the 
Sláintecare Action Plan
• Transformation support and enablement.
A summary of our progress against these priorities can 
be seen below with further detail available throughout 
this Annual Report.
Governance, Leadership and 
Corporate Strategy
Under the Health Service Executive (Governance) Act 
2019 the Board is the new governing body of the HSE and 
is accountable to the Minister for Health for the performance 
of the functions of the HSE. The CEO, appointed in April 
2019, is accountable to the Board. As noted earlier in this 
Report, work progressed on the development of the new 
Corporate Plan, aligned to Sláintecare and focused on 
providing a clear medium-term roadmap for staff, patients, 
service users and all stakeholders.
Transitional Funding to Shift the 
Balance of Care
The publication of the Government’s National Development 
Plan 2018-2027 has been a welcome development, 
creating a funding pipeline for capital developments that 
are aligned to Sláintecare. In addition, in 2019 Sláintecare 
integration funding of approximately €20m was awarded 
to 91 projects from HSE or HSE funded services. This is 
the first year of an annual initiative with selected projects 
being funded for a 12-month period. The objective of the 
integration fund is to test and then scale projects that are 
capable of achieving health or service improvements at a 
whole population level within the areas of chronic disease 
management and prevention, older persons’ services, 
health promotion and moving more care to the community. 
Scaling or mainstreaming of projects is dependent upon 
successful delivery of project objectives and outcomes.
Managing Demand and Continuing 
Productivity Improvement
Through productivity and service redesign, we have the 
opportunity to improve the quality of services for patients 
and create capacity to respond better to rising demand. 
Several improvement initiatives commenced and continued 
in line with existing clinical programmes and international 
best practice in the area of scheduled and unscheduled care. 
Large scale service redesign programmes were progressed, 
including work on the designation of major trauma centres 
and trauma networks, the elective care delivery model, 
clinical networks for specialists services (including non-
consultant led clinics), and urgent and emergency care 
networks. Nine learning sites in the CHOs were agreed, 
representing the commencement of a phased implementation 
of the community healthcare network model that will respond 
to, among other priorities, the needs of people with chronic 
disease and those with frailty in the community. Community 
Intervention Teams (CITs) were reviewed and re-focused to 
support the delivery of an increased volume of complex 
hospital avoidance and early discharge cases.
The Capacity and Access Joint Working Programme 
was jointly established by the HSE and DoH and work 
has commenced to deliver on the recommendations of 
the Health Service Capacity Review 2018. These 
recommendations form the starting point for developing 
our capacity across acute and community services while, 
in parallel, reducing bed demand and improving the health 
of the population.
Delivering Programmes of Work Aligned 
to the Sláintecare Action Plan
Work continued in 2019 to progress a number of 
programmes of work, including:
• Design and development of new health service structures
• Staff engagement
• Population profiling
• Development and implementation of eHealth initiatives












• Review of existing service design for chronic disease 
and access to radiology
• Future capacity expansion
• Healthy Ireland and health and wellbeing initiatives
• Strengthening clinical leadership.
In addition to the detail above, progress against many 
other 2019 priorities aligned with Sláintecare can be seen 
throughout this Annual Report.
Transformation Support and Enablement
A dedicated Strategic Transformation Office has been 
established within the HSE to lead, drive and actively 
support implementation of the reform programme. The 
office will also provide assurance to the Board, highlighting 
issues of concern and identifying corrective actions required. 
The office will also support and enable services to deliver 
strategic reforms at frontline service level where it will be 
best experienced by our communities, people who use 
our services and their families.
Research and Evidence
We are striving towards the vision of making the HSE 
a health system renowned for its culture of building and 
using knowledge for health and wellbeing.
• Research Activity in the HSE and its Funded 
Organisations was launched highlighting the significant 
level of research activity in the health service. The first 
ever HSE Action Plan for Health Research 2019-2029 
was also launched which provides a road map to build 
research capacity and culture in the health service in a 
way that delivers real patient impact.
• Implementation of the National Health Library and 
Knowledge service continued with significant reform to 
provide equitable access to knowledge resources and 
service provision to all HSE healthcare staff. The first 
milestones towards the development of an open access 
National eHealth Library were also successfully 
completed. BMJ Best Practice, a point of care tool 
especially useful for primary and community services will 
be available nationally to enable evidence-based practice 
across the service in 2020.











Our aim is to continually improve the quality of care we deliver, learning from 
patient experience to ensure the safety of all who use our services.
Clinical Leadership
• A review of the national clinical programmes was 
undertaken early in the year offering the opportunity to 
consolidate the programmes along themes that make 
sense to patients and service areas ensuring an 
integrated care approach to service design, in line with 
Sláintecare. A number of recommendations were made 
following the review and work continues to implement 
these. These recommendations include:
– Establishment of a clinical forum
– Alignment with principles of Sláintecare
– Improved governance to connect, align and integrate 
clinical leadership
– Appointment of a National Lead for Integrated Care
– Merging of certain clinical programmes.
• National clinical programmes pilot and evaluate clinical 
designs that treat patients at the lowest level of 
complexity that is safe, timely, efficient and as close 
to home as possible. During the year, work continued 
to deliver care through this approach, including:
– Completion of a COPD collaborative project which 
enabled care improvements in 18 participating hospitals
– Commencement of a back pain pathway pilot
– Commencement of a research project to develop 
a profile of Emergency Department (ED) attendees.
• A number of new models of care were launched to 
define best practice and put the patient at the centre 
of treatment, including:
– Early Intervention in Psychosis Severe and Enduring 
Mental Illness and Complex Needs
– Cystic Fibrosis
– Paediatric Critical Care
– COPD
– Specialist Perinatal Mental Health Services
– Eating Disorders.
• The National Stroke Register Report 2018 was published. 
The report represents the largest data capture to date of 
Irish stroke trends, treatment and outcomes, processes 
of care and provision of therapy to patients. The report 
showed encouraging trends in mortality from stroke due 
to blood clotting (ischaemic stroke) which is at a historic 
low of 7.8%, down from 10.9% in 2015.
• The Clinical Director Development Programme continued to 
provide support to the clinical directorate, with the Executive 
Skills Programme commencing its third programme.
• A health and social care professions (HSCP) leadership 
study was completed HSCP Leadership: An examination 
of context, impact, supports, challenges and areas for 
consideration. It will inform plans to support and develop 
HSCP leadership in 2020.
• A strategic framework setting out a roadmap for HSCPs 
to deliver Sláintecare was substantially completed. It was 
informed by a comprehensive consultation involving 
service users, HSCP and other key stakeholders. 
The framework will be finalised early in 2020.
Enhancing Nursing and 
Midwifery Services
During 2019, the capacity and capability within nursing and 
midwifery was strengthened by developing and delivering 
a number of targeted programmes:
• 710 nurses/midwives were supported to undertake 
leadership training
• 4,000 staff accessed the Clinical Leadership Competency 
on-line resource
• 1,279 nurses and midwives now have authority to 
prescribe medicines
• 488 nurses and midwives registered as nurse and midwife 
referrers on HSE national database for nurse and midwife 
referrers of ionising radiation (x-ray)
• 465 nurses and midwives attended master classes in 
medicines management
• 2,010 nurses and midwives were sponsored to undertake 
postgraduate education programmes
• 3,438 continuing education programmes were provided 
to 40,339 nurses, midwives and healthcare assistants
• 30 health service employees were sponsored nationally 
to commence training as nurses/midwives
• 14 general and mental health nurses from around the 
country successfully completed the Return to Nursing 
Practice programme and are intending to re-join the 
nursing workforce
• 11 nurses/midwives completed the post-graduate 
diploma in nursing (Level 9) Sexual Assault Forensic 
Examination and were employed as Clinical Nurse 
Specialists nationally for adult and child and adolescent 
sexual assault treatment units
• An additional 935 healthcare professionals completed 
the National Frailty Education Programme and a further 
12 Frailty Networks have been established across CHOs 
and acute hospitals
• The number of Registered Advanced Nurse Practitioners 
has increased to 412 and the number of Registered 
Advanced Midwife Practitioners has increased to 13.
In addition the Office of Nursing and Midwifery Services led 
on the development of a Health Passport for people with 
intellectual disabilities accessing healthcare settings. This was 
launched and disseminated nationally. It received Sláintecare 
project funding to support up scaling and further dissemination.











Clinical, Quality and Patient Safety
Antimicrobial Resistance (AMR) 
and Infection Control
Significant improvements have been made in relation to AMR 
and infection control across the health service, with some key 
highlights as follows:
• A single World Health Organisation technique for performing 
hand hygiene has been agreed as the method being 
performed and taught. Previously, there were two different 
methods in place which could cause confusion for staff 
moving between healthcare settings.
• A survey was undertaken to learn about existing 
surveillance activities for surgical site infection. Responses 
received indicated that 69% of respondents had local 
surveillance projects in place and strong interest was 
indicated in developing a national surveillance programme. 
Work continues in establishing standard protocols and 
developing tools for data collection and analysis.
• Campaigns were run to raise awareness amongst 
healthcare professionals and the general public including 
hse.ie/UndertheWeather, European Antibiotic Awareness 
Week, Hand Hygiene week and the winter campaign.
• The first Director of Nursing for Infection Control and 
Prevention for the HSE was appointed.
• A quality improvement project, working to improve 
antibiotic prescribing in the community, was planned and 
implemented with the Primary Care Reimbursement Service.
• In excess of 9,500 staff have received hand hygiene 
education from the train the trainer programme.
• A process was developed for rapid whole genome 
sequencing to track the spread of carbapenemase-
producing enterobacterales (CPE) and other antibiotic 
resistant organisms.
• A number of guidelines were developed/supported 
including:
– Balancing competing demands in relation to bed 
use related to infection prevention and control
– Laboratory testing for CPE and the interpretation 
of clinical application of results
– Prevention and control of CPE in patients on 
haemodialysis treatment
– Infection control principles for buildings.
• CPE screening was rolled out in acute hospitals.
• A survey of hospital acquired infections and antimicrobial 
use in Irish hospitals in 2017 was published. The EU wide 
survey in which 60 Irish hospitals (46 public and 14 private) 
volunteered, provided a snapshot of hospital acquired 
infections and antibiotic use across participating hospitals 
on a single day and there were welcome improvements 
from the previous survey in 2012. All participating hospitals 
now have an infection prevention and control nurse and 
the number of single patient rooms has increased from 
22% in 2012 to 28% in 2017. Additionally, a reduction 
was seen in hospital acquired infections from indwelling 
devices (intravenous drips and urinary catheters).
Patient Safety Strategy 2019-2024
Keeping patients and service users safe is the overriding priority for those working in the health service. 
National and international evidence however shows us that as many as one in eight patients suffer harm 
while using healthcare services, with up to 70% of this harm being preventable.
Many excellent patient safety initiatives have been implemented in recent years resulting in measureable 
improvements. The development of the strategy builds on this and is an important example of how real and 
meaningful partnerships between patients and those working at each level of the health service can generate 
a shared vision for a more compassionate health service, one that learns when things go wrong, responds 
accordingly and reduces harm to those who entrust their lives and care to us.
The strategy sets out six commitments:
• Empower and engage patients to improve patient safety
• Empower staff to improve patient safety
• Anticipate and respond to risks to patient safety
• Reduce common causes of harm
• Measure and learn to improve patient safety
• Provide effective leadership and governance to improve patient safety.
The Patient Safety Strategy 2019-2024 is aligned closely with Sláintecare. A high level implementation plan 
and communication plan are in development and engagement has commenced with various stakeholders 
throughout the service. A consultation process is also being rolled out to seek input into how best to support 
services in the strategy’s implementation.











Quality, Patient Safety 
and Learning
• The Patient Safety (Notifiable Patient Safety Incidents) 
Bill 2019 was published which will legislate for a number 
of important patient safety measures. The legislation 
established a robust framework for mandatory open 
disclosure and includes a new process to designate 
patient safety incidents for which mandatory open 
disclosure must occur. A second purpose of the new 
legislation is to enable national learning and to support 
health service wide improvements so that harm to 
patients can be prevented. Further information on 
open disclosure can be seen in the Safeguarding 
and Protection section of this Annual Report.
• The HSE was awarded a global sepsis award for its 
significant efforts to increase sepsis awareness and raise 
the quality of sepsis prevention and management. The 
jury was particularly impressed by the improvement of 
recognition of sepsis, by all clinicians, in patients who 
are deteriorating due to an infection. Early detection 
and treatment of sepsis is crucial in reducing the mortality 
rate. Between 2011 and 2018, the number of cases 
reported in adults increased from 6,495 to 15,379 
indicating increased recognition and reporting of sepsis. 
This was accompanied by a reduction in the mortality 
from 26.8% to 19.4% in the same time period.
• The Medication Safety programme delivered three phases 
of the Know Check Ask campaign, encouraging people 
to know their medicines and keep a list, check that they 
are using the right medicine the right way and ask their 
healthcare professional if they are unsure. All pharmacies, 
GPs, primary care and health centres received campaign 
posters, and pharmacies also received My Medicines Lists.
• To reduce avoidable falls and pressure ulcers, and increase 
the capacity of quality improvement knowledge and skills 
within the system, two concurrent quality improvement 
collaboratives took place in Cork and in Cavan, involving 
26 multi-disciplinary teams and over 170 participants.
• Clinical audit skills training was delivered to 173 staff from 
acute and community services.
• Audits from the National Office of Clinical Audit are used 
to recognise areas of excellence and those requiring 
improvement, including identifying outliers in acute 
services. The audits also support policy development, 
service planning, best practice and reporting. In 2019:
– The Stroke Register was transitioned to a National 
Clinical Audit of Stroke
– The first national report for the Irish National Clinical 
Audit of Intensive Care Units was published
– New quarterly dashboards for the Irish Hip Fracture 
Database were implemented.
• 138 facilitators have completed a training programme 
to date to support the roll-out of the culture of person-
centeredness programme across acute hospitals, 
primary care services and disability services.
• The building of quality improvement capacity and capability 
across all services continued through designing, developing 
and delivering the following learning programmes:
– Diploma in Leadership and Quality in Healthcare 
and the Diploma in Quality for Community Care
– Foundation in Quality Improvement Programme.
• Quality improvement talktime webinars cover a wide 
range of topics and feature national and international 
speakers. There were over 21 webinars and on average 
79 participants per webinar in 2019 and their regular 
broadcast continues to build a network of quality 
improvers in our health service.
• The Final Report of the Evaluation of the Introduction 
of Schwartz Rounds in Ireland was launched. The report 
highlighted that Schwartz Rounds benefit teamwork and 
support reductions in staff stress levels by offering a forum 
for staff to share experiences in a structured environment, 
irrespective of their role or status within the organisation. 
27 services across the country are now introducing 
Schwartz Rounds and the numbers continue to grow.
• Significant work was undertaken with services to enable 
patient safety improvements in the following priority areas:
– Falls/pressure ulcer collaboratives
– Medication safety
– Quality Improvement for Healthcare Boards
– Deteriorating patient.












All vulnerable people have a right to be safe and to live a 
life free from harm and to have any concerns regarding 
abusive experiences addressed. Safeguarding is everyone’s 
responsibility and through interagency collaboration and 
associated public awareness initiatives the HSE is committed 
to ensuring vulnerable people are safeguarded from abuse 
in all settings.
The Safeguarding Vulnerable Persons at Risk of Abuse – 
National Policy and Procedures (HSE Adult Safeguarding 
Policy) resulted in the setting up of Safeguarding and 
Protection Teams (SPTs) and the HSE National Safeguarding 
Office. This policy publicly declared a ‘No Tolerance’ 
approach to any form of abuse and for all services 
to promote a culture which supports this ethos.
• The focus of SPTs in each CHO is to co-ordinate consistent 
responses to concerns of abuse and neglect providing 
oversight and support to all service providers, including 
those funded by the HSE. There are now over 70 social 
work staff in SPTs supported by administrative staff.
• There are over 1,700 designated officers across the social 
care sector with lead safeguarding roles.
• An independent inter-sectoral National Safeguarding 
Committee has been developed now known as 
Safeguarding Ireland, which involves over 30 partners 
across public, voluntary and private sectors is working 
to promote and advance the rights of vulnerable adults 
at a national level. On-going awareness raising initiatives 
by Safeguarding Ireland help to promote greater public 
awareness about the existence of abuse of vulnerable 
adults and the need for legislative reforms to protect 
their human rights.
• A national adult safeguarding training programme was 
developed which includes an awareness programme 
for all and specific training for designated officers and 
training facilitators.
• Safeguarding Committees in each CHO aims to support 
the development of a culture which promotes the welfare 
of vulnerable adults and provide support and advice to 
the SPTs and senior management.
Further details on the HSE safeguarding service including 
reports are on hse.ie/safeguarding.
In 2019:
• The National Safeguarding Office Annual Report 2018 
was published. It indicates that:
– 11,780 safeguarding concerns were received, 
representing a 14% increase on 2017
– For those aged 18 to 64 years of age, the most 
significant category of abuse alleged remains physical 
abuse at 50%, followed by psychological abuse at 31%
– For those aged over 65 years, the most significant 
category of abuse alleged is psychological abuse at 
33%, with physical abuse at 26% and financial abuse 
at 21%
– Over the past three years, an extensive programme 
of awareness training has been implemented for over 
55,000 staff. 1,743 designated officers with a lead role 
for screening and notifying cases of alleged abuse 
and neglect, who have undergone training are 
registered, 384 of whom were newly trained in 2018.
• A review of Safeguarding Vulnerable Persons at Risk of 
Abuse – National Policy and Procedures which commenced 
in 2017 was completed. The revised policy will be 
implemented in three phases and the first preparatory 
phase will take place in 2020.
Public Awareness Campaign 2019
Public awareness campaigns, commissioned by Safeguarding Ireland have focused on the prevention of abuse, 
planning ahead and the need for greater conversations around abuse within society. The 2019 campaign which 
was launched in May found that:
• 10% of Irish adults have witnessed adult abuse in the past year and 81% have said that tougher laws 
would encourage them to take greater action to combat abuse
• 12% of those who witnessed abuse of a vulnerable adult in the past year did nothing at all, while 47% 
discussed it with the person being abused and 40% discussed it with a trusted person
• Just 15% sought professional advice and 3% reported what they witnessed to an authority such as the 
HSE or Gardaí.
The hse.ie/safeguarding page received more visitors during May than at any other point in the year illustrating 
that the public awareness campaign has a positive impact on social media traffic to sites associated with 
safeguarding.
















The National Independent Review Panel (NIRP) was established 
in 2017 to undertake reviews of serious cases within disability 
services across the health service. The NIRP review the 
circumstances surrounding such cases and present reports 
to the HSE on its findings and recommendations relating 
to service improvement. In addition, the NIRP produces 
an annual report and aggregate analysis of the cases 
investigated, to ensure that the learning can be disseminated 
across health and social care services nationally. Updated 
operational guidelines were published in March, setting out 
the purpose and principles of the NIRP and providing clear 
guidance on the process to be followed for all reviews.
Open Disclosure
A revised Open Disclosure Policy Communicating with 
Patients Following Patient Safety Incidents was published 
and launched in 2019. Open disclosure means that patients 
and their relevant person(s), as appropriate, will be 
communicated with in an open, honest, timely and 
transparent manner if:
• Something goes wrong with patient care
• Patients experience harm as a result of their care
• We think that harm may have occurred as a result 
of patient care.
Under the revised policy, patients have a right to:
• Full knowledge about their care and treatment
• Be informed when things go wrong
• Meet with us to discuss what happened
• A sincere apology if we made an error while caring for them
• Be treated with compassion and empathy.
The National Open Disclosure policy, programme and training 
programme is co-ordinated via the National Open Disclosure 
Office which was established in May. To date over 45,000 staff 
have accessed open disclosure training with over 400 staff 
now trained as trainers across all care areas. The national 
office also supports the implementation of open disclosure 
legislation across all health and social care services.
An Open Disclosure Steering Group has been established. 
Its role is to oversee the progress of the Open Disclosure 
programme of work. In fulfilling this role, the National Open 
Disclosure Steering Committee will champion, advance, 
support and provide strategic advice on the on-going 
implementation of the National Open Disclosure Programme 
and policy. The Steering Group has developed a governance 
framework for monitoring and evaluating the policy and 
compliance with its application throughout the HSE. 
The full policy is available on hse.ie.
Protected Disclosures
The HSE is committed to hearing from and responding to 
concerns raised by employees and workers. Arrangements for 
dealing with protected disclosures have been in place in the 
health service since 2009 under the provisions of the Health 
Act 2004 (as amended) and since 2014 under the Protected 
Disclosures Act 2014 which deals with arrangements for 
protected disclosures in both the public and private sectors.
The Protected Disclosures Unit processes disclosures 
received as well as providing support and guidance to 
disclosers and managers and providing information sessions 
on protected disclosures across the organisation. In 2019 
2,105 protected disclosures were received*.
Assisted Decision-Making
To support the roll-out of the Assisted Decision-Making 
(Capacity) Act 2015, an implementation programme has 
been established in the HSE, with oversight by a National 
Steering Group, made up of staff, service users and expert 
advisors. Part of the purpose of this group is to draft Codes 
of Practice on the Act for Health and Social Care Professions 
and on advanced healthcare directives.
During the year, 49 information and briefing sessions on the 
Act were delivered to approximately 3,600 people across 
health and social care services. Three conferences were 
hosted in November on the Act and its implications, with 
over 550 people in attendance.
Children First applies 
to everyone
• A revised HSE Child Protection and Welfare 
Policy was published, aligning with the 
requirements outlined under the Children 
First Act 2015 and the principles of the 
Children First National Guidance for the 
Protection and Welfare of Children.
• Over 50,000 staff across the HSE and 
HSE funded and contracted services 
completed the mandatory HSE programme 
An Introduction to Children First, bringing 
the total number trained to over 220,000 
since 2016. A new training programme 
was developed and piloted in preparation 
for roll-out from 2020.



















Operational performance in 2019 was measured primarily on 
the basis of how we delivered against our NSP for 2019 which 
set out the type and volume of health and social care services 
to be provided by the HSE in 2019, in response to the funding 
made available and the level of staff to be deployed.
Included within the NSP 2019 are the priorities and actions 
for the organisation by service area, together with targets 
against key performance indicators and expected levels of 
activity. It includes detailed financial and HR data together 
with a schedule of intended capital projects for the year. NSP 
2019 is supported by detailed business plans and operational 
plans, which identify the responsible people for each priority 
and action, together with key timelines against each action.
The HSE National Performance Oversight Group meets 
monthly and reviews performance against the NSP. In support 
of this performance review process, a suite of performance 
reports are produced and published on-line on a quarterly 
basis. A summary of HSE performance against the priorities, 
actions and targets in NSP 2019 is provided below.
Priorities and Actions
The NSP 2019 has over 125 priorities with 555 supporting 
actions across all areas of service delivery and enabling 
functions. The position on these actions is as follows:
• 441 actions (80%) are on schedule to be delivered. 
Of these:
– 142 actions (26%) are completed
– 299 actions (54%) are on track to be completed 
to the timeline set out in the NSP
• 109 actions (almost 20%) are delayed
• 5 actions (1%) have not progressed.
Updates on many priorities and actions are included in this 
Annual Report in the relevant service area sections. Priorities 
and actions that are delayed or have not progressed are 
mainly due to resourcing issues, capacity constraints, 
dependencies on external stakeholders or factors outside 
the direct control of the action owner. These will impact on 
our ability to meet our key performance indicator targets or 
planned activity levels. Any risks are being mitigated through 
further engagement with relevant stakeholders to resolve 
issues and where relevant are included in risk registers.
Key performance indicators 
and activity levels
A high level overview is provided below on the key 
performance indicators and activity data 2019 against 2018. 
The full suite of data can be seen in Appendix 3.
Community healthcare
• Primary care
– Within primary care, access to occupational therapy 
(patients seen within 12 weeks), podiatry, ophthalmology, 
oral health and orthodontic services (those seen for 
assessment within 6 months) improved. Challenges 
remain however within the areas of speech and 
language therapy, audiology, dietetic and psychology 
services in addition to nursing caseloads.
• Mental health services
– Difficulties were experienced in recruiting and retaining 
skilled staff across mental health services.
– Particular challenges were experienced in delivering 7/7 
Child and Adolescent Mental Health Services (CAMHS) 
due to the lack of consultants nationally and 
internationally. The number of CAMHS referrals seen 
continued to increase (3.2%). The number of admissions 
to child and adolescent acute inpatient units as a 
percentage of overall admissions of children to mental 
health acute inpatient units also increased (21.6%).
– Waiting lists worsened slightly compared to 2018 but 
were slightly better than NSP 2019 targets.
– While the number of psychiatry of later life referrals 
seen by mental health services increased (4.3%), those 
offered appointments within 12 weeks by psychiatry 
of later life community mental health teams (-1.6%) or 
offered an appointment and seen (-1.3%), worsened.
• Disability services
– The requirements for services and supports within 
disability services, is greater than the resources 
available and while improvements are being made 
in many areas, other areas remain challenged.
– Compliance with regulations following Health 
Information and Quality Authority (HIQA) inspections 
has improved (0.6%) as has our compliance with the 
percentage of child assessments completed (12.6%) 
within the timelines set out in the regulations (noting 
that the number of applications for assessment of need 
significantly increased in 2019). However, our overall 
compliance is poor (9.8%). The revised Standard 
Operating Procedure for Assessment of Need which is 
a critical enabler to improve assessment timelines will 
be implemented from January 2020. The allocation 
of new therapy posts is aligned to alleviating the 
backlog/delays in completing Assessments of Need.
– More personal assistance hours are being provided 
(0.8%). However, the number of home support hours 
provided to people with a disability has reduced 
(-4.4%) as has our response to school leavers 
(-24.6%) and rehabilitation training graduates 
(-2.4%) in providing them with a placement.
– The number of new emergency placements has reduced 
since 2018 (-39.4%) as has the numbers of people who 
have moved from congregated settings to community 
settings (-33.5%). This is due to a lack of transitional 
and on-going funding to support their transition; it is 
also due to the lack of availability of housing nationally 
and related works to ensure HIQA compliance.











• Older persons’ services
– The number of older people in receipt of home 
support at any time varies depending on the level 
of need of those in receipt of services. Despite the 
significant resource allocated to home support, 
demand for home support continues to exceed 
the level of service that can be funded.
– Waiting lists for home support have become a feature 
of the service as resources have not kept pace with 
population growth or with the increasing dependency 
of the growing numbers of people aged over 80 years, 
within the over 65 years’ cohort.
– There was an increase in the number of home support 
hours provided in 2019 (2.1%); however the numbers 
in receipt of home support from intensive homecare 
packages decreased (-7.2%).
– The National Transitional Care Scheme assists patients 
in acute hospitals who are ready for discharge but need 
nursing homecare or a period of convalescence up 
to a maximum of 4 weeks. The scheme funds these 
patients in private nursing homes which facilitates 
the timely discharge of patients from acute hospitals.
– The number of people at any time supported through 
transitional care in alternative care settings decreased 
(-1.3%), however those funded under the NHSS 
increased (1.4%) as did the percentage of people with 
NHSS who are in receipt of ancillary state support 
(6.3%). Compliance with regulations following HIQA 
inspections worsened (10.2%).
Acute services
Our overall activity in acute hospitals increased in 2019 over 
2018 reflecting the increasing demands being placed on our 
services – this demand continues to grow as the population 
expands and ages and as technological advances facilitate 
new interventions in disease management.
Winter planning is a core component of annual planning in the 
health service to ensure that the system is prepared for the 
additional external pressures associated with the winter period. 
The introduction of a Winter Oversight Group and nine focus 
site Winter Action Teams during the 2018/2019 winter period 
provided the system with a strong grip on service delivery 
during this challenging period, assisting in delivering sustainable 
improvement in unscheduled care performance across primary, 
community and acute services for the winter period. In 
preparing for the 2019/2020 winter, the National HSE Winter 
Plan 2019-20 was published. An allocation of €26m was 
focused on supporting services through the provision of:
• €13m for NHSS to reduce period awaiting funding 
to four weeks until 31 December 2019
• €4.2m transitional care funding to support discharge 
from acute hospitals
• €2m for home support packages to support delayed 
transfers of care and community waiting lists
• €6.8m allocated to Winter Action Team initiatives, 
with funding distributed between the nine CHOs 
areas based on population.
A high level overview is provided below on the acute key 
performance indicators and activity data 2019 against 2018.
• There was an increase in overall acute activity (inpatient and 
day case) (1.5%) but specifically day case treatment (2.8%).
• Inpatient discharges increased for those aged over 75 years 
for both inpatient (1.4%) and day case treatment (5.7%).
• The number of ED attendances (both new (2.2%) and 
return (12.1%)) increased.
• Waiting times for patients to be seen in ED and, as 
appropriate, admitted to hospital continues to be a 
significant challenge.
• Bed days lost due to delayed discharges increased (15.5%).
• The total number of people waiting for an inpatient or day 
case appointment fell in 2019, notwithstanding the impact 
of four strike days resulting in a loss of over 9,500 cases. 
The HSE and National Treatment Purchase Fund (NTPF) 
continue to focus on both the total number of people waiting 
and those people waiting the longest and will continue 
in 2020 to agree individual treatment plans for patients 
within the public system or externally where appropriate.
• Our outpatient waiting lists remain a significant challenge. 
The total number of people waiting for a first outpatient 
appointment increased during 2019. Again, the impact 
of the strike was significant, resulting in a loss of 45,000 
outpatient appointments. A range of actions are being 
pursued to reduce outpatient waiting lists and waiting 
times. As indicated above, the HSE and NTPF continue 
to focus on both the total number of people waiting and 
those waiting the longest and will seek in 2020 to agree 
individual assessment and, as appropriate, associated 
treatment plans for patients within the public system 
or externally where appropriate.
• Our overall ED performance worsened in respect of 
people discharged or admitted within 6 or 9 hours of 
registration (-2.9% and -1.6% respectively) or those in ED 
more than 24 hours (including those aged over 75 years).
• ED patient experience time <24 hours in 2019 improved 
slightly (0.4%) despite significant increases in ED 
attendances in the later part of 2019.
• The number of people waiting 13 weeks or less for a 
routine colonoscopy reduced (-6.3%), and while the 
number of people waiting 4 weeks or less for an urgent 
colonoscopy also reduced (-17.4%), we did not meet 
our target level of performance. The HSE’s Endoscopy 
Programme has identified the requirement for significant 
additional capacity across the system to support on-
going achievement of targets. Progress is being made 
based on additional NTPF and HSE development funding 
being made available however without development of 
additional capacity achievement of the required targets 
will be challenging in the short term.
• While the number of new cases of CPE increased in 2019 
(24.5%), the percentage of hospitals implementing the 
requirements for screening of patients with CPE 
guidelines increased (34.7%), as did the percentage of 
hospitals implementing the national policy on restricted 
antimicrobial agents (62.6%).
• There was an increase in 2019 in the percentage of acute 
stroke patients who received most of their treatment in an 
acute or combined stroke unit (3.8%) and there was also 
an increase in those patients with acute ischaemic stoke 
who received thrombolysis (30.9%).










Population health and wellbeing is about helping our whole population to stay 
healthy and well by focusing on prevention, protection and health promotion 
and improvement.
Supporting and improving the health of the population is a 
fundamental goal of developing a sustainable health service. 
Sláintecare recognises the importance of supporting people 
to look after and protect their own health and wellbeing. 
Healthy Ireland, the national strategy for improved health 
and wellbeing, is underpinned by a whole-system philosophy 
involving cross-government and cross-societal responsibility. 
The health system continues to play an important leadership 
role in driving a whole-system shift towards a culture in 
Ireland that places greater emphasis and value on prevention 
and keeping people well.
Health and Wellbeing
Implementing the Healthy Ireland Framework
• Healthy Ireland Implementation Plans were launched for 
the two remaining CHOs with implementation plans now in 
place for all nine CHOs. Implementation of Healthy Ireland 
plans continued in five of the seven Hospital Groups.
• Men on the Move, A Community Based Physical Activity 
Programme for Adult Men in Ireland – Evaluation Report: 
Executive Summary was published. The report highlights 
how the men who successfully engaged in a 12 week 
physical activity programme in eight Local Sports 
Partnerships (LSPs) reduced their weight and 
cardiovascular risk by 30% and improved their overall 
health and wellbeing. Work commenced on rolling out 
the programme across the national network of 29 LSPs.
• In partnership with Jigsaw, a number of workshops were 
delivered to 411 youth leaders and youth workers including:
– 20 workshops Introduction to Youth Mental Health
– 4 workshops Minding your Wellbeing.
Improving the health and wellbeing 
of the population
• Making Every Contact Count
– Making Every Contact Count (MECC) is a flagship 
training programme designed to use the millions 
of day to day contacts that staff have with patients 
and service users to encourage and support healthy 
behaviour change. In 2019, 1,792 staff completed 
the e-Learning MECC training in brief intervention 
and 367 frontline staff completed the face to face 
MECC training in brief intervention.
• Self-Management Support
– Work continued with the Higher Education Institutions 
to finalise the self-management support (SMS) 
curriculum, including its implementation.
• Healthy Eating and Active Living Programme
– The HSE funded Community Cooking Programme 
Healthy Food Made Easy is a six week programme 
delivered in disadvantaged communities to support 
people to better understand nutrition and to learn 
cooking skills. 5,100 people attended community 
cooking programmes around the country.
– The new Food, Nutrition and Hydration Policy for 
Adult Patients in Acute Hospitals was launched. 
A toolkit to support local implementation was also 
developed and is available on hse.ie. This new policy 
aims to ensure that all adult patients in acute hospitals 
receive a patient-centred food and nutrition service, 
from their admission to their discharge from hospital.
– Delivery of the START campaign in partnership with 
Safefood continued, offering families a number of 
practical, achievable tips to help make healthier 
lifestyle changes. The campaign which is underpinned 
by A Healthy Weight for Ireland: Obesity Policy and 
Action Plan 2016-2025 and Healthy Weight for 
Children (0-6 years) Framework connected directly 
with families through the GAA semi-final in Croke Park 
and the National Ploughing Championships.
• Education Programme
– Primary and post-primary school teachers are 
supported to create positive school environments, 
develop healthy eating policies, integrate physical 
activity into the school day and to introduce coping 
and resilience through social and emotional learning 
programmes. During 2019, 89 training courses were 
delivered to 1,599 primary and post primary teachers 
throughout the country.
– A National Healthy Campus Charter and Framework 
was developed in partnership with the DoH and 
Higher Education Institutions.
• Alcohol Programme
– Know the Score: Substance Use Resource Materials 
for Senior Cycle SPHE was developed as an evidence-
based resource for teachers of students aged 15 to 18 
years. It is designed to engage young people in 
exploring and considering a wide range of topics 
related to the risks associated with drugs and alcohol.
– People were encouraged to look at their relationship 
with alcohol by taking the self-assessment test on 
askaboutalcohol.ie during awareness week on 
alcohol related harm. The self-assessment tool is 
designed to help people understand more about the 
impact their drinking is having on their lives. A total of 
14,000 people used the tool between April 2017 and 
December 2019.















Population Health and Wellbeing
• Tobacco Free Ireland
– Seven out of 10 smokers want to quit and four out 
of 10 make an attempt to quit every year. Behavioural 
support is proven to double a smoker’s chance 
of quitting successfully and is a cost effective 
intervention. The percentage of smokers who used 
HSE QUIT services and who are not smoking at four 
week follow-up exceeded the national target of 45%.
– Implementation of the national tobacco free campus 
policy progressed across all CHO and Hospital Group 
sites. A new bursary award was launched for hospital 
and community services in recognition of improved 
Tobacco Free Campus Policy implementation.
• Sexual health and wellbeing is an important part of overall 
health and wellbeing and is one of the key priorities under 
Healthy Ireland
– The foundation programme in sexual health promotion 
was delivered in 10 locations nationally, supporting 
service providers who want to develop their confidence, 
skills and knowledge in the area of sexual health 
promotion and incorporate sexual health promotion 
into their work.
– The Fast Track Cities is a global initiative that aims 
to boost HIV prevention, treatment and support 
initiatives, while reducing HIV related stigma.
– Funding of €450,000 supported developments in 
community-based HIV testing and outreach services 
in Dublin, Cork, Limerick and Galway, as well as 
public campaigns on reducing stigma.
– A phased introduction of a drug-based HIV prevention 
programme was implemented. The free provision of 
Pre-exposure Prophylaxis (PrEP) for people from at-risk 
populations was announced. The PrEP Programme 
involves the pre-emptive use of antiretroviral medication 
to prevent HIV infection, within a holistic service which 
includes regular monitoring and testing as well as 
advice and counselling on safer sex practices. The 
initial roll-out of this programme in public sexually 
transmitted infections clinics commenced.
– The National Freephone Crisis Pregnancy Counselling 
telephone service My Options was launched and more 
on this can be seen on page [49] of this Annual Report.
– Roll-out of the National Condom Distribution Service 
in third level settings commenced in November 2019 
whereby third level colleges can now order free 
condom dispensers from the HSE, providing free 
condoms and sexual health information to students 
on campuses nationwide.
– A new LGBT+ eLearning course was developed 
and launched in conjunction with LGBT Ireland. It is 
designed to help all staff develop an understanding of 
how making simple changes to everyday practice can 
provide enhanced service to the LGBT+ community.
• Nurture
– The Healthy Weight for Children (0-6 years) Framework 
was published. As part of its implementation two 
on-line training modules for staff working with children 
and families were developed and launched.
– The HSE’s breastfeeding website was merged into 
mychild.ie, together with the Facebook pages to 
provide a single, expert site for advice and a richer 
range of supports regarding child health information 
for parents and parents to be. The merging of the 
sites has shown increased and very positive 
engagement on breastfeeding posts.
Protecting the population from threats 
to their health and wellbeing
• Immunisation
– 42.2% of healthcare workers received seasonal flu 
vaccine during the 2018/2019 period in long-term 
care facilities. This is a substantial increase on 2018 
uptake (33.1%). 53.2% of healthcare workers received 
the seasonal flu vaccine in acute hospitals, an 
increase on 2018 (44.8%).
– The 2019/2020 schools human papillomavirus (HPV) 
vaccine programme was launched. The vaccine is 
now being given to all first year students in secondary 
schools, including for the first time, boys. As part of 
the campaign new and informative videos were 
developed. Over 60,000 information packs were 
delivered across the country in advance of the 
vaccination programme commencing in September. 
The uptake of the vaccine will be available later in 
2020 as the programme is still on-going.
• Health Protection and Surveillance Centre
– The Health Protection and Surveillance Centre protects 
our population from threats to their health and wellbeing 
through investigation, surveillance and management 
of infectious disease control. 644 infectious disease 
outbreaks were notified under the national infectious 
disease reporting schedule.
Environmental Health Service
• Responding to the impact of Brexit, capacity was 
increased to ensure official controls on food imports at 
ports and airports could be carried out and additional 
requests for food export certificates could be met. Further 
information in relation to preparing for Brexit can be seen 
on page [25] of this Annual Report.
• In general, compliance with the Public Health (Tobacco) 
Act, 2002 was high. However, there were 124 
prosecution cases in 2019 which resulted in convictions 
for tobacco related offences.
• The Public Health (Sunbeds) Act 2014 is designed to 
protect young people and promote a more informed choice 
among adults in relation to the use of sunbeds. During 
the year, work continued on conducting inspections, 
test purchases and mystery shopper inspections.















• Work commenced on agreeing a new Food Safety 
Authority of Ireland and HSE Service Contract.
• Work continued with the DoH in preparing for the 
enforcement of significant provisions under the Public 
Health (Alcohol) Act 2018 which will become operational 
in 2020.
• Engagement took place with the DoH and Irish Water 




– Targeted communication and promotion of the 
BowelScreen programme was undertaken to increase 
uptake of the programme amongst eligible men and 
women aged 60-69 years. Participation amongst men 
was still lower than women and focused campaigns 
targeting men were undertaken during the year, 
including promotion of the programme through 
men’s sheds and at the Ploughing Championships.
• Diabetic RetinaScreen
– The project to introduce digital surveillance screening 
was implemented and people are now being invited 
to attend digital surveillance screening nationally. This 
model will enhance the patient treatment pathway 
and support a more community based care model.
• BreastCheck
– The age extension of the BreastCheck programme 
was further implemented with screening extended 
to the remaining women aged 67 years together 
with a portion of women aged 68 years.
– Uptake remained high with a greater number of women 
attending for mammography screening than was 
targeted. However, challenges remain in ensuring 
all women are seen within the recommended 
timeframe, with 49% of women invited to screening 
in BreastCheck waiting longer than 24 months for 
their screening mammogram.
– A report published by the National Cancer Registry 
Ireland indicated that the five-year survival rate for 
female breast cancer improved by 15% between 1994 
and 2015. With improved screening, breast cancer is 
increasingly being diagnosed at an earlier stage, with 
the percentage of stage 1 cases increasing from 21% 
in 1994-1999 to 33% in 2008-2015.
• CervicalCheck
– Since the programme started in 2008, more than 3m 
screening tests have been carried out and the rates of 
cervical cancer in Ireland have decreased by 7% year 
on year. Over 100,000 cases of abnormal cervical 
cells have been detected, many of which could have 
developed into cancer if not detected.
– 234,000 smear tests in all settings were carried out 
in 2019 compared to 370,000 in 2018. The increase 
in 2018 was due to the demand for out-of-cycle 
screening tests during the CervicalCheck crisis. 
It should be noted that for coverage purposes, 
CervicalCheck reports only those tests carried out in 
a primary care setting and these equated to 206,315 
in 2019 compared to 339,161 in 2018.
– The successful contract negotiations with laboratories 
resulted in increased capacity, helping restore 
turnaround times to six weeks for women by August 
2019. This was critical to the continuation of cervical 
screening in Ireland.
– The HPV primary screening project was re-established 
and substantial work was undertaken to prepare for the 
introduction of HPV primary screening early in 2020.
– Substantial investment was made in increasing 
resources including employing advisors in pathology 
and colposcopy. Additional resources were also 
brought into programme management, laboratory, 
support staff and quality assurance.
– A significant team and associated planning process 
was put in place to support the Royal College of 
Obstetricians and Gynaecology (RCOG) review which 
was completed in December. This ensured that 
women received their RCOG reports in a timely 
and compassionate manner.
– Supports continue to be provided to women impacted 
by the CervicalCheck audit through the Community 
Liaison Officer.
Implementation of the Scoping Inquiry into 
the CervicalCheck Screening Programme, 
2018 (Scally Report)
Progress reports on the implementation of the 
recommendations of the Scoping Inquiry into the 
CervicalCheck Screening Programme, 2018 (Scally Report) 
were published during the year demonstrating substantial 
progress. The HSE has responsibility for implementing 42 of 
the 58 recommendations and, since publication of the Scally 
Report, has completed 105 of the 116 actions against these 
recommendations. Many of the recommendations have 
implications across the whole health service and are not 
just related to the CervicalCheck programme.
• An organisation design project resulted in an improved 
governance structure and a significant number of new 
appointments in all programmes. These included clinical 
advisors, operations management and public health 
positions.
• The National Screening Service launched its first Patient 
and Public Partnership Strategy 2019-2023 setting out 
how it will strengthen its partnership with patients and 
the public over the next four years, including ensuring 
that service users can influence decisions on the design, 
delivery and evaluation of services.
• Further work was undertaken to improve the quality 
assurance process across all programmes, including 
updating guidelines and strengthening quality assurance 
committees and resources.

































Sláintecare sets out the need for a shift from provision 
of care from acute to community settings, supporting the 
prevention and management of chronic disease at a 
community level.
It positions Community Healthcare Networks (CHNs) 
as the fundamental unit of organisation for the delivery of 
services in the community. CHNs are geographically-based 
units delivering services to an average population of 50,000. 
There will be 96 CHNs with each CHO having between eight 
and 14 CHNs enabling a co-ordinated multi-disciplinary 
approach to care provision, providing better outcomes for 
people requiring services and supports both within and 
across networks.
• Nine CHN learning sites were agreed and nine 
Community Network Managers recruited. In addition, 
65 staff members were recruited including therapists 
and nurses. Development of these sites will inform the 
future roll-out of the 96 CHNs.
• Building capacity in general practice
– GPs play a central role in achieving the movement 
of care towards primary care services. Agreement 
on GP contractual reform was reached on a set 
of measures on the provision of new services 
including chronic disease management and 
haemochromatosis, involving GPs working closely 
with local multi-disciplinary CHN teams in the delivery 
of care, particularly benefitting those with complex 
health needs.
– Modernisation measures include the areas of eHealth, 
medicines management and multi-disciplinary 
working. Key initiatives include the roll-out of 
electronic prescribing and the development of 
summary and shared care electronic patient records 
which will make healthcare safer and more efficient.
• The recruitment of 40 occupational therapists 
commenced with a focus on addressing patients 
waiting over 52 weeks.
• A number of quality improvement initiatives within 
community intervention teams (CITs) and Outpatient 
Parenteral Antimicrobial Therapy (OPAT) were 
implemented including the commencement of a 
haemochromatosis clinic in Tuam Primary Care 
Centre and a review of OPAT services.
• Through successful negotiations with the Department 
of Justice and Equality, the Atypical Working Scheme 
terms were amended which improve recruitment and 
retention of GPs with a particular emphasis on GP Out 
of Hours services. The Atypical Working Scheme allows 
people outside of the European Economic Area to do 
certain short-term contract work which is not covered 
by the Employment Permits Act 2006.
• The roll-out of the National Dental Record and 
Information system was completed. This is the 
HSE’s first nationwide clinical information system. 
The system is live in 221 primary care locations across 
26 counties and is accessible by all HSE dentists around 
the country.
• Hepatitis C
– As part of the hepatitis C treatment programme, 
six new community treatment sites were developed 
and preparation is underway for two new acute sites. 
A new consultant was appointed to provide outreach 
and clinical governance in community and acute 
outreach services. Nursing services were also 
extended in three acute treatment sites.
– A new proof of concept regarding community 
dispensing and prescribing by GPs commenced. 
Training and support sessions were provided to 
nine GPs and eight community pharmacists.
Primary care centres
Expanding community and primary care is at the heart of 
the Sláintecare vision. Developing modern, well equipped 
and accessible infrastructure is key to changing the way we 
deliver care. Primary care centres support the strategic shift 
of care and services to primary care, ensuring better access 
to care, offering individuals and families a one stop shop to 
a broad range of primary care services in the community. 
341 prioritised locations were identified during 2012 based 
on service need, existing facilities and level of deprivation.
• Of the 341 identified, 129 are operational at the end 
of 2019 with 74 in the process of development. Taken 
together this represents 203 or 60% of the original 341 
locations identified. An overarching review of all primary 
care centres will be completed in 2020 including an 
update of the rankings of proposed locations and a 
determination of how further delivery is to be prioritised.
• A range of delivery models were also identified including 
development of centres through exchequer funded 
development (Capital Plan), Public Private Partnership 
Programme and through operational lease.
Improving health outcomes for the most 
vulnerable in society
• Addiction services
– Additional funding of €2.28m over three years was 
provided to tackle drug and alcohol misuse in the 
community, supporting the 12 strategic health 
initiatives to address priorities set out in the National 
Drugs Strategy Reducing Harm, Supporting Recovery, 
A health-led response to drug and alcohol use in 
Ireland 2017-2025.
– In collaboration with Tusla, the needs of children affected 
by parental problem alcohol and other drug use are 
being addressed. Hidden Harm, Practice Guide was 
published, setting out how to bridge the gap between 
adult and children’s services in favour of a more 
family-focused approach that considers the needs 
of dependent children and other family members. 
An eLearning training programme was developed 
and commenced. The development of the hidden 
harm skills based practice training also commenced. 
A separate Opening our Eyes to Hidden Harm 
information leaflet was also developed to support 
staff to help those families being affected.












– Implementation of Rebuilding Ireland, Action Plan 
for Housing and Homelessness progressed through 
additional Housing First tenancies which have been 
established in Cork, Limerick, Galway, the South East 
region and Dublin. Enhancement of health supports 
has been established in these areas and the 
development of a health monitoring and evaluation 
framework commenced.
• Traveller, refugee, asylum seeker and Roma communities
– Eight Traveller mental health co-ordinators were 
appointed to eight of the CHOs and the development 
of a joint stepped model of care across primary care 
and mental health services was progressed to support 
Travellers with mental health needs.
Termination of Pregnancy Services
The Health (Regulation of Termination of Pregnancy) Act 2018, which was signed into law in 2018, broadens the 
circumstances in which termination of pregnancy may be legally permitted in Ireland and the service, which 
went live on 1 January 2019, is now provided in community and acute care services across the country. 
Additional funding of €12m was provided in 2019 to support services.
• A 24-hour free phone helpline and counselling service My Options was launched (1800 828 010) and 
provides free and confidential information and counselling to those experiencing an unplanned pregnancy. 
Since its commencement on 1 January, the helpline received 16,007 calls including 13,214 to the 
information and support line and 2,793 to the nursing line.
• A new website myoptions.ie was also launched and provides information about continued pregnancy 
supports and how to access termination of pregnancy services.
• A Clinical Lead for Termination of Pregnancy services was appointed in December. The Lead will chair a 
Clinical Advisory Forum which will have representatives from all key stakeholders. The forum will support 
the continued provision of a high-quality, safe service to women who require this service.
• 352 GPs are providing termination of pregnancy services.
• 10 of the 19 maternity hospitals are providing the full range of termination of pregnancy services and 
arrangements are underway for a phased increase to other maternity hospitals. All maternity hospitals are 
providing care for complications following a termination of pregnancy, diagnosis of a fatal foetal abnormality 
or situations where maternal health/life is at risk.
• All maternity hospitals are providing the ancillary services required for termination of pregnancy including 
anti D provision and scans.
• The HSE National Domestic, Sexual and Gender-Based 
Violence Training Resource Manual, Recognising and 
Responding to Victims of Domestic, Sexual and Gender-
Based Violence in Vulnerable or At-Risk Communities 
was launched in partnership with Sonas.
• A drug harm-reduction campaign aimed at young people 
attending Irish music festivals was launched to raise 
awareness of the risks associated with drug use and 
how to reduce the harms. The campaign involved the 
development of tailored resources for festivals including 
the setting up of information stalls at the events offering 
practical harm-reduction information, as well as advice 
on how to reduce the risks of drug use. Research was 
also undertaken in collaboration with Trinity College 
Dublin to investigate drug trends and harm reduction 
practices among Irish festival attendees.











• The Model of Care for People with Severe and Enduring 
Mental Illness and Complex Needs was launched. This is 
part of a range of initiatives developed to provide recovery 
focused care for service users including the establishment 
of two national specialised rehabilitation units and the 
creation of a national referral process.
• A National Framework for Recovery in Mental Health 
2018-2020 builds on the committed efforts of service 
users, family members, carers and service providers to 
develop a more recovery-oriented mental health service. 
The Framework outlines four key principles, including 
actions and measures that underpin a recovery oriented 
service. Each CHO has developed an implementation 
plan for the framework in their area.
• The Wellness Recovery Action Plan (WRAP) supports 
people to manage their wellness recovery and is 
recognised internationally as being one of the most 
popular self-management tools for maintaining mental 
health and wellness. A five day facilitator training day 
was held across a number of CHOs providing an 
opportunity for staff and service users to train together 
as WRAP facilitators.
Promoting positive mental health
• A new 24-hour free phone service (1800 111 888) 
which provides information on how to access services 
was launched. In partnership with National Ambulance 
Service this dedicated phone line will provide help to 
those experiencing mental ill health and their families 
to access information when they most need it. Since 
yourmentalhealth.ie was redeveloped and launched 
in 2018, the site has seen over 845,000 visits.
• Promoting simple and powerful day-to-day steps to 
protect our own mental health and support the people we 
care about continues on radio and social media. Updated 
information is available on yourmentalhealth.ie.
• In line with National Youth Mental Health Task Force 
Report 2017, a new text-based active listening service, 
Crisis Text Line, is being established for people who are 
feeling suicidal or facing a mental health crisis, and is 
recruiting 300 volunteers to provide support. It will be 
Ireland’s first free 24-hour seven day week confidential 
text messaging service for people in crisis anytime, 
anywhere. This initiative is funded by the HSE and is 
aimed predominately at 16 to 34 year olds for whom 
messaging is their preferred method of engagement 
but is available to all ages. The service will connect 
people with a volunteer, working remotely who has 
been trained to listen, reassure and guide people in their 
moment of crisis. In 2019, 255 volunteers were trained. 
There were 3,300 engagements with service users, 79% 
of which were aged between 14 and 34 years. The quality 
rating from service users on these engagements reflects 
a 92% satisfaction rating.
Improving access to mental health services 
and improving service user flow
• Enhancement of primary care-based services
– The Jigsaw network provides a range of early 
intervention services for young people aged 12 to 25 
years experiencing mild to moderate mental health 
difficulties. The development of two new services 
in Co. Wicklow and Co. Tipperary is continuing, 
expanding youth mental services from 12 to 14 
in 2020.
– One new psychiatry of later life team was put in place, 
increasing the total to 32 teams nationally.
• Enhancing secondary mental health services
– One new Child and Adolescent Mental Health 
Services (CAMHS) team was put in place in Cavan/
Monaghan, increasing the total to 71.
Engaging with service users, family members 
and carers
• 80 people, including services users, family members, 
supporters and service providers took part in a three and 
a half day skills based pilot programme. This initiative was 
a collaborative approach to support and build skills for 
mental health engagement and recovery forum training. 
Following success of the pilot, the programme was 
further rolled out across the country.
• My Voice Matters report was launched which includes the 
findings of two national surveys into people’s experience 
of mental health services in the HSE. The research which 
was funded by the HSE included the experience of 1,188 
service users and 786 family members, friends, carers 
and supporters, both positive and negative, with findings 
used to inform service improvements. Areas of 
satisfaction included care received from GPs while areas 
which require improvement include access to written 
recovery/care plans, therapeutic supports in acute 
settings and being treated with dignity and respect. 
A review of recovery/care plans commenced to support 
individual care planning including the training needs 
of staff and service users.
• Development of a stepped model of care is underway 
to establish clear mental healthcare pathways into and 
between primary care, addiction services and specialist 
mental health services for those who are homeless in 
Community Healthcare East, Dublin South, Kildare and 
West Wicklow Community Healthcare and Midlands 
Louth Meath Community Healthcare. This should ensure 
timely access and appropriate mental healthcare to meet 
their mental health needs.
• Significant progress was made in advancing 
the development of digital mental health supports, 
including piloting of initiatives to improve access to 
counselling on-line, establishment of a telephone-based 
YourMentalHealth information line and Crisis Text Line 
Ireland. Other initiatives include piloting internet-based 
cognitive behavioural therapy interventions and remote 
psychiatric consultations (tele-psychiatry).











Implementation of Clinical Programmes
• The model of care for the treatment of eating disorders 
in Ireland continued to be rolled out.
– Eating disorder specialist community teams were 
developed in both adult services and CAMHS. 
The aim is for 16 teams to be established across 
the country and to date three teams are in place.
Suicide prevention
Connecting for Life, Ireland’s National Strategy to Reduce Suicide 2015-2020 sets out a vision of an Ireland 
where fewer lives are lost through suicide and communities and individuals are empowered to improve their 
mental health and wellbeing. During 2019:
• The interim strategy review of Connecting for Life was completed.
• The National Office for Suicide Prevention Annual Report 2018 was launched, highlighting developments 
related to the on-going implementation of Connecting for Life. A key focal point was the improved provision 
of free, evidence informed suicide and self-harm training in communities nationwide.
• Connecting for Life National Education and Training Plan 2019-2020 was published and will build the 
capacity of government departments, non-governmental organisations (NGOs), community organisations, 
groups and individuals to identify and respond appropriately to people at risk of suicide and self-harm.
– In partnership with the Irish Hospice Foundation, the first train-the-trainer programme in suicide 
postvention was held in May for staff who support those bereaved by suicide, to provide them with a 
greater understanding of the grieving process, demonstrating the value of empathy, compassion and 
humanity. Further workshops took place in June within the community
– The report, Improving Suicide Bereavement Supports in Ireland, was finalised and it contains 21 actions 
for implementation.
– The PiLaR programme supports families affected by 
eating disorders. An independent evaluation of the 
programme, undertaken by University College Dublin 
(UCD) in collaboration with service users, clinicians, 
family members and friends confirms that the 
programme is a valued source of information and 
support to those supporting a person with an eating 
disorder. To date over 600 family members and 
friends have attended the free, four-week programme 
gaining information, education and support.
Transforming Lives – reform programme to move 
towards community-based, person-centred models 
of care
• As part of the implementation of Towards Personalised 
Budgets for People with a Disability in Ireland – 
Report of the Task Force on Personalised Budgets 
a number of demonstration projects were progressed. 
The personalised budgets model will give people with 
disabilities more control in accessing health funded 
personal social services, giving them greater independence 
and choice in accessing services which best meet their 
individual needs. It is anticipated that 180 participants will 
participate in the project.
Time to move on from congregated settings 
– A Strategy for Community Inclusion
• Supporting people with disabilities to live well within 
their community and in an ordinary home that supports 
their choices and routine is in line with Time to Move on 
from Congregated Settings – A Strategy for Community 
Inclusion. In 2019, 103 people transitioned from 
institutional settings to residential homes with on-going 
support in their community.
Compliance with residential regulations of centres 
inspected by HIQA
• Work progressed with a number of designated residential 
centres to provide support in developing compliance plans 
for HIQA registration due for renewal during the year.
Engagement with service users
• A number of service user engagements with many 
disability service providers were held during the year 
and a Governance Review Group was established 
with service user representation.











New Directions – improving day services to enable 
people to have choice and options about how they 
live their lives and how they spend their time
• Additional new service development funding of €12m 
benefited 1,416 school leavers and those leaving 
rehabilitation training in 2019.
• A new e-learning resource for staff supporting people with 
a disability attending day services, was launched. It was 
developed with input from service users, family members, 
staff, mainstream community services and employers. The 
module which is available on HSELanD will support almost 
6,000 staff in 1,000 day service locations across the 
county illustrating positive outcomes for people enabling 
access to mainstream services in the community, achieving 
employment and becoming valued team members.
• The national framework for person-centred planning 
focuses the delivery of services and supports on the 
person and how they want to live their life. The learning 
from these demonstration sites will be used to inform a 
process for the wider implementation of this framework 
for all adults with disabilities.
Services for children and young people ensuring 
one clear pathway of services
• 90 additional therapy posts were put in place to support 
assessment of need services.
• As part of the reconfiguration of 0-18s disability services 
into children’s disability network teams the recruitment 
process for children’s disability network managers was 
completed. This is enabling implementation of the 
network teams aligned with the planned 96 CHNs.
Respite support for those with disabilities 
and their families
• Respite care supports families to help reduce stress, 
providing stability. It also provides people with disabilities 
with opportunities for interaction with new people, 
widening their social circle. During 2019 additional 
facilities opened across the CHOs providing 12 new 
houses, one in each CHO and three in the greater Dublin 
area. During 2019, 12 new additional centre-based 
respite centres have opened to date, resulting in an 
additional 6,455 bed nights delivered to 763 people.
Neuro-Rehabilitation Strategy
• The National Strategy and Policy for the provision of 
Neuro-Rehabilitation Services in Ireland from Theory 
to Action Implementation Framework 2019-2021 was 
launched. The aim is to improve patient outcomes by 
configuring neuro-rehabilitation services into population 
based managed clinical rehabilitation networks (MCRN). 
The pilot project in Community Healthcare East and 
Dublin South, Kildare and West Wicklow Community 
Healthcare will see the introduction of the first MCRN. 
To support this, policies, procedures and agreed care 
pathways were developed.
Implementing the Review of the Irish Health Services 
for Individuals with Autism Spectrum Disorders
• A person with a lived experience was selected to sit on 
the Autism Spectrum Disorder (ASD) Programme board. 
The board was established to lead the implementation of 
the Review of the Irish Health Services for Individuals with 
Autism Spectrum Disorders, enabling collaborative team 
work with participation of senior operational and clinical 
decision makers, independent professional and academic 
support and representation of people with lived 
experience of ASD.
• The ASD Service Improvement Programme has 
established two working groups and the following 
areas were progressed:
– The identification of a standardised assessment/
pathway approach for use in all services dealing 
with the assessment of those with autism
– Building awareness of the autistic community 
and the services and supports available.
Providing the appropriate supports to those being 
discharged from acute hospitals, focusing on 
delayed discharges
• Home support services support older people in their choice 
of living within their own home and community. As part of 
winter planning, an additional 410,000 home support hours 
were provided to enhance service delivery during the winter 
months (including 550 home support packages).
• Additional funding of €2m was provided on a once-off 
basis in October to provide a further 1,100 home support 
packages to support 510 people leaving hospital and 600 
home support packages to support the provision of 
community home supports.
• Through the transitional care scheme 11,094 people were 
supported to move from acute hospitals to private nursing 
homes while waiting for their NHSS application to be 
finalised or for a period of convalescence up to four 
weeks to support their return home.
• To support those leaving hospital and to continue their 
care and assessment for longer term needs in the most 
appropriate community setting, work has commenced 
on developing a discharge to assess protocol.
Statutory home support scheme and regulation
• A joint programme of work between the DoH and the 
HSE, for the design and development of a statutory home 
support scheme and regulation was established and work 
is being progressed along four work-streams:
– A reformed model of service delivery
– A sustainable funding model
– A service commissioning model
– Options for regulation of service providers.











Supporting implementation of the Integrated Care 
Programme for Older Persons
• A range of initiatives to progress the roll-out of the 
Integrated Care Programme for Older Persons was 
implemented. New models of integrated care continued 
to be embedded in the 13 existing pioneer sites nationally, 
including the development of redesigned care pathways.
• Through the provision of more targeted care planning 
to people with complex needs, a sample of data from 
a typical pioneer site hub indicates that:
– 97% of people had high levels of complexity at point 
of referral
– 78% are managing at home
– 85% of those seen had a care plan developed 
and reviewed
– 95% were seen for a period of four weeks or less 
and transferred to their primary care team.
Implementation of the National Carers’ Strategy
• The roll-out of the carers’ needs assessment module 
is being progressed.
Implementation of the interRAI Ireland System
• interRAI is a software supported information system 
which provides a comprehensive assessment of an 
individual’s healthcare needs to support personalised care 
planning. Formerly the Single Assessment Tool project, 
which was piloted in Beaumont Hospital, University Hospital 
Galway and Tallaght University Hospital, implementation 
has expanded across hospital and community settings 
nationally so that care is provided in the most appropriate 
setting based on the person’s identified needs.
• The procurement of a new software vendor for the 
assessment system was progressed and a successful 
vendor was awarded.
• interRAI assessments were conducted in over 30 acute 
and community locations across Ireland resulting in care 
needs assessment of over 6,000 older people.
Improving services and supports for people 
with dementia
Implementation of The Irish National Dementia Strategy 
2014 progressed with a focus on developing care pathways 
across all care settings, and implementing flexible and 
personalised approaches to care.
• The Continuum of Care Report for People Living with 
Dementia In Ireland was published in 2019. This report 
reviewed models of long-term care and provides 
recommendations to support the future development 
of both residential and home-based care for people 
with dementia.
• The final evaluation reports from the HSE/Genio-supported 
dementia specific initiatives which focused on personalised 
and flexible approaches to care were published. The 
learning from this programme will inform the review of 
homecare services and the delivery of home supports.
• Following the success of the Understand Together 
campaign at the Bloom Festival in 2018, Memories are 
Made of This was the 1950s themed show garden for 
2019 which focused on reminiscence, highlighting the 
importance and value of what is remembered and not 
what is forgotten. There are now over 40 national partners 
and almost 300 community activation champions working 
to increase awareness on how everyone can play a role in 
making communities inclusive.
• The number of memory technology resource rooms in the 
community increased to 26, supporting people who are 
living at home by providing information and advice for those 
who may have concerns about themselves or a loved one 
with memory impairment or a diagnosis of dementia.
• As part of the Post Diagnostic Support Programme, 
guidance on psycho-education for people with dementia 
at the post-diagnostic stage was published.
• Roll-out of training and education in dementia continued 
with primary care teams, home support services, GPs 
and acute hospitals.
Palliative care focuses on helping people of all ages to live 
well with an illness that is life-limiting and to achieve the best 
quality of life as their illness progresses.
Improving palliative care services for patients 
and families facing life-limiting illnesses
• Three new palliative care inpatient units were completed 
in Waterford, Mayo and Wicklow and are due to open 
in 2020.
• Adult Palliative Care Services – Model of Care for Ireland 
was launched which will provide a framework to support 
every person with a life-limiting or life threatening 
condition to access a level of palliative care appropriate 
to their needs in order to optimise quality of life. As part 
of its roll-out, the development of a new palliative care 
electronic referral form commenced which will streamline 
the referral process for GPs, while improving the quality 
and consistency of referral data received by hospitals.
• Ireland’s second paediatric palliative medicine consultant 
was appointed to Children’s Health Ireland.
• In partnership with primary care services, the Clinical 
Nurse Co-ordinators for Life Limiting Conditions lead 
the development of the new HSE National Patient – 
Held Folder for Children and Young People called 
My Story. The folder shares both clinical and personal 
information relevant to the patient with professionals 
in both the acute and community settings.












Pre-Hospital and  
Acute Hospital  
Services
Acute services play a key role in improving the health of the 
population by providing essential services including pre-
hospital care, emergency care, urgent care, scheduled care, 
trauma care, surgery and critical care.
Improving quality of care and patient safety
• A survey of hospital acquired infections and antimicrobial 
use in Irish hospitals was published which demonstrated 
welcome improvements from the previous survey in 2012. 
Further information can be seen in the Clinical, Quality 
and Patient Safety section of this Annual Report.
• A new regulation came into operation in 2019 to help 
enhance patient safety by protecting the pharmaceutical 
supply chain from infiltration by falsified (or counterfeit) 
medicines. The European Commission’s Delegated 
Regulation (EU) 2016/161 for Safety Features on 
Medicinal Products for Human Use is being implemented 
to ensure an end-to-end verification system is in place in 
acute hospitals.
• A number of national clinical guidelines were developed 
or updated including:
– Clinical guidelines on sepsis management
– Clinical guidelines on the national early warning score 
(NEWS)
– Clinical guidelines on the appropriate prescribing of 
psychotropic medication for non-cognitive symptoms 
in people with dementia.
Improving access to scheduled (planned) and 
unscheduled (unplanned) care
• An additional 31,000 patients were seen in outpatient 
departments in collaboration with the NTPF. An additional 
27,000 patients requiring inpatient or day case procedures 
were treated and an additional 6,400 scopes were 
completed.
• The level of delayed transfers of care remains a concern 
across our hospitals and impacts negatively on acute 
services’ capacity to support unscheduled care demand. 
The focus on improving patient flow has continued and 
work is on-going with community services on an 
integrated approach to the challenge.
• In February, the Model of Care for Otolaryngology Head 
and Neck Surgery: a model of care for Ireland was 
launched. The model of care was developed to define 
best practice in otolaryngology (Ear, Nose and Throat) 
surgery in Irish hospitals.
• Acute hospitals continue to promote greater integration 
between smaller and larger sites to ensure the optimum 
and safest configuration to deliver high quality scheduled 
care services.
• Acute services continue to work with the national clinical 
programmes to progress the delivery of care pathway 
initiatives in three priority scheduled care specialist 
areas in line with Sláintecare.
• A core component of scheduled care redesign is the 
development of practitioner led clinic services which 
can safely deliver low acuity components of the service.
• Work is on-going through the national clinical programmes 
and with community services to develop diagnostic 
services with a particular focus on winter planning.
• An additional 75 beds were opened under the Winter Plan.
• Six high dependency beds and one intensive care unit 
bed were opened in the Mater Misericordiae University 
Hospital, along with the phased opening of seven 
transplant assessment beds.
• The Emergency Medicine Early Warning System (EMEWS) 
went live in Our Lady of Lourdes Hospital, Drogheda and 
the Mater Misericordiae University Hospital in December. 
Further sites are scheduled to commence in early 2020.
Developing and improving national specialist services
• Implementation of recommendations in relation to the 
Department of Health Policy Review: Sexual Assault 
Treatment Units continued.
• Acute services and the NTPF worked with designated 
sites to improve access to bariatric surgery and weight 
management services.
• All-Island Cardiology
– An additional paediatric intensive care unit (PICU) bed 
opened in Children’s Health Ireland (CHI) at Crumlin 
in October with the full complement of 25 additional 
PICU beds scheduled to be on stream by early 2020.
Improving integration between community and 
acute services to promote a modernised and 
streamlined service model in line with Sláintecare
• Work continued on the development of integrated service 
provision through outreach services, telemedicine, virtual 
clinics and cross-sector working.
• Work commenced on the development of scheduled 
care community based initiatives.
Improving patient and staff health and wellbeing
• Work continued in the acute hospitals on the on-going 
implementation of Healthy Ireland plans.
• Implementation of the MECC Framework continued 
as a key enabler in promoting life style behavioural 
change among service users.
• Engagement with SMS co-ordinators continued to 
support chronic disease prevention and SMS strategies.
• Staff were supported and encouraged to engage with 
initiatives and campaigns, including resilience training, 
to improve their own health and wellbeing in the hospital 
workplace.
• National communication campaigns were rolled out 
in hospitals, reinforcing positive health messages for 
both service users and staff.
• Tobacco Free Campuses were promoted in all acute 
hospital settings.















Improving performance management 
of operational services
• Work continued to embed the Consultant Contract 
Compliance Framework in 2019, and improvements 
were made in relation to the consistency of applications 
of the framework.
Supporting the development of eHealth capability
• Further progress was made on the development and 
implementation of key eHealth programmes including the 
delivery of an Integrated Patient Management System for 
CHI and the preparation of acute hospital IT systems for 
the population of the Individual Health Identifier (IHI).
Trauma Strategy
Injury is a public health problem of enormous magnitude, whether measured by years of productive life 
lost, prolonged or permanent disability, or financial cost. Injuries place a significant burden on individuals, 
their families and the health service. Improvements in outcomes for patients can be achieved by providing 
patient-focused and planned trauma care.
A Trauma System for Ireland – Report of the Trauma Steering Group recommended the introduction of an 
inclusive trauma system for Ireland with one Major Trauma Centre to be based in Dublin servicing the Central 
Trauma Network, and another to be based in Cork University Hospital servicing the South Trauma Network. 
The trauma system will link the Major Trauma Centres, Trauma Units, local emergency hospitals and injury 
units into networks of trauma care that will also include pre-hospital care and rehabilitation.
A key action from the Trauma Strategy is to designate the Major Trauma Centre for the Central Trauma 
Network and this was progressed by developing a designation framework of service specifications, options 
and assessment criteria. The framework was the subject of a public consultation. The revised framework 
was used by an Independent Assessment Panel to review submissions from six Dublin hospitals identified 
as options for the Major Trauma Centre and Dublin Trauma Units. The panel will provide advice to the HSE 
in early 2020 on the hospitals to be designated as the Major Trauma Centre for the Central Trauma Network 
and Dublin Trauma Units and the HSE will make a recommendation to the Minister.
The appointment of a National Clinical Lead for Trauma Services in June, one of the immediate actions 
prioritised in the report, will provide an essential foundation for the implementation and oversight of the new 
trauma system.
• On-going eHealth projects were supported, such as 
the National Medical Laboratory Information System, 
the Acute Floor Information System, the National 
Integrated Medical Imaging System, and the Maternal 
and Newborn Clinical Management System.
Supporting the progress of policies and initiatives 
led by the Office of the Chief Nursing Officer
• The roll-out and implementation of the Framework for 
Safe Nurse Staffing and Skill Mix in General and Specialist 
Medical and Surgical Care Settings in Adult Hospitals in 
Ireland 2018 continued and work commenced on phase 
two of the framework (in emergency care settings).
The key focus in progressing cancer services in 2019 
was the continued implementation of the National Cancer 
Strategy 2017-2026. The strategy sets out four key priorities: 
reduce the cancer burden; provide optimal care; maximise 
patient involvement and quality of life; and enable and assure 
change.
Reducing the cancer burden
• The Irish Cancer Prevention Network was established by the 
National Cancer Control Programme (NCCP), Marie Keating 
Foundation, Irish Cancer Society and Breakthrough Cancer 
Research. The network encourages collaborative working 
with the aim of reducing cancer risk for the population.
• The NCCP contributed to the development of the Skin 
Cancer Prevention Plan 2019-2022, published in March 
2019. The plan is aimed at tackling the most common 
type of cancer in Ireland. Over 11,000 cases of skin 
cancer are diagnosed each year and the number of 
cases is projected to more than double by 2045. 
The Plan focuses on the fact that most skin cancers 
could be prevented and has identified the priority groups 
as children, outdoor workers, those who participate 
in outdoor leisure activities and sunbed users.
• Establishment of an early detection Board progressed 
with three meetings held.















• An analysis of retrospective data for colorectal cancer 
patients diagnosed in ED was carried out to inform 
the development of a pilot project.
• Nutrition guidelines for cancer patients are in 
development.
Providing optimal care
• The newly constructed Radiation Oncology Unit in Cork 
University Hospital (CUH) was opened. CUH provides 
cancer care to approximately 2,000 patients every year 
and is the centre of excellence for cancer treatment for 
the south west region. It is the first public hospital in the 
country to use Surface Guided Radiation Treatment 
which improves speed and accuracy and reduces the 
need for immobilisation of patients during their treatment, 
improving the patient experience.
• A Clinical Lead has been appointed for the development 
of a children, adolescent and young adult (CAYA) service 
for Ireland. CAYA working groups have also been 
established, which will progress the areas of survivorship, 
palliative care, fertility, educational needs and shared care 
facilities.
• A model of care for a national cancer genetics programme 
is in development with good progress made on the 
development of family history services for patients with 
breast cancer. A national genomics lead has also been 
appointed.
• Work is on-going to develop rapid access clinics for 
all cancers. A haematuria clinic has been established 
for those with signs and symptoms of renal and bladder 
cancer.
• The surgical oncology centralisation project is underway 
with an implementation plan approved by the Minister 
for Health.
Implementation Report on National Cancer Strategy 2017-2026
The first implementation report on the National Cancer Strategy 2017-2026 was published, setting out the 
progress achieved on the 52 recommendations of the strategy.
The report found that significant progress has been made since the launch of the strategy, with key highlights 
including:
• Integration of cancer prevention into the messaging under Healthy Ireland
• Uptake rates for cancer screening
• Publication of a model of care for oral anti-cancer medications
• Progress being made by Working Groups on survivorship and psycho-oncology
• Ensuring appropriate staff are in place remains a challenge for the specialist cancer workforce. However, 
key appointments continue to be made to ensure better, safer services for our patients
• The pilot phase for the New Cancer Framework for Quality and Safety concluded during the year, with next 
steps including its national roll-out for lung cancer.
Additional information on other key highlights can be found further in this section.
• National guidelines for oesophageal and for 
ovarian cancers were launched and protocols for 
multi-disciplinary teams have been established for 
skin, colorectal, lung and breast cancers.
• 2019 marked a significant point for the National 
Cancer Information System (NCIS) project with the 
first ‘go live’ occurring in St Luke’s Hospital, Rathgar. 
University Hospital Galway became the second site to 
go live with the system in November 2019. NCIS allows 
for the recording of information about a patient’s cancer 
case, diagnosis and treatment with cancer drugs, and 
supports the care of oncology and haemato-oncology 
patients across Ireland.
Maximising patient involvement and quality of life
• The National Cancer Survivorship Needs Assessment 
was launched. It provides data on the current situation 
for cancer survivors and services in Ireland and details 
actions to develop cancer survivorship care in the lifetime 
of the National Cancer Strategy 2017-2026.
• A Clinical Lead for Psycho-Oncology has been appointed, 
tasked with creating psychological support services 
nationally for cancer patients and their families.
• The first meeting of the Cancer Patient Advisory 
Committee was held. Further information on the 
committee can be seen on page [28] this Annual Report.
• A new Immunotherapy Patient Education Programme has 
been created by the cancer nurse specialist team at the 
Mater Misericordiae University Hospital. The programme 
educates patients on how immunotherapy works and 
supports them on their treatment journey, improving 
the overall treatment process.














We are committed to the development of health services 
for women and children through the National Women and 
Infants’ Health Programme (NWIHP) and the National Model 
of Care for Paediatric Healthcare Services. The focus of both 
is on strengthening services by bringing them together in an 
integrated way.
National Women and Infants’ 
Health Programme
Ireland’s first National Maternity Strategy 2016-2026 – 
Creating a Better Future Together was launched in 2016. 
The strategy sets out a blueprint to significantly improve 
the service provided to mothers and their babies, and 
its implementation is a key focus for the health service. 
During the year, work progressed to address the priorities 
of the strategy and examples of this can be seen below.
• A particular focus was assigned to the supported care 
pathway. This pathway, identified as the least developed 
across maternity services, is intended for pregnancies 
deemed to be normal-risk where care is primarily 
delivered by midwives working within a multi-disciplinary 
framework. A baseline review of maternity services was 
conducted and completed. This review found that 10% 
to 35% of women were now being managed within the 
supported care pathway during the antenatal period, 
across 16 maternity hospitals/units. The review also 
identified that women in the supported care pathway 
engage in a shared model of care with their GP. 15 of the 
16 services had a community based presence of which 
10 provided booking in clinics in the community.
• Each maternity network is at a different level of development. 
During 2019 advances were made across each but further 
work on their development is required. Currently, maternity 
networks also provide other services including termination of 
pregnancy, general gynaecology (including creating capacity 
for colposcopy clinics), and fertility services. Work is also 
underway to transition the home birth service into the 
maternity networks, further emphasising the important 
role the maternity networks play across primary and 
secondary care, as well as health and wellbeing.
• Fourteen maternity units/hospitals now provide women 
with a 20-week foetal anomaly scan, and a fifteenth site 
provides the scan but at a later stage in pregnancy. The 
remaining four units are working towards full provision 
as posts are filled and capacity grows on the ground.
• A national plan for ambulatory gynaecology was 
developed. The aim of the plan is to increase the capacity 
in the area of general gynaecology, with the objective of 
reducing waiting times for women, which is inclusive of 
patients with endometriosis. The plan aims to re-orient 
general gynaecology services to an ambulatory (see and 
treat) care model rather than the traditional care model 
of outpatient referral to day case/inpatient procedure.
• A Clinical Lead for Termination of Pregnancy services 
was appointed at the end of 2019. Further information 
can be seen on page [49] of this Annual Report.
• The Specialist Perinatal Mental Health Service has developed 
an app for healthcare staff to provide information on perinatal 
mental health and related services. The aim of the app is to 
provide information to support standardised quality evidence-
based practice, across the health service, for women with 
mental health problems in the perinatal period.
• A plan was published on implementing the recommendations 
from The Use of Uro-Gynaecological Mesh in Surgical 
Procedures report from the Chief Medical Officer, DoH. 
As part of the implementation plan, a dedicated website 
has been developed to provide information and frequently 
asked questions regarding signs and symptoms of 
complications with uro-gynaecological implants.
Paediatric Model of Care
Continuing to oversee the new children’s hospital 
development and development of paediatric services
• In January 2019, the three children’s hospitals in Dublin 
and the Children’s Hospital Group transitioned from four 
separate, independently governed entities into one new 
single organisation, CHI.
• The new Paediatric Outpatient and Urgent Care Centre 
at Connolly Hospital opened in July, providing a range 
of services. The Urgent Care Centre treats minor injuries 
or illnesses that require prompt treatment, but are not 
life threatening. The Paediatric Outpatient Department is 
expected to see up to 17,000 children a year, once fully 
operational and should contribute to significant reductions 
in waiting lists. In its first five months of opening the 
general paediatric waiting list fell by 38%. The Centre 
also contains a HSE Dental Unit and Child Sexual Abuse 
Assessment and Treatment Unit.
• The HSE continued to work with the DoH, CHI and 
the National Paediatric Hospital Development Board 
to progress the opening of the second Urgent Care 
Centre at Tallaght and the new Children’s Hospital.
• Further development of the regional paediatric units in 
CUH, University Hospital Galway (UHG) and University 
Hospital Limerick (UHL) through the recruitment of 
additional paediatric consultants will aid the implementation 
of one of the key concepts of the National Model of Care 
for Paediatric Healthcare Services which is to provide care 
as close to the patient’s home as is clinically appropriate.
• A €1.2m capital investment project saw the Cardiac Risk 
in the Young (CRY) Unit at CHI move to a larger purpose 
built outpatient facility in September. The treatment of CRY 
involves the comprehensive evaluation and treatment 
of those diagnosed with, or at risk from, inherited heart 
conditions that are a leading cause of sudden cardiac 
death in the young.
• Additional staff were recruited to support additional 
services in CHI including:
– Rheumatology services
– Haematology stem cell service
– Outpatient antibiotic therapy
– Neurosurgery services.
• Scoliosis services continued to be developed to reduce 
access waiting times for surgery.














Women and Children’s Services
The National Ambulance Service (NAS) is the statutory 
pre-hospital emergency and intermediate care provider 
for the State. In the Dublin metropolitan area, ambulance 
services which are funded by the HSE are provided by 
the NAS and Dublin Fire Brigade. The NAS responds to 
emergency and urgent calls, transports intermediate care 
patients and undertakes adult, paediatric and neonatal 
retrievals.
Supporting the Sláintecare Implementation Strategy
• Work has continued to support and expand community 
first responder schemes with over 260 community first 
responder groups and over 4,000 community volunteers 
now in place throughout the country.
• The NAS Critical Care Retrieval Service held its inaugural 
symposium in June. The theme of the symposium was 
Connectivity in Critical Illness and there was excellent 
representation from all areas of the health service, the 
DoH and from the Northern Ireland Retrieval Service.
• The NAS in partnership with mental health services 
initiated a new YourMentalHealth information phone 
line in October to provide information on mental health 
supports and services across the country. Operating 
24/7, the Freephone number is 1800 742 444 informing 
service users on the local supports and services available 
and how to access them. In preparation for the phone line 
going live, the NAS call takers received additional training 
from mental health professionals to assist them in 
signposting the most appropriate service.
Implementation of A Trauma System for Ireland – 
Report of the Trauma Steering Group
• A service level agreement was reached between the 
HSE and Irish Community Rapid Response to provide 
an aeromedical service from Rathcoole Aerodrome near 
Millstreet in Co. Cork. The service went live in July 2019.
• Trauma and orthopaedic bypass protocols were 
implemented from Portiuncula to Galway and from 
Naas to Tallaght.
Delivery of improved governance and patient safety
• Work on the implementation of the NAS Fleet and 
Equipment Plan continued. This included the procurement 
of new special purpose, specially adapted vehicles 
which allow the NAS to be winter ready. These vehicles 
are four-wheel drive and will assist in the delivery of 
pre-hospital care during adverse weather conditions.
• A NAS Business and Data Analysis team has been 
established to strengthen clinical governance. The team 
will support the analysis of clinical information assisting 
in understanding patient demographics, treatments 
provided, etc. in a more timely manner.
• The Emergency Motorcycle Response Unit was launched 
in Cork City. This unit provides a rapid response to serious 
and life threatening 112/999 calls and is able to manoeuvre 
more quickly through heavy traffic or difficult to access 
areas to stabilise the patient before ambulance arrival.

































Office of Chief Information Officer
• The Office of the Chief Information Officer delivers ICT 
services and support throughout the HSE, facilitating 
integration within and across community services, hospitals 
and other specialised care providers. In 2019, the ICT 
capital allocation was €85m. Some key projects were 
progressed which advanced implementation of Sláintecare.
• The Individual Health Identifier (IHI) enables the 
identification of patients and clients availing of health 
services and their health records and is critical for eHealth 
and Electronic Health Records (EHRs). The IHI is 
operated by the Health Identifier Service, which was 
formally established this year as part of Sláintecare.
– The technical infrastructure supporting the IHI Register, 
originally populated in 2017 with 6.7m records, has been 
operational since 2017 and is providing IHI numbers for 
8,000 electronic transactions per day. A programme of 
work was completed in 2019 to enhance and improve 
the IHI’s record matching capability. To date IHI numbers 
have been created for 8m individuals in Ireland.
– The provision of IHIs for the National Newborn and 
Maternity System is on track for delivery in Q2 of 
2020. This is in addition to the on-going programme 
of work to roll-out the IHI to GP, hospital and national 
systems and other projects highlighted in this report.
• The National Cancer Information System went live. It allows 
for the recording of information about a patient’s cancer 
case, diagnosis and treatment with cancer drugs across 
Ireland. Implementation began on a phased basis across 
the 26 Systemic Anti-Cancer Therapy (Chemotherapy) 
sites enabling a digital support for prescribing and 
administering chemotherapy.
• Primary care dental staff now have access to fully 
digitised dental treatment records for all of their patients 
following the completion of a nationwide roll-out of the 
HSE National Dental Record and Information System. 
The system is now live in 221 locations in 26 counties.
• Work is progressing on procurement of the national EHR 
system and the shared care record. As a first step the 
acute EHR business case was developed and work is 
progressing on the approval process with the relevant 
government departments. A new and innovative advanced 
eHealth system for haemophilia and inherited bleeding 
disorders was initiated. Developed in collaboration with the 
National Coagulation Centre in St. James’s Hospital, CHI 
at Crumlin, CUH, UHG and the Irish Haemophilia Society, 
it was financed by the HSE as one of three innovative 
Lighthouse projects which aim to optimise the use of 
eHealth technologies in the Irish healthcare system.
• A foundational programme to guide staff through utilising 
the digital tools they already have access to and to build 
on their digital literacy skills was launched in conjunction 
with Health Business Services (HBS) and in collaboration 
with the Department of Communications, Climate Action 
and Environment. Its aims are to inspire and encourage 
staff to become confident on-line by working on existing 
digital platforms and services along with fostering valuable 
partnerships in supporting digital transformation.
• 4,500 devices (laptops, desktops) and 3,900 smartphones 
have been delivered to front line community-based staff, 
including public health nurses, physiotherapists, speech 
and language therapists, dental staff, dieticians etc. This 
was a national project and included all nine CHOs.
• Communications technology upgrades were undertaken 
to support existing and new community sites including 
18 fixed telephony upgrades, 20 new builds and over 
50 network connections.
• The Maternal and Newborn Clinical Management System 
Project is the design and implementation of an EHR for all 
women and babies in maternity and neonatology services 
in Ireland. This record allows patient information to be 
shared with relevant providers of care, in a standardised 
format, as and when required through the use of a 
technology enabled solution.
• The inaugural Digital Academy Forum was held in 
September 2019. These Forums will be held quarterly 
and are a place for sharing and shaping thought and 
practice on digital health issues, digital transformation 
and innovations across the health service by medical 
staff, academics, industry leaders, patients and citizens.
National Human Resources
Developing a new People Strategy
• The development process for the new People Strategy 
was completed following a comprehensive consultation 
process.
• Work continued to implement People’s Needs Defining 
Change – Health Services Change Guide through a 
focus on communication and awareness, education 
and practice development, synergy at national level 
and change practice improvement within the delivery 
system. The Health Services Change Guide is the policy 
framework and agreed approach to change for the health 
service and is a key foundation for delivering the people 
and culture change required to implement Sláintecare, 
public sector reform and corporate priorities.
• A review of the existing Recruitment Model was carried 
out. Initial work has commenced on this model and is 
expected to be completed in 2020.
• The Health Service Leadership Academy delivered one 
cohort of each of the flagship leadership development 
programmes, Leading Care I, Leading Care II and Leading 
Care III. The Health Service Leadership Academy HSE 
won the national award for the best Learning and 
Development Strategy at the HR Leadership and 
Management Awards.
• An Action Plan was developed in response to the 
results of the 2018 staff survey findings. This document 
defines staff engagement, highlights the benefits for 
staff and patients of having an engaged workforce, 
and emphasises that staff engagement is a core 
component in developing policies and strategies.











• More than 1m eLearning programmes have been 
completed to date on the HSE’s on-line learning and 
development portal, HSELanD. This milestone was 
reached following the roll-out of further mandatory national 
and local training programmes including: An Introduction 
to Children First, Hand Hygiene for Clinical Staff, Dignity 
at Work and a range of health and safety modules.
• The implementation of a single National Integrated Staff 
Records and Payroll (NiSRP) system is currently being 
rolled out nationally. The programme went live in the East 
and plans are at an advanced stage for implementation 
in the South East in May 2020.
• A National Steering Group, co-chaired by Quality 
Improvement and National HR, is in place to oversee the 
implementation of the Linking Service and Safety Strategy 
which addresses work related violence and aggression. 
A status update on this strategy is currently underway.
• The Healthy Workplace Framework will focus on the 
physical, psychosocial and personal health of staff in 
the workplace. Work commenced during the year on the 
development of a resource pack to provide information 
for managers and their staff on developing a healthy 
workplace including the supports/resources available 
to support implementation. The Healthy Workplace 
Framework is expected to be launched in 2020.
• Critical incident stress management training is on-going 
nationally with three training sessions, covering 32 newly 
trained staff, and 12 in-service supervision training days 
undertaken.
National Finance
• Significant support was provided to the operational 
system to improve financial management arrangements 
during 2019, including bringing forward the financial 
planning cycle (estimates/service planning and budgeting) 
for 2020 by a minimum of 4-6 weeks.
• The implementation of an Integrated Financial Management 
System (IFMS) for the public funded health and social care 
system (including all section 38 funded organisations and 
larger section 39 funded organisations) is proceeding as 
part of the Finance Reform Programme. This programme 
is one of the HSE’s most important non-clinical priorities 
and is a key enabler for Sláintecare and the wider health 
service improvements it underpins. During the year, work 
continued on the process designs, chart of accounts 
and enterprise structure for the IFMS with procurement 
completed for an external systems implementation 
support partner. The preparations phase for the detailed 
national design and build stage commenced in December.
• The community costing framework project was completed 
and its outputs have fed into, amongst other things, the 
draft Activity Based Funding Implementation Plan 2020 
to 2022 (incorporating community costing) which the HSE 
is seeking, with DoH support, to take forward via the 
Healthcare Pricing Office, in line with Sláintecare. It has 
also informed the reporting strategy that is included with 
the HSE Financial Management Framework that underpins 
the development and implementation of IFMS.
Health Business Services
• The National Integrated Staff Records and Payroll 
Programme (NiSRP) successfully implemented a SAP 
HR and payroll solution with self-service in the Eastern 
region. This was carried out in collaboration with the 
Office of the Chief Information Officer. The system 
went live in May 2019 and serves 18,000 staff.
• The roll-out of the HSE Payroll Stabilisation Project 
was completed in the West and South, migrating 
HSE employees and pensioners onto a new payroll 
software solution.
• The National Logistics Service was further expanded 
and now services approximately 80% of the statutory 
health environment.
• The Pension Improvement Programme is a multi-year 
project relating to pension services, with phase 1 of 
the programme focused on compliance with the Single 
Public Service Pension Scheme. HSE employees under 
the scheme (35,000) are now receiving yearly pension 
statements, with the first statement reflecting the period 
from 2013-2018.
• HBS collaborated with the University of Limerick to 
develop and deliver an accredited bespoke Public 
Procurement Supply Chain Excellence Certificate and 
Diploma programme.
• A Lean Strategy to deliver savings and efficiencies 
successfully implemented projects across a range 
of services, and will continue to embed a sustainable 
model of operational excellence to deliver job 
development and efficiency within the health system.
Capital Investment in Healthcare
The health service requires healthcare facilities that enhance 
wellness in patients and service users, empower staff and 
allow services to be delivered efficiently and effectively, 
aligned with the Government’s National Development Plan 
2018-2027. To ensure this, the five-year HSE Capital Plan is 
refreshed every year, taking into account works commenced, 
changing need, emerging strategies and budget available.
• HBS Estates launched a revised toolkit for delivery of 
capital projects. The toolkit describes in detail the 
established approvals protocol for the appraisal, initiation, 
management and administration of all capital projects. The 
implementation of the protocol should ensure consistency, 
quality and value for money across the healthcare estate 
and is available for all staff through HBS intranet.
• Work progressed on a number of key capital projects to 
create and sustain a physical environment that enhances 
wellness in patients and service users. These projects 
included:
– National Rehabilitation Hospital
– National Forensic Mental Health Service
– Primary care centres
– National Maternity Hospital
– Social care residential programme housing.











• In partnership with the Sláintecare Programme 
Implementation Office, work was undertaken on the HSE 
Digital Roadmap to transform the on-line user experience. 
Over 30 stand-alone websites, micro-sites and content 
collections have been integrated with the new hse.ie.
• The HSE digital team redesigned and migrated the content 
from 15 standalone HSE websites into the new public 





• breastfeeding.ie was also integrated with over 200 new 
health guides on topics related to child health and 
pregnancy in collaboration with the Nurture Programme 
and clinicians across the health service.
• Work commenced on an on-line directory of services 
which will enable patients and service users to find 
the information they need about services in their area.
• The social media team (part of the digital team) provided 
strategic support, advice and training to a number 
of social media accounts across all the major social 
networks. Social media was used to inform, educate 
and help people with healthcare queries. The most 
recent addition to the suite of social media channels 
was the creation of an Instagram account for the HSE.
• HSELive received 182,000 contacts during the year, by 
email, phone and web chat. They provided information, 
support and signposting to enable people to navigate 
the health service and access the care that they need.
• The HSE Press Office provided 2,100 written responses 
to journalists’ queries during 2019.
• Responding to feedback from the staff survey Your Opinion 
Counts 2018, an internal communications team was 
established to drive initiatives which would improve staff 
awareness of organisational objectives. These included 
the development of healthservice.ie/staff, a dedicated 
public staff website and monthly video updates from 
the CEO and senior leaders. Since the launch of these 
initiatives, there has been improved engagement through 
our website, reducing the need for HSE broadcast emails.
• A range of behaviour change and service information 
campaigns were planned and supported in 2019; 
highlights included the new My Options unplanned 
pregnancy service, the Dementia Understand Together 
Bloom Garden, and the launch of the HSE’s mychild.ie 
support service and book for parents and parents-to-be.
Primary Care Reimbursement 
Service (PCRS)
• The Primary Care Eligibility and Reimbursement Service 
Strategic Plan 2019-2021 was published in 2019 with six 
strategic goals and 26 high-level actions identified in line 
with the Sláintecare vision. Ensuring a high quality and 
responsive public service requires continually innovating 
and adapting the way we do business with our customers 
and stakeholders. This plan will drive these choices while 
enabling prioritisation of efforts.
• Reimbursement services were provided to over 7,000 
contractors for the provision of health services to 
members of the public in their own community.
• Hospitals were centrally reimbursed under the National 
Drugs Management Scheme for a range of specified 
high cost medicines in the areas of oncology, neurology 
and hepatitis C.
• Since 1 June 2019, all Long-Term Illness applications 
were processed by the PCRS. An express on-line 
registration process was also made available to 
pharmacies for patients diagnosed with specific 
long-term illness, for example diabetes and epilepsy.
• Visitors to the hsepcrs.ie website now have access 
to a variety of reports on medical claims and payments 
which are updated on a monthly basis, along with 
up-to-date data on the wide range of primary care 
services supported by PCRS.
• The National Medical Card Unit, which assesses eligibility 
across a range of community healthcare schemes, was 
awarded ISO 9001 certification. The certification indicates 
demonstration by the unit of a commitment to quality and 
efficiency, with client satisfaction a core part of the business.
• The prices of patent-expired, non-exclusive, non-biologic 
medicines where first generic and biosimilar products 
become available continued to be reduced under the 
Framework Agreement on the Supply and Pricing of 
Medicines 2016-2020.
• Work commenced on clarifying roles and responsibilities for 
the centralisation of services regarding health entitlement 
under EU Regulations for citizens coming to Ireland from 
another European Union/European Economic Area (EU/
EEA) State and for citizens going from Ireland to other 
EU/EEA States.
• Significant software development work took place to 
support the phased implementation of the European 
Commission’s Electronic Exchange of Social Security 
Information (EESSI).
• The withdrawal agreement which facilitated the UK’s exit 
from the EU has negated the immediate need for special 
arrangements for persons living in Northern Ireland. The 
final position will not be clear until the future relationship 
agreement has been agreed between the UK and the EU. 
Preparatory work undertaken will provide a basis for any 
arrangement should the need arise.
EU and North South Unit
• During 2019, engagement took place with:
– Key stakeholders on the future of EU structural 
funds available for health and social care services 
along the border.
– EU-funded Interreg projects as Lead partner in 
the areas of acute services, mental health services, 
population health and children’s services. These 
projects are designed to support cross border 
co-operation in order to overcome issues that 
arise from the existence of a border.
– Scottish Lead Partners in the areas of primary 
care and older people, and polypharmacy.










– Cross border and all-island projects such as the 
North West Cancer Centre, Primary Percutaneous 
Coronary Intervention and the Human Milk Bank.
– Key workstreams as Brexit project co-ordinator, 
including engagement with agencies along the 
border to map services of a cross border nature 
as part of on-going Brexit preparation. Additional 
work was also undertaken on GDPR as part of 
Brexit preparations. Further information on Brexit 
can be seen on page [25] of this Annual Report.
• In addition to North/South linkages, arrangements are 
also being taken forward by the HSE and DoH to develop 
linkages between Ireland and Scotland. In September 
2019, the Minister for Health welcomed the Scottish 
Cabinet Secretary for Health and Sport and her officials 
to the DoH for a collaborative symposium which focused 
on priority areas to improve health in both countries. 
These areas were Public Health and Health Improvement; 
Patient Safety; Data and Digital; Patient Access and Flow; 
and Service and System Integration. Opportunities for 
collaboration with Scotland will continue to be progressed 
on these and other issues.
Emergency Management
• Emergency Management continued to work with services to 
advance preparedness for a Mass Casualty Incident (MCI). 
A Clinical Lead was appointed in order to work with the 
Emergency Management Services to continue to develop 
and promote MCI contingency planning across all sectors.
• Work continued during the year at both national and 
regional level with health services and on an inter-agency 
basis to ensure that appropriate emergency plans were 
developed, updated and tested as required.
• Severe weather planning guidance for HSE services 
was updated in October.
• Focus on the development and preparedness with regard 
to the Ebola virus disease continued throughout the year. 
Emergency Management chaired the High Consequences 
Infectious Diseases Group, the Repatriation Group and 
the Waste Management Group.
• Public consultation was facilitated in relation to Upper 
Tier Seveso sites, as required under the Chemicals Act 
(Control of Major Accident Hazards Involving Dangerous 
Substances) Regulations 2015.
• The development of a Business Continuity Management 
Policy and Framework was advanced. The working group 
was chaired by Emergency Management and was 
represented by most HSE service areas.
• Work continued with partners in the principle response 
agencies and cross government to develop new 
paradigms in the response to chemical, biological, 
radiological and nuclear threats. A working group has 
been established under the National Steering Group that 
will make recommendations to the Government Task 
Force on Emergency Planning for large crowd events.
Internal Audit
• The Internal Audit Division Statement of Strategy 2019-
2021 was developed, setting out a roadmap for the 
development of Internal Audit over the coming years.
• The Internal Audit Charter was reviewed and updated.
• Recommendations arising from the External Quality 
Assessment were implemented.
• 184 audit reports were issued including 35 reports 
in respect of HSE funded agencies and 20 reports 
in respect of TUSLA.
• Special investigations were undertaken in the areas 
of Income and Cash Handling, Recruitment and 
Appointment Processes, Maintenance, Time and 
Attendance, along with Travel and Subsistence.
• The implementation of audit recommendations, contained 
in internal audit reports issued in 2019 and prior years, 
was monitored and reported on.
• Advice and guidance on controls and processes, 
including ICT security and assurance, was provided 
to senior management.












• Executive Management Team (details of this membership can be found on page [18] of this Annual Report)
• Mr Liam Woods (National Director, Acute Operations)
• Mr David Walsh (National Director, Community Operations)
• Mr John Hennessy (National Director, Acute Strategy and Planning)
• Mr Pat Healy (National Director, Community Strategy and Planning)
• Dr Stephanie O’Keeffe (National Director, Strategic Planning and Transformation)
• Mr John Swords (National Director, Health Business Services)
• Ms Fiona Bonas (National Director, National Cancer Control Programme)
• Mr Patrick Lynch (National Director, Quality Assurance and Verification)
• Dr Philip Crowley (National Director, Quality Improvement)
• Mr Damien McCallion (National Director, Screening Services and CAWT)
• Mr Joe Ryan (National Director, National Services incl. VIP, GDPR)
• Mr Shaun Flanagan (Head of PCRS)
• Mr Martin Dunne (Head of National Ambulance Service)
Community Healthcare Organisations Chief Officers
• Mr John Hayes (Donegal, Sligo Leitrim, Cavan Monaghan)
• Mr Martin Greaney (Community Healthcare West)
• Ms Maria Bridgeman (Mid West Community Healthcare)
• Mr Ger Reaney (Cork Kerry Community Healthcare)
• Ms Kate Killeen White (South East Community Healthcare) 
• Ms Martina Queally (Community Healthcare East)
• Ms Ann O’Shea (Dublin South, Kildare and West Wicklow Community Healthcare)
• Mr Pat Bennett (Midlands Louth Community Healthcare)
• Ms Mellany McLoone (Dublin North City and County Community Healthcare)
Children’s Hospital Ireland and Hospital Groups Chief Executive Officers
• Ms Eilish Hardiman (Children’s Health Ireland)
• Mr Ian Carter (RCSI Hospital Group)
• Mr Trevor O’Callaghan (Dublin Midlands Hospital Group)
• Professor Colette Cowan (UL Hospitals Group)
• Mr Gerry O’Dwyer (South/South West Hospital Group)
• Mr Tony Canavan (Saolta University Health Care Group)
• Professor Mary Day (Ireland East Hospital Group)







Appendix 1: Membership of the Senior Leadership Team 























































































































































































































































































































































































































































































































































































































































































































































































• Information included in this Annual Report is based on the latest data available at time of finalisation. However, recognising the impact 
of COVID-19 on its completion, where anomalies may subsequently arise on information or data, these will be rectified in subsequent 
HSE reports.
• Reported data position for 2018 and 2019 is based on the latest data available at time of development of this report and may not 
reflect end-of-year position (due to data being reported in arrears).































Gross expenditure variance from plan (pay + non-pay) ≤0.1% –
Non-pay expenditure variance from plan ≤0.1% –
Capital
Capital expenditure versus expenditure profile 100.0% 100% 100.0% 0.0%
Governance and Compliance
Procurement – expenditure (non-pay) under management 53.0% 25% increase 85.0% 18.8%
Audit
% of internal audit recommendations implemented, 
against total no. of recommendations, within six months 
of report being received
71.0% 75% 73.0% -2.7%
% of internal audit recommendations implemented, 
against total no. of recommendations, within 12 months 
of report being received
86.0% 95% 89.0% -6.3%
Service Arrangements/Annual Compliance Statement
% of number of service arrangements signed 92.6% 100% 86.0% -14.0%
% of the monetary value of service arrangements signed 95.0% 100% 88.3% -11.7%
% annual compliance statements signed 99.0% 100% 100.0% 0.0%
Workforce
Attendance Management
% absence rates by staff category 4.6% ≤3.5% 4.7% 34.2%
Pay and Staffing Strategy/Funded Workforce Plan













<24-hour shift (acute – NCHDs) 96.9% 95% 97.1% 2.2%
<24-hour shift (mental health – NCHDs) 97.9% 95% 98.3% 3.5%
<24-hour shift (disability services – social care workers) 81.0%** 95% 80.0% -15.8%
<48-hour working week (acute – NCHDs) 82.5% 95% 83.6% -12.0%
<48-hour working week (mental health – NCHDs) 90.9% 95% 93.3% -1.8%
<48-hour working week (disability services – 
social care workers)
88.0%** 90% 88.0% -2.2%







Appendix 3: Performance against National Service Plan 






















% of staff who complete the HSELanD Respect and 
Dignity at Work module




% of staff who have engaged with and completed a 
performance achievement meeting with his/her line 
manager
New PI NSP 
2019





% of complaints investigated within 30 working days of 
being acknowledged by the complaints officer
56.0% 75% 65.0% -13.3%
Serious Incidents
% of serious incidents being notified within 24 hours of 
occurrence to the senior accountable officer
29.0% 80% 37.0% -53.8%
% of serious incidents requiring review completed within 
125 calendar days of occurrence of the incident
2.0% 80% 24.0%**** -70.0%
Incident Reporting
% of reported incidents entered onto NIMS within 30 
days of occurrence by CHO/Hospital Group/NAS
52.0% 90% 53.0% -41.1%
Extreme and major incidents as a % of all incidents 
reported as occurring
0.62% <1% 0.6% -40.0%
% of claims received by State Claims Agency that were 
not reported previously as an incident
66.2% <30% 65.4% >100.0%
* Target NSP 2019 reflects an affordable limit (excluding nationally and DoH held service developments)
** Outturn 2018 revised following a data validation exercise
*** Due to impact of COVID-19, this data is not available at this time































% of smokers on cessation programmes who were quit 
at four weeks
48.2% 45% 48.3% 7.2%
Immunisations and Vaccines
% of children aged 24 months who have received three 
doses of the 6 in 1 vaccine
94.3% 95% 93.4% -1.7%
% of children aged 24 months who have received the 
measles, mumps, rubella (MMR) vaccine
92.2% 95% 91.0% -4.3%
% of first year girls who have received two doses of 
HPV vaccine
59.4% 85% 70.1% -17.6%
% of healthcare workers who have received seasonal 
Flu vaccine in the 2018-2019 influenza season (acute 
hospitals)
44.8% 60% 53.2% -11.3%
% of healthcare workers who have received seasonal 
Flu vaccine in the 2018-2019 influenza season 
(long-term care facilities in the community)
33.1% 60% 42.2% -29.7%
% uptake in Flu vaccine for those aged 65 and older 
with a medical card or GP visit card
57.6% 75% 68.5% -8.6%



































% BreastCheck screening uptake rate 72.8% 70% 72.5% 3.6%
% of women offered hospital admission for treatment 
within three weeks of diagnosis of breast cancer
88.8% 95% 91.7% -3.5%
CervicalCheck
% of eligible women with at least one satisfactory 
CervicalCheck screening in a five year period
79.3% 80% 79.1% -1.2%
BowelScreen
% of client uptake rate in the BowelScreen programme 39.9% 45% 42.5%* -3.4%*
Diabetic RetinaScreen
% Diabetic RetinaScreen uptake rate 61.8% 68% 66.6% -2.1%

























Healthcare Associated Infections: Medication Management
Consumption of antibiotics in community settings 
(defined daily doses per 1,000 population) per day 
based on wholesaler to community pharmacy sales 
– not prescription level data
24.2 <23.1 21.4 -7.3%
Nursing
% of new patients accepted onto the nursing caseload 
and seen within 12 weeks
100.0% 100% 98.5% -1.5%
Physiotherapy
% of new patients seen for assessment within 12 weeks 80.4% 81% 78.6% -2.9%
% on waiting list for assessment ≤52 weeks 94.3% 95% 92.0% -3.1%
Occupational Therapy
% of new service users seen for assessment within 12 weeks 64.9% 68% 68.2% 0.3%
% on waiting list for assessment ≤52 weeks 74.4% 85% 70.8% -16.7%
Speech and Language Therapy
% on waiting list for assessment ≤52 weeks 93.6% 100% 91.6% -8.4%
% on waiting list for treatment ≤52 weeks 90.6% 100% 82.1% -17.9%
Podiatry
% on waiting list for treatment ≤12 weeks 29.5% 32% 33.7% 5.3%
% on waiting list for treatment ≤52 weeks 69.0% 77% 73.6% -4.4%
Ophthalmology
% on waiting list for treatment ≤12 weeks 25.7% 26% 27.8% 6.9%
% on waiting list for treatment ≤52 weeks 61.2% 66% 67.5% 2.3%































% on waiting list for treatment ≤12 weeks 35.6% 41% 29.0% -29.0%
% on waiting list for treatment ≤52 weeks 86.3% 88% 83.6% -5.0%
Dietetics
% on waiting list for treatment ≤12 weeks 39.8% 37% 35.3% -4.6%
% on waiting list for treatment ≤52 weeks 77.7% 79% 77.1% -2.5%
Psychology
% on waiting list for treatment ≤12 weeks 27.1% 36% 22.4% -37.9%
% on waiting list for treatment ≤52 weeks 75.8% 81% 67.7% -16.4%
Oral Health
% of new patients who commenced treatment within 
three months of scheduled oral health assessment
90.0% 90% 91.9% 2.1%
Orthodontics
% of patients seen for assessment within six months 29.1% 46% 31.2% -32.2%
% of orthodontic patients (grades 4 and 5) on the 
treatment waiting list longer than four years
6.4% <6% 11.6% 93.6%
Child Health
% of children reaching 10 months within the reporting 
period who have had child development health 
screening on time or before reaching 10 months of age
93.0% 95% 92.1% -3.0%
% of newborn babies visited by a PHN within 72 hours 
of discharge from maternity services
97.3% 98% 98.7% 0.7%
% of babies breastfed (exclusively and not exclusively) 
at first PHN visit
55.7% 58% 57.6% -0.5%
% of babies breastfed exclusively at first PHN visit 40.4% 48% 39.6% -17.5%
% of babies breastfed (exclusively and not exclusively) 
at three month PHN visit
40.2% 40% 42.3% 5.8%
% of babies breastfed exclusively at three month PHN visit 30.6% 30% 31.4% 4.6%
Social Inclusion Services
Opioid Substitution
Average waiting time from referral to assessment for 
opioid substitution treatment
6.4 days 4 days 2.9 days -27.5%
Average waiting time from opioid substitution 
assessment to exit from waiting list or treatment 
commenced
24.9 days 28 days 29.2 days 4.3%
Homeless Services
% of service users admitted to homeless emergency 
accommodation hostels/facilities whose health needs 
have been assessed within two weeks of admission
86.3% 87% 83.1% -4.5%
Substance Misuse
% of substance misusers (over 18 years) for whom 
treatment has commenced within one calendar month 
following assessment
93.2% 100% 95.2% -4.8%
% of substance misusers (under 18 years) for whom 
treatment has commenced within one week following 
assessment
96.0% 100% 95.5% -4.5%































General Adult Community Mental Health Teams
% of accepted referrals/re-referrals offered first 
appointment within 12 weeks by General Adult 
Community Mental Health Team
92.3% 90% 92.9% 3.2%
% of accepted referrals/re-referrals offered first 
appointment and seen within 12 weeks by General 
Adult Community Mental Health Team
72.7% 75% 73.0% -2.7%
% of new (including re-referred) General Adult 
Community Mental Health Team cases offered 
appointment and DNA in the current month
22.5% <22% 22.2% 1.1%
Psychiatry of Later Life Community Mental Health Teams
% of accepted referrals/re-referrals offered first 
appointment within 12 weeks by Psychiatry of 
Later Life Community Mental Health Teams
97.7% 98% 96.1% -2.0%
% of accepted referrals/re-referrals offered first 
appointment and seen within 12 weeks by Psychiatry 
of Later Life Community Mental Health Teams
95.2% 95% 94.0% -1.0%
% of new (including re-referred) Psychiatry of Later Life 
Psychiatry Team cases offered appointment and DNA 
in the current month
2.9% <3% 2.3% -23.3%
Child and Adolescent Mental Health Services
Admissions of children to Child and Adolescent Acute 
Inpatient Units as a % of the total no. of admissions of 
children to mental health acute inpatient units
70.7% 75% 86.0% 14.7%
% of bed days used in HSE Child and Adolescent Acute 
Inpatient Units as a total of bed days used by children in 
mental health acute inpatient units
93.7% 95% 96.0% 1.1%
% of accepted referrals/re-referrals offered first 
appointment within 12 weeks by Child and Adolescent 
Community Mental Health Teams
79.7% 78% 78.4% 0.5%
% of accepted referrals/re-referrals offered first 
appointment and seen within 12 weeks by Child 
and Adolescent Community Mental Health Teams
72.6% 72% 72.2% 0.2%
% of new (including re-referred) child/adolescent referrals 
offered appointment and DNA in the current month
9.7% <10% 8.5% -15.0%
% of accepted referrals/re-referrals seen within 12 
months by Child and Adolescent Community Mental 
Health Teams excluding DNAs
95.6% 95% 95.8% 0.9%
% of urgent referrals to Child and Adolescent Mental 
Health Teams responded to within three working days







Safeguarding (combined KPIs with Older Persons’ Services)
% of preliminary screenings for adults aged 65 years and 
over with an outcome of reasonable grounds for concern 
that are submitted to the safeguarding and protection 
teams accompanied by an interim safeguarding plan
98.1% 100% 96.2% -3.8%
% of preliminary screenings for adults under 65 years 
with an outcome of reasonable grounds for concern 
that are submitted to the safeguarding and protection 
teams accompanied by an interim safeguarding plan
99.7% 100% 98.8% -1.2%































% of compliance with regulations following HIQA 
inspection of disability residential services
88.9% 80% 89.4% 11.8%
Day Services including School Leavers
% of school leavers and rehabilitation training (RT) 
graduates who have been provided with a placement
93.1% 100% 92.8% -7.2%
Disability Act Compliance
% of child assessments completed within the timelines 
as provided for in the regulations
8.7% 100% 9.8% -90.2%
Progressing Disability Services for Children and Young People (0-18s) Programme
% of Children’s Disability Network Teams established 0.0% 100% 0.0% -100.0%
Older Persons’ Services
Safeguarding (combined KPIs with Disability Services)
% of preliminary screenings for adults aged 65 years and 
over with an outcome of reasonable grounds for concern 
that are submitted to the safeguarding and protection 
teams accompanied by an interim safeguarding plan
98.1% 100% 96.2% -3.8%
% of preliminary screenings for adults under 65 years 
with an outcome of reasonable grounds for concern 
that are submitted to the safeguarding and protection 
teams accompanied by an interim safeguarding plan
99.7% 100% 98.8% -1.2%
Residential Care




% of compliance with regulations following HIQA inspection 
of HSE direct-provided Older Persons’ Residential Services
84.0% 80% 75.4% -5.8%
Intensive Homecare Packages (IHCPs)
% of clients in receipt of an IHCP with a key worker assigned 95.2% 100% 100.0% 0.0%
Nursing Homes Support Scheme (NHSS)
% of population over 65 years in NHSS funded beds 
(based on 2016 Census figures)
3.4% ≤3.5% 3.5% 0.0%
% of clients with NHSS who are in receipt of ancillary 
state support
14.4% 13.5% 15.3% 13.6%
% of clients who have Common Summary Assessment 
Reports (CSARs) processed within six weeks
88.7% 90% 91.3% 1.4%
Palliative Care Services
Inpatient Palliative Care Services
Access to specialist inpatient bed within seven days 
during the reporting year
98.1% 98% 98.1% 0.1%
% of patients triaged within one working day of referral 
(inpatient unit)
98.6% 90% 97.9% 8.8%
Community Palliative Care Services
Access to specialist palliative care services in the community 
provided within seven days (normal place of residence)
86.7% 90% 85.9% -4.5%
% of patients triaged within one working day of referral 
(community)
95.8% 95% 95.7% 0.7%
































New: Return Ratio (excluding obstetrics, warfarin and 
haematology clinics)
1:2.5 1:2.3 1:2.6 13.0%
Activity Based Funding (MFTP) model
HIPE Completeness – Prior month: % of cases entered 
into HIPE
94.0% 95% 89.0% -6.3%
Inpatient, Day Case and Outpatient Waiting Times
% of adults waiting <15 months for an elective 
procedure (inpatient)
84.3% 85% 86.0% 1.2%
% of adults waiting <15 months for an elective 
procedure (day case)
92.9% 95% 93.3% -1.8%
% of children waiting <15 months for an elective 
procedure (inpatient)
89.8% 85% 91.9% 8.1%
% of children waiting <15 months for an elective 
procedure (day case)
83.9% 90% 85.4% -5.1%
% of people waiting <52 weeks for first access 
to OPD services
70.4% 80% 68.9% -13.8%
Colonoscopy/Gastrointestinal Service
% of people waiting <13 weeks following a referral 
for routine colonoscopy or OGD
59.1% 70% 55.4% -20.8%
No. of people waiting > four weeks for access 
to an urgent colonoscopy
253 0 209 >100.0%
Emergency Care and Patient Experience Time
% of all attendees at ED who are discharged 
or admitted within six hours of registration
64.6% 75% 62.7% -16.4%
% of all attendees at ED who are discharged 
or admitted within nine hours of registration
79.4% 99% 78.1% -21.1%
% of ED patients who leave before completion of treatment 6.4% <5% 6.6% 32.0%
% of all attendees at ED who are in ED <24 hours 96.5% 99% 96.1% -2.9%
% of all attendees aged 75 years and over at ED who are 
discharged or admitted within six hours of registration
42.4% 95% 40.6% -57.3%
% of all attendees aged 75 years and over at ED who are 
discharged or admitted within nine hours of registration
60.7% 99% 58.7% -40.7%
% of all attendees aged 75 years and over at ED who are 
discharged or admitted within 24 hours of registration
91.5% 99% 90.2% -8.9%
Length of Stay
ALOS for all inpatient discharges excluding LOS over 
30 days
4.7 ≤4.8 4.8 0.0%
Medical
Medical patient average length of stay 7.0 ≤7.2 7.2 0.0%
% of medical patients who are discharged or admitted 
from AMAU within six hours AMAU registration
61.9% 75% 61.9% -17.5%
% of all medical admissions via AMAU 31.2% 45% 32.5% -27.8%
% of emergency re-admissions for acute medical conditions 
to the same hospital within 30 days of discharge
11.3% ≤11.1% 11.4% 2.7%































Surgical patient average length of stay 5.5 ≤5.5 5.5 0.0%
% of elective surgical inpatients who had principal 
procedure conducted on day of admission
74.2% 82% 75.2% -8.3%
% day case rate for Elective Laparoscopic Cholecystectomy 45.4% 60% 43.6% -27.3%
% hip fracture surgery carried out within 48 hours of 
initial assessment (Hip fracture database)
New PI NSP 
2019
85% 76.4% -10.1%
% of surgical re-admissions to the same hospital within 
30 days of discharge
2.0% ≤3% 1.9% -36.7%
Healthcare Associated Infections (HCAI)
Rate of new cases of hospital acquired Staph. Aureus 
bloodstream infection
1.0 <1/10,000 bed 
days used
1.0 -0.3%
Rate of new cases of hospital acquired C. difficile infection 2.1 <2/10,000 bed 
days used
2.6 29.3%
% of acute hospitals implementing the requirements 
for screening of patients with CPE guidelines
55.3% 100% 74.5% -25.5%
% of acute hospitals implementing the national policy 
on restricted antimicrobial agents
34.0% 100% 55.3% -44.7%
Medication Safety
Rate of medication incidents as reported to NIMS 
per 1,000 beds
New PI NSP 
2019
2.4 per 1,000 
bed days
2.6 8.3%
National Early Warning System (NEWS)
% of hospitals with implementation of NEWS in all 
clinical areas of acute hospitals (as per 2019 definition)
New PI NSP 
2019
100% 27.1% -72.9%
% of hospitals with implementation of PEWS (Paediatric 
Early Warning System)
51.7% 100% 55.6% -44.4%
National Standards
% of hospitals that have completed a self-assessment 
against all 53 essential elements of the National 
Standards for Safer, Better Healthcare
New PI NSP 
2019
100% 26.2% -73.8%
% of acute hospitals which have completed and published 
monthly hospital patient safety indicator report
68.5% 100% 67.0% -33.0%
Stroke
% acute stroke patients who spend all or some of their 
hospital stay in an acute or combined stroke unit
71.0% 90% 73.7% -18.1%
% of patients with confirmed acute ischaemic stroke 
who receive thrombolysis
9.4% 12% 12.3% 2.5%
% of hospital stay for acute stroke patients in stroke unit 
who are admitted to an acute or combined stroke unit
68.0% 90% 70.1% -22.1%
Acute Coronary Syndrome
% STEMI patients (without contraindication to 
reperfusion therapy) who get PPCI
94.6% 95% 92.2% -2.9%
% of reperfused STEMI patients (or LBBB) who get 
timely PPCI
64.1% 80% 64.9% -18.9%






























National Women and Infants Health Programme (NWIHP)
Irish Maternity Early Warning System (IMEWS)
% of maternity units/hospitals with full implementation 
of IMEWS (as per 2019 definition)
New PI NSP 
2019
100% 52.6% -47.4%
% of all hospitals with implementation of IMEWS (as per 
2019 definition)
New PI NSP 
2019
100% 16.3% -83.7%
% maternity hospitals/units which have completed 
and published Maternity Patient Safety Statement and 
discussed same at hospital management team/Hospital 
Group/NWIHP meetings each month
100.0% 100% 89.5% -10.5%
Cancer Services
% of new patients attending rapid access breast, lung 
and prostate clinics within recommended timeframe
New PI NSP 
2019
95% 71.7% -24.5%
Symptomatic Breast Disease Services
Non-urgent
% of attendances whose referrals were triaged as 
non-urgent by the cancer centre and adhered to the 
national standard of 12 weeks for non-urgent referrals 
(% offered an appointment that falls within 12 weeks)
67.6% 95% 70.6% -25.7%
Clinical Detection Rate – breast cancer
% of new attendances to the rapid access clinic, triaged 
as urgent, that have a subsequent primary diagnosis of 
breast cancer
10.2% >6% 9.3% 55.0%
Clinical Detection Rate – lung cancer
% of new attendances to the rapid access clinic that 
have a subsequent primary diagnosis of lung cancer
29.0% >25% 35.9% 43.6%
Clinical Detection Rate – prostate cancer
% of new attendances to the rapid access clinic that 
have a subsequent primary diagnosis of prostate cancer
34.7% >30% 30.3% 1.0%
Radiotherapy
% of patients undergoing radical radiotherapy treatment 
who commenced treatment within 15 working days of 
being deemed ready to treat by the radiation oncologist 
(palliative care patients not included)





























Return of spontaneous circulation (ROSC) at hospital in 
bystander witnessed out of hospital cardiac arrest with 
initial shockable rhythm, using Utstein comparator 
group calculation
46.0% 40% 43.6% 9.0%
Audit
National Emergency Operations Centre (NEOC) Tallaght 
and Ballyshannon – % medical priority dispatch system 
(MPDS) protocol compliance
93.6% 93% 92.9% -0.1%



































% of clinical status 1 ECHO incidents responded to by 
a patient-carrying vehicle in 18 minutes and 59 seconds 
or less
79.5% 80% 79.5% -0.6%
% of ECHO calls which had a resource allocated within 
90 seconds of call start
97.3% 95% 97.8% 2.9%
% of clinical status 1 DELTA incidents responded to by 
a patient-carrying vehicle in 18 minutes and 59 seconds 
or less
57.4% 80% 55.6% -30.5%
% of DELTA calls which have a resource allocated within 
90 seconds of call start
87.7% 90% 88.7% -1.4%
Intermediate Care Service
% of all transfers provided through the intermediate care 
service
90.6% 90% 88.6% -1.5%
Ambulance Turnaround
% of ambulance turnaround delays escalated where 
ambulance crews were not cleared nationally (from 
ambulance arrival time through clinical handover in ED 
or specialist unit to when the ambulance crew declares 
readiness of the ambulance to accept another call) in 





















































% of completed medical card/GP visit card applications 
processed within 15 days
99.8% 99% 99.8% 0.8%
% of medical card/GP visit card applications, assigned 
for medical officer review, processed within five days
97.8% 95% 98.5% 3.7%
% of medical card/GP visit card applications which are 
accurately processed from a financial perspective by 
National Medical Card Unit staff
95.9% 96% 99.2% 3.3%






































No. of initial tobacco sales to minors test purchase 
inspections carried out
390 384 391 1.8%
No. of test purchases carried out under the Public 
Health (Sunbeds) Act 2014
32 32 32 0.0%
No. of mystery shopper inspections carried out under 
the Public Health (Sunbeds) Act 2014
32 32 32 0.0%
No. of establishments receiving a planned inspection 
under the Public Health (Sunbeds) Act 2014
274 242* 242 0.0%
No. of official food control planned, and planned 
surveillance, inspections of food businesses
32,252 33,000 31,108 -5.7%
No. of inspections of e-cigarette and refill container 
manufacturers, importers, distributors and retailers 
under E.U. (Manufacture, Presentation and Sale of 
Tobacco and Related Products) Regulations 2016
38 40 40 0.0%
Tobacco
No. of smokers who received face to face or telephone 
intensive cessation support from a cessation counsellor
10,608 11,500 7,198** –
No. of smokers who are receiving on-line cessation 
support services




No. of people who have completed a structured patient 
education programme for type 2 diabetes
3,259 4,190 3,580 -14.6%
Public Health
No. of infectious disease (ID) outbreaks notified under 
the national ID reporting schedule
727 500 644 28.8%
Making Every Contact Count
No. of frontline staff to complete the eLearning Making 
Every Contact Count training in brief intervention
397 1,425 1,792 25.8%
No. of frontline staff to complete the face to face module of 
Making Every Contact Count training in brief intervention
16 284 367 29.2%
* Expected Activity revised from 295 to 242 in May 2019
** Data is in relation to January to September 2019 and so an end of year variance is not appropriate for inclusion





























No. of women in the eligible population who have had 
a complete mammogram
170,583 185,000 170,957 -7.6%
CervicalCheck
No. of unique women who have had one or more smear 
tests in a primary care setting
339,161 255,000 206,315 -19.1%


































No. of clients who have completed a satisfactory 
BowelScreen FIT test
105,416 125,000 122,724 -1.8%
Diabetic RetinaScreen
No. of Diabetic RetinaScreen clients screened 
with final grading result


























Total no. of CIT referrals 44,406 45,432 52,454 15.5%
Paediatric Homecare Packages
Total no. of packages 377 457 471 3.1%
Health Amendment Act: Services to people with State Acquired Hepatitis C
No. of Health Amendment Act card holders who were 
reviewed
101 340 71 -79.1%
GP Activity
No. of contacts with GP Out of Hours Service 1,065,567 1,147,496 1,124,100 -2.0%
Nursing
No. of patients seen 695,062 743,605 436,470 -41.3%
Therapies/Community Healthcare Network Services
Total no. of patients seen 1,553,140 1,557,484 1,584,822 1.7%
Physiotherapy
No. of patients seen 576,409 581,661 572,006 -1.7%
Occupational Therapy
No. of patients seen 356,716 356,314 382,219 7.3%
Speech and Language Therapy
No. of patients seen 276,343 279,803 273,639 -2.2%
Podiatry
No. of patients seen 83,917 83,100 85,018 2.3%
Ophthalmology
No. of patients seen 101,405 99,192 101,047 1.9%
Audiology
No. of patients seen 51,573 52,548 55,526 5.7%
Dietetics
No. of patients seen 64,402 63,382 70,428 11.1%































No. of patients seen 42,375 41,484 44,939 8.3%
Orthodontics
No. of patients seen for assessment within six months 1,463 2,406 1,859 -22.7%
GP Trainees
No. of trainees 194 202 199 -1.5%
National Virus Reference Laboratory
No. of tests 908,071 945,228 963,925 2.0%
Social Inclusion Services
Opioid Substitution
No. of clients in receipt of opioid substitution treatment 
(outside prisons)
9,848 10,063 9,974 -0.9%
Needle Exchange
No. of unique individuals attending pharmacy needle 
exchange
1,779 1,650 2,113* –
Homeless Services
No. of service users admitted to homeless emergency 
accommodation hostels/facilities whose health needs 
have been assessed within two weeks of admission
1,252 1,126 1,299 15.4%
Traveller Health
No. of people who received information on type 2 
diabetes or participated in related initiatives
4,000 3,735 4,887 30.8%
No. of people who received information on 
cardiovascular health or participated in related initiatives
5,387 3,735 5,381 44.1%
Substance Misuse
No. of substance misusers (over 18 years) for whom 
treatment has commenced within one calendar month 
following assessment
4,219 4,884 2,906* –
No. of substance misusers (under 18 years) for whom 
treatment has commenced within one week following 
assessment
315 340 236* –
Mental Health Services
General Adult Community Mental Health Teams
No. of adult referrals seen by mental health services 27,124 28,716 27,056 -5.8%
No. of admissions to adult acute inpatient units 12,277 12,148 9,170* –
Psychiatry of Later Life Community Mental Health Teams
No. of Psychiatry of Later Life referrals seen by mental 
health services
8,553 8,896 8,921 0.3%
Child and Adolescent Mental Health Services
No. of CAMHS referrals received by mental health services 18,650 18,128 18,831 3.9%
No. of CAMHS referrals seen by mental health services 10,796 10,833 11,139 2.8%































An agreed Standardised Assessment Tool will be 
developed through the 9 demonstration sites with testing 
of the tool commenced in one of the 9 sites in Q4 2019




No. of residential places for people with a disability 8,235 8,568 8,190 -4.4%
New Emergency Places Provided to People with a Disability
No. of new emergency places provided to people with 
a disability
132 90 80 -11.1%
Congregated Settings
Facilitate the movement of people from congregated 
to community settings
155 160 103 -35.6%
Day Services including School Leavers
No. of people with a disability in receipt of work/
work-like activity services (ID/autism and physical 
and sensory disability)
2,364 2,513 1,782 -29.1%
No. of people (all disabilities) in receipt of rehabilitation 
training (RT)
2,269 2,282 2,214 -3.0%
No. of people with a disability in receipt of other day 
services (excl. RT and work/work-like activities) (adult) 
(ID/autism and physical and sensory disability)
17,551 22,272 16,245 -27.1%
Respite Services
No. of day only respite sessions accessed by people 
with a disability
35,876 32,662 35,861 9.9%
No. of people with a disability in receipt of respite 
services (ID/autism and physical and sensory disability)
6,036 6,559 5,847 -10.9%
No. of overnights (with or without day respite) accessed 
by people with a disability
158,368 182,506 158,441 -13.2%
Personal Assistance (PA)
No. of PA service hours delivered to adults with 
a physical and/or sensory disability
1,639,481 1.63m 1,652,030 1.4%
No. of adults with a physical and/or sensory disability 
in receipt of a PA service
2,553 2,535 2,522 -0.5%
Home Support Service
No. of home support hours delivered to persons with 
a disability
3,176,796 3.08m 3,036,182 -1.4%
No. of people with a disability in receipt of home support 
services (ID/autism and physical and sensory disability)
7,491 8,094 6,725 -16.9%
Disability Act Compliance
No. of requests for assessment of need received for children 5,060 5,065 6,596 30.2%
Progressing Disability Services for Children and Young People (0-18s) Programme
No. of Children’s Disability Network Teams established 0 80 0 -100.0%































Single Assessment Tool (SAT)
No. of people seeking service who have been assessed 
using the Single Assessment Tool (SAT) (commencing Q4)




No. of home support hours provided (excluding provision 
of hours from Intensive Homecare Packages (IHCPs))
17,130,453 17.9m 17,484,366 -2.3%
No. of people in receipt of home support (excluding 
provision from Intensive Homecare Packages (IHCPs)) 
– each person counted once only
53,016 53,182 51,345 -3.5%
Intensive Homecare Packages (IHCPs)
Total no. of persons in receipt of an Intensive Homecare 
Package
250 235 188 -20.0%
No. of home support hours provided from Intensive 
Homecare Packages
406,047 360,000 376,665 4.6%
Transitional Care
No. of persons at any given time being supported 
through transitional care in alternative care settings
991 1,160 978 -15.7%
No. of persons in acute hospitals approved for 
transitional care to move to alternative care settings
11,079 10,980 10,116 -7.9%
Nursing Homes Support Scheme (NHSS)
No. of persons funded under NHSS in long-term 
residential care during the reporting month
23,305 23,042 23,629 2.5%
No. of NHSS beds in public long stay units 4,961 4,900 4,945 0.9%
Residential Care
No. of short stay beds in public long stay units 1,946 1,850 1,867 0.9%
Palliative Care Services
Inpatient Palliative Care Services
No. accessing specialist inpatient beds within seven 
days (during the reporting year)
3,764 3,809 3,674 -3.5%
Community Palliative Care Services
No. of patients who received specialist palliative care 
treatment in their normal place of residence in the month
3,461 3,405 3,484 2.3%
Children’s Palliative Care Services
No. of children in the care of the Clinical Nurse 
Co-ordinators for Children with Life Limiting Conditions 
(children’s outreach nurse)
275 280 308 10.0%
No. of children in the care of the acute specialist paediatric 
palliative care team (during the reporting month)
35 97 36* –
* Data is in relation to January to September 2019 and so an end of year variance is not appropriate for inclusion
































Inpatient 641,959 637,173 636,550 -0.1%
Day case (includes dialysis) 1,073,916 1,069,702 1,104,495 3.3%
Total inpatient and day cases 1,715,875 1,706,875 1,741,045 2.0%
Emergency inpatient discharges 439,443 444,010 438,961 -1.1%
Elective inpatient discharges 91,808 85,660 91,371 6.8%
Maternity inpatient discharges 110,708 107,503 106,218 -1.2%
Inpatient discharges >75 years 124,774 124,094* 126,565 2.0%
Day case discharges >75 years 192,784 190,526 203,776 7.0%
Emergency Care
New ED attendances 1,224,495 1,228,415 1,251,506 1.9%
Return ED attendances 99,236 99,570 111,252 11.7%
Injury unit attendances 93,997 96,518 99,222 2.8%
Other emergency presentations 49,918 50,633 44,456 -12.2%
Births
Total no. of births 61,092 60,861 59,406 -2.4%
Outpatients
No. of new and return outpatient attendances 3,337,048 3,339,859 3,354,919 0.4%
Delayed Discharges
No. of bed days lost through delayed discharges 206,606 ≤200,750 238,544 18.8%
No. of beds subject to delayed discharges 476 ≤550 545 -0.9%
Healthcare Associated Infections (HCAI)
No. of new cases of CPE 532 N/A 661 –




























Total no. of AS1 and AS2 (emergency ambulance) calls 337,754 333,800 348,053 4.3%
Total no. of AS3 calls (inter-hospital transfers) 32,983 34,000 31,738 -6.7%
No. of intermediate care vehicle (ICV) transfer calls 29,875 32,000 28,122 -12.1%
No. of clinical status 1 ECHO calls activated 5,101 5,100 5,215 2.3%
No. of clinical status 1 ECHO calls arrived at scene 
(excludes those stood down en route)
4,877 4,940 4,965 0.5%
No. of clinical status 1 DELTA calls activated 140,249 141,000 145,136 2.9%
No. of clinical status 1 DELTA calls arrived at scene 
(excludes those stood down en route)
128,574 129,000 132,775 2.9%
Aeromedical Service – Hours (Department of Defence) 451 480 454 -5.4%
Irish Coast Guard – Calls (Department of Transport, 
Tourism and Sport)
121 200 109 -45.5%









































No. of persons covered by medical cards as at 31 December 1,565,049 1,541,667 1,544,374 0.2%
No. of persons covered by GP visit cards as at 31 December 503,329 528,079 524,494 -0.7%
Total 2,068,378 2,069,746 2,068,868 0.0%
General Medical Services Scheme
Total no. of items prescribed 58,192,133 58,347,423 59,397,043 1.8%
No. of prescriptions 18,691,105 18,685,315 18,946,154 1.4%
Long-Term Illness Scheme
Total no. of items prescribed 8,892,719 8,829,947 9,423,721 6.7%
No. of claims 2,525,456 2,506,941 2,690,489 7.3%
Drug Payment Scheme
Total no. of items prescribed 7,585,690 7,544,139 7,864,176 4.2%
No. of claims 2,310,928 2,272,160 2,336,973 2.9%
Other Schemes
No. of high tech drugs scheme claims 714,937 708,859 773,906 9.2%
No. of dental treatment services scheme treatments 1,113,777 1,185,985 1,049,293 -11.5%
No. of community ophthalmic services scheme treatments 793,540 793,256 775,146 -2.3%














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In response to legislation SI 426 of 2014 (previously SI 542 
of 2009), which requires public sector organisations to report 
annually, this appendix outlines the HSE’s position on its 
energy use and actions taken to reduce consumption.
As one of the largest public sector energy users the health 
service must act as an exemplar of best practice in taking 
climate action, reducing emissions and the mitigation of the 
adverse health effects of climate change.
Key measures set out in the Climate Action Plan for the 
public sector include targets of 50% energy efficiency 
and 30% greenhouse gas emissions reduction by 2030. 
In addition, all public sector buildings, including healthcare 
buildings, must be upgraded to a B2 energy rating which will 
require an unprecedented major refurbishment programme.
A number of programmes of work have been established as 
part of the Estates Energy Reduction Implementation Plan.
Overview of Energy Usage in 2019
The National Health Sustainability Office is fully compliant 
with the requirements of SI 426 and has verified all HSE 
meter points for 2019. This data is currently being validated 
by the Sustainable Energy Authority of Ireland (SEAI) and 
it is anticipated that this verified energy consumption data 
will be available from the SEAI in mid-2020.
The overview below is the verified energy usage in 2018 
(excluding section 38 and section 39 agencies). The verified 
2019 energy usage, when issued by SEAI, will be made 
available at hse.ie/sustainability.
• 227,200 MWh of electricity
• 596,826 MWh of fossil fuels
• 374 MWh of renewable fuels.
Actions undertaken in 2019
• HBS Estates Offices improved energy management 
practices and performance through the formation of Estates 
Energy Bureaux, which were established in partnership with 
the SEAI. This was developed as a scalable pilot initiative in 
the East Region and roll-out to the West and South Areas 
progressed in 2019. This included the implementation 
of energy awareness programmes and development of 
registers of opportunities for energy efficiency projects 
in order to progress grant funding for projects.
• Initial Energy Efficiency Projects which were identified 
on registers of opportunities were progressed.
• The requirement for an Energy Efficient Design Review is 
now included in the Scope of Services for design teams 
for new projects and major refurbishments. This ensures 
the design of new healthcare buildings maximise energy 
efficiency and are in compliance with energy standards.
• Continuation of the Optimising Power at Work Staff Energy 
Awareness Programme in partnership with the Office 
of Public Works (OPW), including the Big Switch Off 
Competition which aimed to empower hospital staff in eight 
acute hospitals to take control of the energy consumed 
in their workplace and to embed energy saving habits.
• A dedicated session on Energy Efficiency at the Health 
Sector Climate Action Seminar was attended by over 
200 healthcare staff.
Actions planned for 2020
• Consolidate the works of the Estates led Energy 
Bureaux in all HSE regions and offices.
• Expand the Energy Bureaux to support section 38 
and 39 voluntary organisations.
• Develop further the Optimising Power at Work Programme.
Engage with the Department of Public Expenditure and 
Reform to progress access to Climate Action Funding to 
support an on-going carbon emission reduction programme.







Appendix 5: Annual Energy Efficiency Report











2019 was a year of continued challenges for the HSE driven 
by the complexities of on-going demand for services in our 
acute, community and social care services.
It was also a year that saw the welcomed re-establishment, 
on the 28 June 2019, of an external Board arising from the 
introduction of the Health Service Executive (Governance) 
Act 2019. Four committees have been established to help 
the Board in the performance of its functions. These 
committees are:
• Audit and Risk Committee
• People and Culture Committee
• Performance and Delivery Committee
• Safety and Quality Committee
The HSE is currently in the process of developing a new 
corporate plan, fully informed by Sláintecare, which will focus 
on providing a clear medium-term roadmap for staff, patients, 
service users and all stakeholders.
Strategic Context
The HSE is required to use the resources available to it to 
deliver the type and volume of services provided for in the 
national service plan while prioritising improving the health of 
the population through promoting wellness and the provision of 
safe health and social care services for the citizens of Ireland.
The environment in which the HSE operates is increasingly 
complex. There were over 4.9 million (m) people living in 
Ireland during 2019 representing a 3.8% increase since 
Census 2016 and 8.1% since 2010. According to the 
Economic Social Research Institute (ESRI), the population in 
Ireland will have increased by circa another 1.1m people by 
the end of 2030 therefore adding to the number of people 
requiring HSE services.
People in Ireland are also living longer and life expectancy 
in Ireland has increased by almost two and a half years 
since 2007. The increase in life expectancy in Ireland was 
consistently higher than the EU average over the past 
decade. These predicted changes in our population will 
have implications for how we fund and deliver increasingly 
complex care and services.
While the population is growing across age groups, the most 
significant increases are evident in the age group cohort of 65 
years or over. The ESRI has predicted that by 2030 the share 
of the population aged 65 and over will have increased from 
1 in 8 to 1 in 6 while the number of people aged over 85 is 
expected to double.
Although we are living longer with improved health, there is 
evidence that in the older age groups, people are presenting 
with complex health challenges such as cognitive loss and 
multiple chronic illnesses. The Irish Longitudinal Study on 
Ageing (TILDA) 2018 predicted that the number of people 
aged 50 and older living with one or more chronic disease 
will have increased by up to 40% since 2016 by 2030.
Lifestyle factors also contribute to the complexity of health 
provision in Ireland. This includes the impact of smoking, 
drug use, alcohol consumption and obesity. While the 
number of adults smoking in Ireland has decreased from 
27% in 2002 to 14% in 2019, almost one third of Irish adults 
reported regular heavy alcohol intake and the obesity rates 
in Ireland has increased from 15% in 2007 to 18% by 2015.
The HSE is fully supportive of the need to make significant 
changes to the current models of health and social care and 
is committed to working with Sláintecare Programme and the 
Department of Health to deliver this change. This will involve 
a greater cross government and society focus on helping 
people to stay healthy, new and more integrated models 
of health and social care, including better integration with 
the voluntary sector, and greater involvement of citizens, 
patients and service users in the design and delivery of care. 
Sláintecare sets out the vision to deliver a transformation 
in the way care is organised, delivered and experienced in 
Ireland over the next 8 to 10 years, which aims to achieve 
more positive experiences and better outcomes for patients, 
service users and local communities.
Financial Overview
Significant efforts have been made during 2019 to improve 
the overall financial planning and financial management of the 
HSE which resulted in the delivery of a small surplus on our 
non-capital expenditure of €60.5m or 0.35% of total funding.
Income Analysis
The HSE received revenue funding from the DoH of 
€16.471bn for the provision of health and social care 
services. This included the allocation of once off net 
additional funding of €426m provided by way of a 
supplementary estimate for 2019. Of the supplementary 
estimate received €50m was available for acute services, 
€50m for disabilities, €157m for Primary Care Reimbursement 
Service (PCRS), €26m for Winter Plan, €51m for pay 
agreements, €9m for Brexit and €83m for areas such as 
State Claims Agency costs and which also covers demand 
led areas such as pensions and overseas treatment. Overall 
this represented an increase of circa €1.249 billion or an 
8.2% increase over 2018.
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Department of Health Grant 16,471,023 15,221,624 8.2%
“First Charge” (85,174) (139,871) -39.1%
Private Patient Income 408,249 406,079 0.5%
Superannuation Income from staff 374,122 419,502 -10.8%
Other Income 130,075 113,846 14.3%
Total Income per AFS 17,298,295 16,021,179 8.0%
Table 6: HSE Income Graph 2005 to 2019
While Table 6 shows that there has been an increase in HSE income and funding particularly in the years since 2016, this has to 
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Table 7: Percentage Changes in Public Health Expenditure Per Capita, 2010 to 2018
Irish public health expenditure (capital and revenue) has been on the increase from a low of €13.4bn in 2013 to €17.9bn in 2019. 
However, the rate of increase for each person in Ireland is far slower than the average Organisation for Economic Co-Operation 
and Development (OECD) increase. In fact, between 2010 and 2018, the per person increase in public health expenditure was 
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€000 % Var % of Total
Acute Hospitals 6,813,419 6,299,385 8% 40%
Primary Care 4,157,149 3,997,759 4% 24%
Social Care 3,441,315 3,264,017 5% 20%
Corporate Support Services 480,691 393,445 22% 3%
Mental Health 964,101 891,376 8% 6%
Health and Wellbeing 240,647 214,181 12% 1%
Other Demand Led 1,140,512 1,046,190 9% 7%
Total Expenditure 17,237,833 16,106,353 7% 100%
Expenditure and Outcome Analysis
At the end of 2019 the HSE delivered a modest surplus of 
income over expenditure of €60.5m or 0.35% of its overall 
income. This surplus arose primarily as a result of one off 
funding measures and savings that are not expected to 
be replicated in 2020.
The year remained challenging in operational services 
particularly in the area of acute hospital operations 
which reported a deficit in 2019 arising from greater 
than anticipated expenditure directly related to operational 
activity and demand for services. In general, the impact of 
additional supplementary funding and savings measures 
enabled other key service areas to report surpluses for 
2019 which are not necessarily achievable in 2020.
The overall expenditure reported for 2019 is €17.238bn 
which is 7% higher than the expenditure in 2018. The 
table above analyses this expenditure by HSE service 
area. Primary care and social care together account for 
circa 44% of the expenditure whilst the provision of acute 
hospital and National Ambulance Services accounts for 
almost 40% of that spend.
The overall increased expenditure in 2019 of 7% or €1.1bn 
is mainly in respect of additional pay measures, payment of 
consultant settlements and increased expenditure in respect of 
demand led areas such as pensions and state claims agency.
A more detailed analysis per service area is provided later 
in this report.
Acute Hospitals Services
Acute services are provided for adults and children within 
six Hospital Groups, Children’s Health Ireland and the 
National Ambulance Service (NAS). These services include 
scheduled care (planned care), unscheduled care (unplanned/
emergency care), diagnostics, cancer treatment, maternity 
and children’s services, as well as the pre-hospital emergency 
and intermediate care provided by NAS.
Acute hospitals continually work to improve access to 
healthcare, whilst striving to ensure that quality and patient 
safety issues, including the management of infection, are 
prioritised within allocated budgets. The six Hospital Groups 
provide the structure to deliver an integrated hospital network 
of acute care to the adult population in each geographic area. 
Children’s Health Ireland provides paediatric services in the 
greater Dublin area and incorporates the National Paediatric 
Hospital Development Board which is responsible for 
overseeing the building of the new children’s hospital.
Overall the acute hospitals services reported a deficit for 
2019. Operational service pressures drove increased clinical 
non pay cost, particularly drugs and laboratory. Other 
non-pay cost pressures include cleaning and maintenance 
required in respect of increased infection control and 
compliance requirements. From an income perspective, 
the continued reduction in receipts from hospital private 
maintenance changes continues to be a challenge.
The volume of inpatient activity was marginally below the 
target set out in the NSP 2019 (0.1%), although overall 
complexity was slightly higher than planned (0.2%). Day 
case activity exceeded the targets set out in the NSP 2019, 
in terms of both activity volume and overall complexity (3.5% 
and 4.3% respectively). Outpatient activity was also ahead 
of NSP 2019 target (0.4%). The higher than expected 
operational costs experienced is significantly driven by 
this level of service delivery.
Social Care – Comprising Disability 
and Older Persons Services
The challenge in 2019 for the social care services was to 
continue to meet the rising demand for services as a result of 
an aging population with a longer life expectancy. The change 
in demographics in Ireland has meant that the health service 
has to adapt to the changing needs of its service users and 
patients including providing services for an increasing number 
of older people presenting with challenges such as disabilities, 
cognitive loss and chronic disease. Overall the service area 
reported a combined surplus which was partly driven by a first 
surplus from 2018 and one off savings in the year under review.










Managing the year on year growth in demand for community-
based social services has been one of the key challenges for 
older persons’ services in 2019. The largest increase in 
Ireland’s population is in the age range of 65 and over, 
presenting a particular challenge for serving a growing, 
ageing and increasingly diverse population with more 
complex service needs. Older persons services provide a 
wide range of services including home supports, community 
supports, intermediate care (both residential and in the 
home), as well as short stay and long stay care when 
remaining at home is no longer feasible (Nursing Homes 
Support Scheme (NHSS)). Overall the surplus reported in the 
older persons services has arisen from one time savings and 
a brought forward first surplus from 2018.
Disability Services
Disability services are provided to those with physical, 
sensory, intellectual disability and autism in day, respite 
and residential settings. Services include personal assistant, 
home support, multi-disciplinary and other community 
supports. The costs of providing residential care to people 
with an intellectual disability, including the provision of 
emergency placements, where individual placements can 
cost up to €0.5m, continued to be a significant financial 
pressure for this service area in 2019. The cost is primarily 
driven by the clients need and the complexity of each 
individual case presenting. Another significant increased 
spend in 2019 related to the cost associated with home 
support hours compared to other years in order to mitigate 
high cost residential placements. Overall this service area 
reported a deficit in the year under review.
Mental Health Services
Specialist mental health services are provided in local 
community areas. These services include acute inpatient 
services, day hospitals, outpatient clinics, community-based 
mental health teams (CAMHS, general adult and psychiatry of 
later life services), mental health of intellectual disability, 
community residential and continuing care residential 
services. Sub-specialties include rehabilitation and recovery, 
eating disorders, liaison psychiatry and perinatal mental 
health. A National Forensic Mental Health Service is also 
provided, including inpatient and in-reach prison services with 
a new modern and fit for purpose facility, increasing capacity 
to 130 beds, opening in 2020.
Mental health services reported a minor deficit in 2019 arising 
from a high level of reliance on agency and overtime due 
to a difficulty in recruiting staff as well as an increasing level 
of high cost residential placements with external private 
providers. The level of expenditure on external high costs 
residential placements is growing year on year due to the 
increasing complexity of patient’s needs, along with our 
own capacity and staffing constraints.
Primary Care Services
Core operational services within primary care, social inclusion 
and palliative care reported a surplus at the end of 2019, 
mostly attributable to once off time related savings relating 
to the delay or deferral of staff recruitment.
Primary care centres will support the strategic shift of care 
and services to primary care, ensuring better access to care, 
offering individuals and families a one stop shop to a broad 
range of primary care services in the community. Of the 341 
prioritised locations identified in 2012, 129 are operational at 
the end of 2019 with 74 in the process of development. Whilst 
the opening of these primary cares centres over recent years 
have placed additional pressure on the primary care operational 
cost base, these facilities form a key part of the infrastructure 
required to provide primary care services to an aging 
demographic and underpin the overall shift to primary care.
Health and Wellbeing Services
Health and wellbeing services, including the National Screening 
Service and environmental health service, support our whole 
population to stay healthy and well by focusing on prevention, 
protection, health promotion and improvement, reducing 
health inequalities, and protecting people from threats to 
their health and wellbeing. The services within health and 
wellbeing support people and communities to protect 
and improve their health and wellbeing; turning research, 
evidence and knowledge into action; acting as the authority 
on health, wellbeing and policy development; building an 
intelligent health system and a healthier population. The 
overall surplus reported in this division in 2019 has arisen 
mainly from a brought forward first surplus from 2018.
Primary Care Reimbursement Scheme
The PCRS supports the delivery of a wide range of primary 
care services to the general public through primary care 
contractors like general practitioners (GPs), dentists, 
opticians or pharmacists for the free or reduced cost services 
they provide to the public across a range of community 
health schemes or arrangements. These schemes or 
arrangements form the infrastructure through which the 
Irish health system funds a significant proportion of primary 
care to the public. The schemes are operated by PCRS 
on the basis of legislation and/or government policy. 











The Finance Reform Programme continues to support 
the progression of the one of the key non-clinical strategic 
priorities of the HSE, namely to implement a single modern 
integrated financial management and procurement system 
(IFMS) across the Irish health service. This system, along 
with the standard national processes it will support, aims 
to change how Finance operates in the health service. 
It will enable our finance teams to better support our 
services in operating within their available resources while 
also enhancing their ability to deliver and demonstrate value 
for patients.
During 2019, work continued on the process designs, 
chart of accounts and enterprise structure in respect 
of the IFMS project. The HSE concluded the successful 
procurement of an external systems implementation support 
partner in 2019. Preparation for the national design and 
build stage commenced in December 2019.
Activity Based Funding
The HSE continued to progress the embedding of activity 
based funding (ABF) in 2019. This form of funding is in 
place to varying extents in a number of HSE service areas 
including Primary Care Reimbursement Service, NHSS 
and acute hospitals.
Additionally, as part of the Sláintecare plan, the HSE has 
prepared a 3 year ABF development plan which has been 
submitted to the DoH for its consideration and approval 
prior to publication.
Outlook for 2020
The HSE is very conscious of the overall service levels, 
and significant savings requirements, set out in the National 
Service Plan (NSP) 2020, which was adopted by the Board 
in November 2019, and approved by the Minister in 
December 2019.
Since the early part of 2020, the population of Ireland, 
and indeed the world, have been experiencing the impact 
of the current and on-going Coronavirus pandemic, or 
COVID-19 as it has been designated by the World Health 
Organisation (WHO).
The HSE has clearly flagged that it will not be possible 
to deliver on many of the savings measures set out in 
NSP 2020 due to the need to apply resources to the 
COVID-19 response as it continues to develop along 
with the requirement to maintain all existing capacity 
and open additional capacity as part of that response.
The HSE’s Department of Public Health Officials who 
play a very significant role in supporting the HSE in the 
management of the on-going COVID-19 pandemic report 
to the Chief Clinical Officer (CCO) and their costs are 
reported in corporate support services.
The HSE acknowledges that the on-going COVID-19 
measures have placed significant additional pressure 
on many of our staff, particularly our front line and clinical 
staff who are giving their all and who have our utmost 
respect and appreciation.










During 2019, there were two distinct governance 
arrangements in place within the HSE.
During the period 01 January to 27 June the Health Service 
Executive (HSE) Directorate was the governing body of the 
HSE under the Health Service Executive (Governance) Act 
2013, with the Director General accountable to the Minister 
for Health.
Since 28 June the Board is the governing body of the 
HSE and is accountable to the Minister for Health for the 
performance of its functions. The Chief Executive Officer 
(CEO) is in turn accountable to the Board and is responsible 
for managing and controlling generally the administration 
and business of the HSE. The HSE exercises a wide range 
of statutory functions which may have significant implications 
both for individuals and for the public generally.
Under the Health Service Executive (Governance) Act 2019, 
the Minister for Health can issue directions to the HSE on the 
implementation of Ministerial and government policies and 
objectives and determine priorities to which the HSE must 
have regard in preparing its Service Plan. The HSE must 
comply with directions issued by the Minister for Health.
In line with the implementation of the recommendations of 
Sláintecare with regard to governance, the establishment 
of an independent Board was an important step in 
modernising and strengthening governance arrangements 
and sustaining reform.
2. Role of the HSE Board
Board Duties and Responsibilities
In accordance with the Health Act 2004 (as amended) 
the Board has the following key functions:
• It is the governing body of the Executive with authority, 
in the name of the Executive, to perform the functions 
of the Executive
• It is required to satisfy itself that appropriate systems, 
procedures and practices are in place
(i) to achieve the HSE’s objectives
(ii) for the internal performance and accountability 
in respect of the HSE’s:
a. performance of its functions
b. achieving its objectives in accordance with 
the corporate plan
(iii) to enable compliance with the policies (whether set 
out in codes, guidelines or other documents, or any 
combination thereof) of the Government or a Minister 
of the Government to the extent that those policies 
may affect or relate to the functions of the Executive.
• It is required to establish and implement arrangements 
for the management of the performance of the Chief 
Executive Officer.
The Board is accountable to the Minister for the performance 
of its functions above and shall inform the Minister in writing 
of any matter that it considers requires the Minister’s attention.
Under the Code of Practice for the Governance of State 
Bodies (2016), the Board is collectively responsible for 
leading and directing HSE’s activities within a framework 
of prudent and effective controls which enables risk to be 
assessed and managed.
The Board is required to act on a fully informed and ethical 
basis, in good faith, with due diligence and care, and in the 
best interest of the State body, having due regard to its legal 
responsibilities and the objectives set by Government.
The Board is responsible for holding the CEO and senior 
management to account for the effective performance 
of their responsibilities. It is the responsibility of the CEO 
and his senior management team to ensure that the Board 
is provided with all the necessary information to enable it to 
perform its functions. The CEO must also provide assurance 
to the Board that the functions which it has delegated to him 
are being appropriately discharged.
In line with the Code, the HSE Board does its job by 
executing its role in terms of:
• Providing Leadership – by having plans that are aligned 
with government objectives and policies and ensuring 
that there is best use of resources in achieving these 
plans
• Providing oversight to management
• Setting high ethical standards
• Compliance
• Collective responsibility
• Providing advice to the Minister.
On its establishment the Minister for Health set out the 
Board’s key priorities as follows:
• Developing and implementing an effective Corporate 
Governance Framework, incorporating clinical 
governance, and a performance management and 
accountability system.
• Developing a plan for building public trust and confidence 
in the HSE and the wider health service.
• Ensuring the HSE’s full support for and implementation 
of the Government’s programme of health reform as 
set out in the Sláintecare Implementation Strategy.
• For 2019, exercising effective budgetary management, 
including improving the value achieved with existing 
resources and securing target saving, with the objective 
of delivering the National Service Plan within Budget.









Governance Statement and 
Board Members’ Report 2019
2.1 Decision Making, Oversight and Control
The Board has established the following mechanisms 
to ensure that it exercises appropriate decision-making, 
oversight and control of the HSE’s functions.
2.1.1 Delegation Policy Framework and 
Governance Arrangements
The HSE’s Delegation Policy Framework and Governance 
Arrangements list the functions that have been delegated 
by the Board to the CEO, and by the CEO in turn to his 
Executive Management Team. Provision is also made in 
law for employees to whom functions have been delegated 
or sub-delegated to further sub-delegate those functions.
2.1.2 Reserved Functions
The Board has a formal schedule of matters specifically 
reserved to it for decision (reserved functions) to ensure 
that the direction and control of the HSE is firmly in its hands 
(some of the matters may require Ministerial approval). The 
reserved functions of the Board are listed in the Delegation 
Order issued to the CEO and include:
• The adoption of the HSE’s Corporate Plan with 
appropriate objective, indicators and targets 
against which performance can be measured
• Reviewing and guiding strategic direction and 
major plans of action
• Risk management policies and procedures
• Approval of annual service plans and budgets
• Setting performance objectives
• Monitoring implementation, and evaluating 
the HSE’s performance
• Overseeing major capital expenditure and 
investment decisions, and
• Approval of the HSE’s annual accounts and 
annual reports.
2.1.3 Schedule of Attendance, Fees and Expenses
In accordance with Part 3A of the Health Act 2004 (as 
inserted by Section 16K of the Health Service Executive 
(Governance) Act 2013), the Directorate were required to 
hold no fewer than one meeting in each of 11 months of 
the year. For the period 01 January – 27 June 2019, the 
HSE Directorate met on 10 occasions. See Table 10A.
In accordance with Schedule 2, paragraph 2A of the Health 
Act 2004, (as amended by Section 32(b) of the Health Service 
Executive (Governance Act 2019), the Board are required 
to hold no fewer than one meeting in each of 11 months 
of that year. Since its establishment on the 28 June 2019, 
the HSE Board have met on nine occasions holding six 
monthly Board meetings and three additional meetings. 
The attendance at Board meetings is recorded in Table 10A. 
The Board meetings deal with the reserved functions and 
other key areas.


















Anne O’ Connor       –   – 8 €526.00
Dean Sullivan           10 €11,041.00
Colm Henry          – 9 €5,101.00
Rosarii Mannion     –      9 €4,555.00
Stephen Mulvany  –         8 n/a
Liam Woods –       – – – 6 €3,903.00
Paul Reid 
(Appointed 14/05/2019) – – – – – – –    3 €3,411.00

























(Chairperson)    –      8 €39,996
Deirdre Madden*
(Deputy Chairperson)      –    8 n/a
Fergus Finlay          9 €7,500
Aogán Ó Fearghaíl     –     8 €7,500
Sarah McLoughlin          9 €7,500
Fiona Ross          9 €7,500
Mark Molloy    – –   – – 5 €7,500
Fergus O’Kelly          9 €7,500
Brendan Lenihan          9 €7,500
Yvonne Traynor    –      8 €7,500
Tim Hynes         – 8 €7,500
*  Deirdre Madden does not receive a fee in respect of her membership of the HSE Board under the one person one salary rule. 
However an equivalent value is made to University College Cork in relation to backfilling her post.




Ciarán Devane (Chairperson) €3,090.06 
Deirdre Madden (Deputy Chairperson) €2,569.69
Fergus Finlay n/a









The Board is responsible for holding the CEO and Senior 
Management to account for the effective performance 
of their responsibilities. It is the responsibility of the CEO 
and his Senior Management Team to ensure that the Board 
is provided with all the necessary information to enable it to 
perform its functions. The CEO must also provide assurance 
to the Board that the functions which it has delegated to him 
are being appropriately discharged.










The Health Service Executive (Governance) Act 2019 
provides for the establishment of an Audit Committee and 
any other Committees that the Board deem as necessary 
for the purpose of providing assistance and advice in relation 
to the performance of the Board’s functions.
The previous Audit Committee and Risk Committees of the 
HSE which had been established in 2014 in accordance with 
the provisions of the 2013 Act were stood down and an Audit 
and Risk Committee, was established on 26 July 2019 in 
accordance with the provisions of the 2019 Act.
Along with the establishment of an Audit and Risk Committee, 
the Board has established three other Committees to provide 
more detailed oversight of specific areas as defined in the 
respective Committee’s terms of reference. Terms of reference 
for the Board Committees are published on the HSE’s website 
https://www.hse.ie/eng/about/who/board-members/
committees-of-the-board/ and are subject to periodic 
review.
These Committees are:
• People and Culture Committee
• Performance and Delivery Committee
• Safety and Quality Committee.
Each of these Committees operates under an agreed 
Chairperson who is a Board member and membership is 
made up of no fewer than three Board members and no 
fewer than four independent external personnel. All 
Committee members have the relevant skills and experience 
to perform the functions of the relevant Committee. Each 
external member has a letter of appointment and a specific 
term of office.
Committees are entitled to request the attendance of any 
HSE manager/staff member to attend and present at a 
meeting of the Committee and this provision is used regularly 
by the Committees. Where the Committee is not satisfied with 
the detail contained in verbal or written updates by managers, 
it reserves the right to seek further information and additional 
attendance before the Committee if deemed necessary.
Each Committee Chairperson provides an update at each 
Board meeting on the work of their Committee since the 
previous Board meeting. Copies of the approved minutes of 
Committee meetings are circulated to each Board member 
on a regular basis. A detailed Action Log is maintained for 
each Committee to record and track actions arising from 
meetings of the Committee and these are reviewed at each 
meeting to ensure appropriate actions are being progressed.
While the Audit and Risk Committee provide oversight 
and advice with regards to the overall operation of Risk 
Management, each Committee reviews relevant risk within 
their area of responsibility to ensure that there is appropriate 
and effective managing of risk.
Oversight of the HSE’s Corporate Risks has been allocated 
to the Committees as follows:
Audit and Risk Committee
• Capital infrastructure and critical equipment
• Cyber security
• Organisational reputation
• ICT systems and Infrastructure
• System of internal controls including management 
and prioritisation of resource allocation
• Children’s Hospital
• HSE Funded agencies
• Brexit.
People and Culture Committee
• Medical and clinical workforce
• Managing change including culture change
• Safety, health and wellbeing of staff
• Individual Performance management and accountability
• Industrial action and Business Continuity.
Performance and Delivery
• Capacity and access demand
• Disability services
• Policy and legislation development and implementation.
Safety and Quality Committee
• Current configuration of hospitals





In order to prepare the agenda for forthcoming meetings 
and to follow up on outstanding actions, Committee 
members meet for a period in the absence of members 
of HSE management. The Committee takes comfort and 
assurance from and works in concert with the work of other 
Board Committees, each of which has a specific remit as 
documented in their own terms of reference. Liaison between 
the four Committees of the Board is provided through regular 
engagement between the Committee Chairpersons, sharing 
of minutes and with a joint meeting of the Audit and Risk and 
Safety and Quality Committees taking place early in 2020 to 
consider issues of mutual significance.
External members of Committees are entitled to fees, and 
these are sanctioned by the DoH and DPER. Fees are paid 
to the majority of external members apart from those who are 
already public servants. There is a set rate for each meeting 
they attend up to a maximum amount each year and this is 
processed through payroll.









For the period 01 January – 27 June, the following applied:
• Risk Committee Chairperson – Rate per meeting €402.39 
to a maximum of €2,414 per annum
• The fee sanctioned by the DoH and DPER for the 
Chairperson of the Statutory Audit Committee is the rate 
for the Chairperson of a category 4 non-commercial state 
body which is €8,978 per annum.
All other members – Rate per attendance at meeting is €285 
to a maximum of €1,710 per annum.
Audit and Risk Committee
The Audit and Risk Committee is established and maintained 
in accordance with Section 40H of the Health Act 2004 as 
amended by Section 23 of the Health Service Executive 
(Governance) Act 2019. The legislation also recognises that the 
Audit Committee has a role to provide oversight and advice on 
risk management. Therefore, its title has been expanded to the 
‘Audit and Risk Committee’ to reflect the full nature of its remit.
Legislation obliges membership of the Committee to comprise 
no fewer than three Board members and not fewer than four 
other persons who, in the opinion of the Board, have the 
relevant skills and experience to perform the functions of the 
committee, at least one of whom shall hold a professional 
qualification in accountancy or auditing.
Under current legislation the Committee is required to:
• Advise the Board and the CEO on financial matters 
relating to its function
• Report in writing at least once in every year to the Board 
and CEO on those matters and on the activities of the 
Committee in the previous year and provide a copy of 
that report to the Minister.
The functions of the Audit and Risk Committee include a 
range of financial, statutory, compliance and governance 
matters as set out in legislation.
In support of its statutory remit, the Committee has established 
terms of reference approved by the Board. These provide for 
the Committee’s role to extend to the following areas:
• Advising the Board and the CEO on financial matters 
and carrying out related reporting activities, including 
compliance reporting to the Board and the Minister 
for Health as required
• Reviewing the appropriateness of HSE’s accounting 
policies, annual financial statements, annual report and 
required corporate governance assurances and any 
matters and advice relating to making a satisfactory 
recommendation of same to the Board
• Providing oversight to the operation of HSE internal 
controls and, in particular, advising on the 
appropriateness, effectiveness and efficiency 
of the HSE’s procedures relating to public procurement 
and the acquisition, holding and disposal of assets
• Providing oversight and advice in relation to the HSE 
Internal Audit function
• Providing oversight and advice with regard to the 
operation of the HSE Risk Management framework and 
related activities within the function of risk management
• Providing oversight and advice relating to anti-fraud 
policies, oversight of the operation of protected disclosure 
policies and processes, and arrangements for special 
investigations
• Reviewing the arrangements for, and results of, internal 
and external audits and management’s response to 
the recommendations and points arising from same
• Any other roles and responsibilities devolved to the 
Committee by the HSE Board.
The CEO is required to ensure that the Audit and Risk 
Committee is provided with all the Executive’s audit reports, 
audit plans and monthly reports on expenditure, and if he 
has reason to suspect that any material misappropriation 
of the Executive’s money, or any fraudulent conversion or 
misapplication of the Executive’s property, may have taken 
place, report that matter to the Audit and Risk Committee 
as soon as practicable.
In addition, the CEO provides to the Audit and Risk Committee 
information on any financial matter or procedure necessary 
for the performance of its functions by the committee when 
requested to do so by the Audit and Risk Committee and 
where such information relates to:
a. Any contract that the Executive proposes to enter 
into involving expenditure of an amount in excess 
of a threshold specified by the committee, and
b. Any legal proceedings taken or threatened against the 
Executive that may give rise to potential financial liability.
In order to provide for the maximum continuity between 
the two Committees, the Chairperson of the previous 
Committee remained in place until the end of December 
2019. In addition, another member of the previous Audit 
Committee was joined by two members of the old Risk 
Committee on the new Audit and Risk Committee as well 
as one additional external member.
The Audit and Risk Committee has agreed a detailed workplan 
to cover 2020 which seeks to address in a systematic and 
comprehensive manner the key roles and responsibilities of 
the committee. In preparing its initial workplan for 2019 and 
subsequently for 2020, the Committee took account of the 
workplans of both the previous Audit Committee and the 
previous Risk Committee where relevant and incorporated 
elements into new workplans.
The CEO has assigned the following members of the HSE 
Senior Management Team to attend meetings of the Audit 
and Risk Committee. The Chief Financial Officer, the National 
Director of Internal Audit and the National Director of Quality 
Assurance and Verification.
















Fee Paid for Period
01 January – 30 June
2019
Tom O’ Higgins (Chairperson)     €4,489
Patricia Barker  –  – €570
Richard George     €1,140
Ann Markey     n/a
Stephen McGovern     €1,140
Liam Woods (internal)  –  – n/a
Anne O’ Connor (internal) – – –  n/a






Fee Paid for Period
01 January – 30 June
2019
Sheila Ryan (Chairperson)    €1,207.17
Colm Campbell    €855
Laverne Mc Guinness    €855
Pat Kirwan    One Person One Salary rules
Peter Lachman –  – One Person One Salary rules
Anne Carrigy   – Received €570 for 
Risk Committee membership up 
until 08 April 2019
Bernie O’Reilly    €855
Colm Henry (internal)   – n/a
Margaret Murphy –   €570



















Fee Paid for Period
01 July – 31 December
2019
Tom O Higgins (Chairperson)       €4,489
Brendan Lenihan (Vice Chairperson)       Board Member
Fiona Ross       Board Member
Fergus Finlay  –     Board Member
Tim Hynes   – –  – Board Member
Ann Markey       €1,710
Colm Campbell  –  –   €855
Pat Kirwan    –   One Person One Salary rules
Martin Pitt – – – –  
Table 13B: Audit and Risk Committee Relevant Competency and Experience
Audit and Risk
Committee
Member 2019 Relevant Competency and Experience
Tom O Higgins (Chairperson) Chartered Accountant; Former PWC Partner; Former President of Chartered Accountants 
Ireland; Professional Independent Non Exec Director.
Brendan Lenihan 
(Vice Chairperson)
Chartered Accountant; Former President of Chartered Accountants Ireland; Professional 
Independent Non Exec Director; former financial executive and now consultant.
Fiona Ross Chairperson, CIÉ Group; Former Director CEO National Library of Ireland; Professional 
Independent Non Exec Director.
Fergus Finlay Former CEO of Barnardos; Former political adviser; columnist; Member of the Charities 
Regulatory Authority.
Tim Hynes Chief Information Officer AIB plc.
Anne Markey Chartered Accountant; Professional Independent Non Exec Director; former financial 
executive and now consultant.
Colm Campbell Retired Assistant Chief of Staff Irish Defence Forces with responsibility for Risk Management.
Pat Kirwan Deputy Director – State Claims Agency, with special responsibility for risk and operations.
Martin Pitt Chartered Accountant; former PWC Partner; Professional Independent Non Exec Director; 
Chairperson of Advisory Board of Northern Ireland Audit Office.









People and Culture Committee
The role of the People and Culture Committee is to enhance 
the environment that supports and values the staff of the 
health service in order to engage the talent and nurture 
the leadership capability of individuals and teams working 
together to drive the desired culture throughout the health 
service to deliver safer better healthcare.
In pursuit of its role, the Committee will provide strategic 
oversight of and advice on matters to support the ambition 
of the People Strategy to have the right people, with the 
right skills, in the right place and at the right time.
It will focus its attention on the key areas of: Leadership, 
Culture, Talent and Capability.
The Committee is not responsible for any executive functions 
and is not vested with any executive powers. In relation to its 
duties and functions, it fulfils an advisory and support role only.
The Committee is authorised by the Board of the HSE to use 
its oversight role to:
• Oversee the development of a person-centred open and 
learning culture that is caring and compassionate, which 
nurtures talent and inspires innovation and excellence
• Monitor the implementation of the HSE’s people mandate 
with a focus on improved governance with effective 
performance and accountability
• Assure the Board that these arrangements are robust 
and effective and support the delivery of its objectives
• Review risks relating to its people mandate and advise on 
management mechanisms and actions to improve these
• Seek any information or explanations that it requires from 
any employee of the HSE or agency totally or partially 
funded by the HSE
• Obtain independent legal or professional advice procured 
in accordance with the HSE’s procurement policy
• Seek the attendance of persons with relevant experience 
and expertise at the People and Culture Committee 
meeting as necessary
• Report on and escalate any matter it deems relevant 
to be brought to the attention of the Board.
A detailed workplan focused on these areas has been 
adopted by the People and Culture Committee covering 
key roles and responsibilities of the committee to ensure 
that all areas within its remit and terms of reference receive 
the appropriate focus. The committee took account of the 
implementation plan developed for the People Strategy.
The CEO has assigned the following members of the HSE 
Senior Management Team to attend meetings of the People 
and Culture Committee: Anne Marie Hoey, National Director 
of Human Resources, Dr Philip Crowley, National Director of 
Quality Improvement and Dr Paul Connors, National Director 
of Communications.
Table 14: People and Culture Committee Membership, Attendance and Remuneration




Fee Paid for Period
01 July – 31 December
2019
Yvonne Traynor (Chairperson)    Board Member
Aogán O’Fearghail    Board Member
Mark Molloy   – Board Member
Sarah Mc Loughlin –   Board Member
Bernie O’ Reilly    €855









Performance and Delivery Committee
The role of the Performance and Delivery Committee is 
to advise the Board on all matters relating to performance 
within the health service to ensure that such performance 
is optimised across all relevant domains of the agreed 
balanced-scorecard to ensure better experience for 
patients and service users.
In pursuit of its role, the Committee provides strategic 
oversight of and advice on matters relating to planning for, 
developing and monitoring of relevant plans to ensure that 
they are delivering on the Board’s objectives.
Attention is focused on the key areas of performance 
achievement, improvement and learning in the context of 
an appropriate accountability framework and an incremental 
approach to developing a comprehensive scorecard.
The Committee is authorised by the Board of the HSE 
to use its oversight role in relation to:
• All aspects of performance and delivery within 
the health service
• Progress in relation to delivery of the Board’s objectives
• Development of strategic and annual service plans
• Assuring the Board that these plans are comprehensive, 
robust and appropriately reflect the priorities of the 
Minister and of the Board
• Performance against such plans
• Use of technology to improve performance and 
to report on performance achievement
• Review high-level risks relating to performance delivery
• Seek any information or explanations that it requires from 
any employee of the HSE or agency totally or partially 
funded by the HSE
• Obtain independent legal or professional advice procured 
in accordance with the HSE’s procurement policy
• Seek the attendance of persons with relevant experience 
and expertise at the Performance and Delivery Committee 
meeting as necessary
• Receiving reports on the identification of risks to staff 
safety and overseeing development plans to anticipate 
and respond to such risk with the aim of creating and 
maintaining a safe working environment and reducing 
adverse events
• Report on and escalate any matter it deems relevant 
to be brought to the attention of the Board.
A detailed workplan has been adopted by the Performance 
and Delivery Committee covering key roles and responsibilities 
of the committee to ensure that all areas within its remit and 
terms of reference receive the appropriate focus.
The CEO has assigned the following members of the 
HSE Senior Management Team to attend meetings of 
the Performance and Delivery Committee: Anne O’Connor, 
Chief Operations Officer, Dean Sullivan, Chief Strategy and 
Planning Officer, Stephen Mulvany, Chief Financial Officer.
Table 15: Performance and Delivery Membership, Attendance and Remuneration






Fee Paid for Period
01 July – 31 December
2019
Tim Hynes (Chairperson)      Board Member
Brendan Lenihan      Board Member
Fergus Finlay      Board Member
Sarah Mc Loughlin      Board Member
Louis Flynn –     One Person One Salary rules
Regina Moran –   –  €855









Safety and Quality Committee
Given the profile and nature of services provided by the 
HSE, the Board decided on the establishment of a specific 
Committee to focus on the clinical aspects of the provision 
of health and personal social care. Accordingly, it established 
a Safety and Quality Committee.
The scope of the Committee’s authority extends to all aspects 
of safety and quality within the public health service. The role 
of the Committee is to provide strategic oversight of and 
advice on:
• the Patient and Service User Safety Framework
• the Quality Assurance Framework
• the Quality Improvement Framework of the HSE.
The Committee is not responsible for any executive functions 
and is not vested with any executive powers. In relation to 
its duties and functions, it fulfils an advisory and support role 
only. The Chairperson of the National Independent Review 
Panel reports to the Committee Chairperson.
The Committee has established terms of reference approved 
by the Board. These provide for the Committee’s role to 
extend to the following areas:
• Overseeing the development and implementation 
of National Programmes and Strategies relevant 
to the safety and quality agenda of the HSE
• Overseeing the development of a national suite 
of tested key safety and quality performance indicators 
and measuring and monitoring safety improvements 
against them
• Scrutinising quality and safety assurance in areas such 
as but not limited to: regulatory reports, incident reports, 
health care audit reports, clinical complaints and risk
• Monitoring the implementation of new safety practices 
and ensuring that appropriate systems and programmes 
are in place to support staff in implementing and nurturing 
a culture of safety and quality improvement
• Receiving reports on the identification of risks to 
both patient and service user safety and overseeing 
development plans to anticipate and respond to such 
risk with the aim of creating and maintaining safe 
systems of care and reducing adverse events
• Reviewing the effectiveness of the systems established 
by management to identify, assess, manage, monitor 
and report on risks, by receiving regular reports from 
the relevant National Director
• Reviewing and endorsing the National Service Plan and 
related annual work programmes of the relevant National 
Director service areas as they relate to safety and quality 
and advising the Board on the adequate resourcing and 
appropriate positioning of these functions within the HSE
• Overseeing the implementation of good practice to ensure 
that lessons learnt from incidents, reviews, reports, 
complaints, claims and other channels are acted upon in 
a timely manner underpinned by effective communication
• Providing assurance that appropriate systems are in 
place to ensure compliance with all statutory obligations 
imposed on the HSE relating to patient and service user 
safety and quality matters
• Championing the establishment of collaborative working 
relationships across the health service between 
professions to improve the safety and quality of care.
A detailed workplan has been adopted by the Safety and 
Quality Committee covering key roles and responsibilities 
of the committee to ensure that all areas within its remit 
and terms of reference receive the appropriate focus. 
The committee took account of the workplan of the 
previous Risk Committee during its deliberations and 
incorporated all relevant elements into new workplan.
The CEO has assigned the following members of the HSE 
Senior Management Team to attend meetings of the Safety and 
Quality Committee: Dr Colm Henry, Chief Clinical Officer, Patrick 
Lynch, National Director of Quality Assurance and Verification 
and Dr Philip Crowley, National Director of Quality Improvement.
Table 16: Safety and Quality Membership, Attendance and Remuneration






Fee Paid for Period
01 July – 31
December 2019
Deirdre Madden (Chairperson)      Board Member
Mark Molloy     – Board Member
Fergus O’ Kelly  –   – Board Member
Yvonne Traynor   –   Board Member
Margaret Murphy  – – – – €285
Cathal O Keeffe      One Person One Salary rules
Anne Carrigy –     €855
Chris Luke – –    €855









Support to the Board and Committees
The Secretary of the HSE Board acts as Secretary to the 
Committees and additional administrative support is provided 
through the Office of the Board.
Disclosures Required by the Code of Practice 
for the Governance of State Bodies (2016)
The Board is responsible for ensuring that the HSE has 
complied with the requirements of the Code of Practice for the 
Governance of State Bodies (‘the Code’), as published by the 
Department of Public Expenditure and Reform in August 2016.
The following disclosures are required by the Code.
Employee Short-Term Benefits
Employee short-term benefits in excess of €60,000 are 
set out in note 7 of the Annual Financial Statements.
Consultancy Costs*
Consultancy costs include costs of external expert analysis 
and advice to management which contributes to decision 
making or policy direction. It excludes outsourced ‘business 
as usual’ functions.






Legal Advice 220 5,038
Tax and Financial advisory -11 348
Public Relations/Marketing 227 575
Human Resources and Pensions 400 896
Strategic Planning and Business Improvement 6,414 8,658
IT Consultancy 2,829 2,352
Other 15,712 23,529
Total Consultancy Costs 25,791 41,396
Total consultancy costs further analysed as follows:
Consultancy costs capitalised – –
Consultancy costs charged to Income and Expenditure and Retained Revenue Reserves 25,791 41,396
Total Consultancy Costs 25,791 41,396
* Included in Note 8 Non Pay Expenditure, Office and Administration Expenses, Legal and Professional Fees.
Legal Costs and Settlements*
Table 18 below provides a breakdown of amounts recognised as expenditure in 2019 in relation to legal costs, settlements 
and conciliation and arbitration proceedings relating to contracts with third parties. This does not include expenditure incurred 
in relation to general legal advice received by the HSE which is disclosed in Consultancy costs shown above in Table 17.









Table 18: Legal Costs and Settlements





Legal fees – legal proceedings 17,920 15,789
Conciliation and arbitration payments 97 91
Settlements 1,616 2,833
Total 19,633 18,713
* Included in Note 8 Non Pay Expenditure, Office and Administration Expenses, Legal and Professional Fees.
There are no costs in relation to on-going matters involving other State bodies.
The number of cases covered by the above legal costs amounted to 1,964 in 2019 (2018: 1,671).
Additional legal costs and settlements were paid by the HSE’s Insurance Company. The legal costs associated with claims 
processed by the State Claims Agency under the terms of the Clinical and General Indemnity Schemes are disclosed in 
Note 11 of the Annual Financial Statements.
Travel and Subsistence Expenditure*
Table 19 below provides a breakdown of travel and subsistence as follows:
Table 19: Travel and Subsistence Expenditure





Travel and subsistence expenditure is categorised as follows:
Domestic
– Directorate 21 31
– Employees 72,553 67,719
International
– Directorate 4 8
– Employees 789 904
Total 73,367 68,662
* Included in Note 8 Non Pay Expenditure, Office and Administration Expenses, Legal and Professional Fees.
Hospitality Expenditure*
The aggregate total expenditure incurred in relation to hospitality 
was €Nil. All entertainment type expenses disclosed in the 
financial statements relate to Client/Patient clinical programmes 
and are disclosed under Miscellaneous/Recreation.
*  Included in Note 8 Non Pay Expenditure, Office and 
Administration Expenses, Legal and Professional Fees.
Statement of Compliance
The HSE has complied with the requirements of the Code of 
Practice for the Governance of State Bodies, 2016 and has 
put in place procedures to ensure compliance with the Code













This Statement on Internal Control represents the position 
for the year ended 31 December 2019. It sets out the Health 
Service Executive’s approach to, and responsibility for, Risk 
Management, Internal Controls and Governance.
1.  Responsibility for the System 
of Internal Control
On behalf of the Health Service Executive (HSE) I acknowledge 
the Board’s responsibility for ensuring that an effective system 
of internal control is maintained and operated. This statement 
has been prepared in accordance with the requirement set out 
in the Department of Public Expenditure and Reform’s (DPER’s) 
Code of Practice for the Governance of State Bodies (2016).
The Health Act 2004 as amended by the Health Service 
Executive (Governance) Act 2019 made provision for the 
establishment of a board (the “Board”), which is the HSE’s 
governing body, with authority, in the name of the HSE, to 
perform its functions. The Board is accountable to the Minister 
for Health for the performance of its functions. The amended 
2004 Act also provides for a Chief Executive Officer (CEO) 
who is accountable to the Board. The Board must satisfy 
itself that appropriate systems of internal control are in place.
The Board is required to review the controls and procedures 
adopted by the HSE in order to provide itself with reasonable 
assurance that they are adequate to secure compliance by the 
HSE with its statutory and governance obligations. The Board 
is also responsible for strengthening governance, oversight 
and performance. The Board members have sufficient 
experience and expertise relating to matters connected with 
the functions of the HSE to enable them to make a substantial 
contribution to the effective and efficient performance of those 
functions. The amended 2004 Act also provides for the 
establishment of an Audit and Risk Committee and such 
other committees or sub-committees that the Board deem 
necessary to assist it in the performance of its functions.
The Board has established four committees to provide more 
detailed oversight of specific areas as defined in the respective 
committee’s terms of reference. These committees are:
• the Audit and Risk Committee
• the Performance and Delivery Committee
• the Safety and Quality Committee
• the People and Culture Committee.
Terms of reference for the Board Committees are published 
on the HSE’s website, and are subject to periodic review.
2.  Purpose of the System 
of Internal Control
The system of internal control is designed to manage and 
reduce risk rather than to eliminate risk and as such the 
review of the system of internal control is designed to provide 
reasonable but not absolute assurance of effectiveness. 
The system of internal control seeks to ensure that assets 
are safeguarded, transactions are authorised and properly 
recorded and that material errors and irregularities are either 
prevented or detected in a timely manner.
The system of internal control is also designed to ensure 
appropriate protocols and policies are in place and operating 
effectively in the context of clinical and patient safety.
The system of internal control, which accords with guidance 
issued by DPER, has been in place in the HSE for the year 
ended 31 December 2019, and up to the date of approval 
of the financial statements, except for the control issues 
outlined below.
3.  Capacity to Handle Risk
The Board, as the governing body of the HSE, has overall 
responsibility for the system of internal control and risk 
management. The Board may establish committees to 
provide assistance and advice in relation to the performance 
of its duties and functions.
The Audit and Risk Committee, was established on 
26 July 2019 in accordance with the provisions of the 
2019 Act. This Audit and Risk Committee replaced the 
previous Audit Committee and Risk Committee which 
were previously established in 2014 in accordance with 
the provisions of the Health Service (Governance) Act 2013. 
The membership of the Audit and Risk Committee consists 
of an independent external Chairperson, three other external 
members and four members of the Board. All members have 
the relevant skills and experience to perform the functions of 
the Committee including highly experienced and qualified 
finance professionals.
Among its responsibilities the Audit and Risk Committee 
is required:
• to advise the Board and the CEO on financial matters 
relating to their respective functions and a number of 
compliance matters related to same
• to provide advice to the Board and the CEO on the 
regularity and propriety of transactions recorded in 
the accounts and on the effectiveness of the system 
of internal control operated by the HSE
• to provide oversight and advice with regard to the 
operation of the HSE Risk Management framework 
and related activities
• to provide oversight and advice in relation to the HSE 
Internal Audit Function.









Statement on Internal Control
The Audit and Risk Committee operates under an agreed 
Charter which sets out in detail the role, duties and authority 
of the Committee. The Audit and Risk Committee is required 
to meet at least four times annually. In 2019 the Audit and 
Risk Committee met on six occasions since its appointment 
in June. The previous Audit Committee met on four occasions 
and the previous Risk Committee met on three occasions 
with a joint meeting of the Audit and Risk Committees on 
one further occasion.
The HSE has an Internal Audit function with appropriately 
trained personnel operating in accordance with a written 
charter approved by the Audit and Risk Committee.
The National Director of Internal Audit reports to the Audit 
and Risk Committee and to the CEO and is a member 
of the HSE Executive Management Team (EMT). The work 
programme of Internal Audit is agreed and monitored by 
the Audit and Risk Committee.
The HSE’s Internal Audit function is responsible for ensuring 
that a comprehensive programme of audit work is carried out 
continually throughout the HSE. The purpose of this work is to 
provide assurance that controls and procedures are operated 
in accordance with best practise and with the appropriate 
regulations and to make recommendations for the 
improvement of such controls and procedures. The scope 
of the Internal Audit function covers all systems and activities 
throughout the HSE including bodies funded by the HSE.
During 2019 Internal Audit completed a substantial body of 
work as part of its annual risk based work plan, issuing 164 
audit reports, containing 1,159 recommendations, in relation 
to HSE and its funded agencies. Particular focus was placed 
on auditing funded agencies as well as ICT audits. The 
findings of these reports were considered by the HSE 
Audit and Risk Committee and EMT.
Based on the work of Internal Audit and the results of the 
individual internal audit engagements, the 2019 Annual 
Report of the National Director of Internal Audit provided an 
overall audit opinion that limited assurance can be provided 
in respect of governance, risk management and financial 
control processes.
The Internal Audit opinion is based on the following three 
possible ratings and their definitions:
Type of Overall 
Opinion Rating Definition
1. Adequate Overall there is an adequate system 
of governance, risk management 
and control.
2. Limited There are weaknesses within the 
governance, risk management 
and control framework which need 
to be addressed.
3. Unsatisfactory The system of governance, risk 
management and control has 
substantial weaknesses that need 
to be addressed urgently.
The HSE has developed an integrated risk management 
policy which clearly defines the roles and responsibilities for 
all levels of staff in relation to risk (financial and non-financial). 
The policy is communicated across all levels of staff. The 
HSE is committed to ensuring that risk management is seen 
as the concern of everyone, is embedded as part of normal 
day to day business and informs the strategic and operational 
planning and performance cycle.
Management at all levels of the HSE are responsible to the 
CEO for the implementation and maintenance of appropriate 
and effective internal control in respect of their respective 
functions and organisations. This embedding of responsibility 
for the system of internal control is designed to ensure not 
only that the HSE is capable of detecting and responding to 
control issues should they arise, with appropriate escalation 
protocols, but also that a culture of accountability and 
responsibility pertains throughout the whole organisation.
Informed by the Scoping Inquiry into the CervicalCheck 
Screening Programme (Scally Report) the EMT commissioned 
a Risk Management Working Team to prepare proposals in 
relation to risk management in the HSE.
This working group was comprised of key senior HSE 
management representing all National service areas, 
Community Healthcare Organisations (CHOs) and Hospital 
Groups. It was sponsored by the National Director, Quality 
Assurance and Verification and was supported by external 
risk management experts.
This review was completed in 2019 and the review report 
and recommendations were accepted by the Board in 
September 2019.
The recommendations of the Review include the need 
for the HSE to:
• Adopt an Enterprise Risk Management (ERM) approach
• Establish an ERM Programme
• Appoint a dedicated Chief Risk Officer.
Implementation of the recommendations of this working 
group will be progressed in 2020.
The HSE has an established Healthcare Audit function 
which forms a key part of Quality Assurance and Verification. 
The Healthcare Audit Team consists of appropriately trained 
personnel. The purpose of this team is to provide assurance 
that controls and procedures related to the delivery of 
healthcare are operated in accordance with best practise 
and with the appropriate regulations and to make 
recommendations for the improvement of such controls 
and procedures. The scope of the Healthcare Audit Team 
covers all systems and activities throughout the HSE 
including bodies funded by the HSE.
The work programme of healthcare audit is agreed with 
the Safety and Quality Committee (previously the Risk 
Committee). During 2019, the healthcare audit team 
completed 56 audits and the findings which were considered 
by the HSE Safety and Quality Committee.









The annual work programme of Internal Audit is co-ordinated 
with the work programme of the healthcare audit function and 
in 2020 this will be further developed to involve joint audits.
The HSE Performance and Delivery Committee has been 
set up to provide the Board with advice on all matters relating 
to performance within the health service to ensure that such 
performance is optimised across the relevant domains of the 
agreed balanced-scorecard to ensure better experience for 
patients and service users.
The HSE Safety and Quality Committee provide advice to 
the Board in relation to Patient Safety and Quality issues.
The HSE People and Culture Committee provide advice to the 
Board on all matters relating to staff and workforce planning.
All HSE Committees meet regularly in line with their specific 
charters and fulfil an additional monitoring role on behalf of 
the Board.
4.  Risk and Control Framework
Management of risk is an integral part of good governance. 
The HSE has developed an Integrated Risk Management 
policy which has been guided by the principles of risk 
management outlined in ISO 31000 (ISO 31000 is an 
internationally recognised standard informed by experts 
in the area of risk management). This policy, and its guidance 
documentation, has been updated and communicated to all 
relevant staff. The Quality and Patient Safety leads in service 
areas facilitate and support staff in the application of this policy.
The HSE’s risk management policy involves proactively 
identifying risks that threaten the achievement of objectives 
and putting in place actions to reduce these to an acceptable 
level. The policy sets out the risk management processes 
in place and details the roles and responsibilities of staff 
in relation to risk. Risk management is the responsibility 
of all managers and staff at all levels within the HSE.
The CEO is responsible for leading and directing the HSE’s 
activities, including the development of the risk management 
policy. The HSE’s risk management framework is approved 
by the Audit and Risk Committee and by the Board.
The Audit and Risk Committee on behalf of the Board provide 
oversight and advice on the operation of the HSE’s Risk 
Management Framework.
Risk registers are in place at key levels in the organisation. 
These identify the key risks facing the HSE. Risks on these 
registers have been assessed and evaluated according to 
their significance. At an organisational level the Corporate 
Risk Register is subject to monitoring and updating on a 
quarterly basis. The risk registers set out the existing controls, 
the risk rating and any additional controls required to mitigate 
each risk, and assigns both persons and timescales for 
completion of these. An aspect of the quarterly monitoring 
process is to monitor the completion of additional controls 
required and to re-evaluate the risk based on this.
At the end of 2019 the EMT undertook a major revision of the 
Corporate Risk Register. This was approved in February 2020.
The responsibility for the management of claims from clinical 
and operational incidents under the Clinical Indemnity Scheme 
(CIS) and General Indemnity Scheme (GIS) has been delegated 
to the State Claims Agency (SCA) under the National Treasury 
Management (Amendment) Act 2000. The SCA also provides 
specialist advice, including risk management advice, to the 
HSE which is supported by the electronic National Incident 
Management Reporting System (NIMS).
The HSE has in place an internal control framework which 
is monitored to ensure that there is an effective culture of 
internal control. The HSE’s Code of Governance is set out 
on hse.ie and includes the following:
(At the time of writing the Code of Governance is being 
updated to take account of the HSE’s current governance 
arrangements arising from the appointment of the Board in 
June 2019).
• The Code of Governance reflects the current behavioural 
standards, policies and procedures to be applied within 
and by the HSE, and the agencies it funds, to provide 
services on its behalf
• The Performance and Accountability Framework 
describes in detail the means by which managers 
in the health service, including those in CHOs and 
Hospital Groups will be held to account for performance 
in relation to service provision, quality and patient safety, 
finance and workforce
• There is a framework of administrative procedures in place 
including segregation of duties, a system of delegation 
and accountability, a system for the authorisation of 
expenditure and regular management reporting
• The HSE’s National Financial Regulations form an integral 
part of the system of internal control and have been 
designed to be consistent with statutory requirements 
and to also ensure compliance with public sector 
guidelines issued by DPER
• The HSE has in place a devolved annual budgetary 
system and each year the Minister for Health formally 
approves the annual National Service Plan. Defined 
accountability limits are set which are closely monitored 
by the National Performance Oversight Group (NPOG) 
on behalf of the CEO
• The HSE has in place a wide range of written policies, 
procedures, protocols and guidelines in relation to 
operational and financial controls
• The HSE carries out an annual comprehensive review 
of the system of internal control, details of which are 
covered in a later section of this report
• There are systems and controls aimed at ensuring the 
security of the information and communication technology 
systems within the HSE. This is an area of high priority 
for the HSE given the challenges of managing multiple 
systems across the entire HSE. There are on-going 
developments to improve security and to ensure that 
the HSE has the appropriate level of resources and skills 
to protect the integrity of its systems to ensure that data 
and information is protected.









Additionally an annual Controls Assurance Statement (CAS) 
must be completed by all senior management at Grade VIII 
and above. This statement requires management to confirm 
that they are aware of and comply with the key controls and 
the code of governance in place within the HSE.
5.  Procurement
The HSE has procedures and policies in place to ensure 
compliance with current procurement rules and guidelines. In 
procuring goods and services, all areas within the HSE must 
comply with the relevant procurement procedures which are 
set out in detail in the HSE’s National Financial Regulations.
Matters arising regarding controls over procurement are 
highlighted under heading 8 Internal Control Issues.
6.  On-going Monitoring 
and Review
Formal procedures have been established for monitoring 
control processes and control deficiencies and are 
communicated to those responsible for taking corrective 
action and to the Board and senior management. I confirm 
that the following on-going monitoring systems are in place:
• Key risks and related controls have been identified and 
there is a process in place to monitor the operation of 
these controls
• Reporting arrangements have been established at all 
levels where responsibility for financial management 
has been assigned
• There are regular reviews by senior management of 
periodic and annual performance and financial reports 
indicating HSE performance against budgets/forecasts
• There are regular reviews by the Department of Health 
of the HSE’s performance in terms of budget and service 
plans as well as including other key non-financial 
reporting such as workforce planning
• The CEO and EMT meet as part of normal business 
at least twice monthly
• There are monthly Board meetings which are attended 
by the CEO and members of the EMT
• All Committees of the Board meet regularly to review 
areas that fall under their specific remit and to provide 
advice and feedback to the Board
The National Performance Oversight Group (NPOG) has 
responsibility as part of the overall accountability process 
to oversee performance against the National Service Plan.
NPOG members meet on a monthly basis to review 
performance against the National Service Plan. A monthly 
report on performance is prepared for the CEO which 
includes details of any serious performance issues requiring 
formal escalation.
The CEO provides a performance update to the Board 
on a monthly basis which includes the relevant outputs 
from the NPOG.
Additionally as referenced in section 3 the Board has 
appointed appropriate committees to provide advice 
to the Board in the implementation of its functions.
The work of Internal Audit forms an important part of the 
monitoring of the internal control system within the HSE. The 
annual work plan of Internal Audit is informed by analysis of 
the key risks to which the HSE is exposed and is approved 
by the Audit and Risk Committee. The National Director of 
Internal Audit attends all Audit and Risk Committee meetings 
and has regular one to one meetings with the Chairperson 
of the Audit and Risk Committee as well as the CEO.
Monitoring and review of the effectiveness of the HSE’s 
internal controls is also informed by the work of the 
Comptroller and Auditor General (C&AG). Comments and 
recommendations made by the C&AG in his management 
letters, audit certificates or annual reports, are reviewed by 
the Board, EMT and the Audit and Risk Committee, and 
actions are taken to implement recommendations.
7.  Review of the Effectiveness of 
the System of Internal Control
I confirm that the HSE has procedures to monitor the 
effectiveness of its risk management and control procedures. 
The HSE’s monitoring and review of the effectiveness of the 
system of internal control is informed by the work of the internal 
and external auditors, the Audit and Risk Committee and senior 
management within HSE responsible for the development 
and maintenance of the internal control framework.
I confirm that the HSE conducted an annual review of the 
effectiveness of the Internal Controls for 2019 which took 
into consideration:
• Audit and Risk Committee minutes/reports
• Findings, recommendations and Audit Opinions from 
internal audit reports
• Annual Report of the National Director of Internal Audit
• Findings arising from the Internal Control Questionnaire
• Status of the recommendations of previous years’ reports 
on the Review of the Effectiveness of the System of 
Internal Control
• Recommendations from management letters of the C&AG
• The 2019 audit programme of the C&AG and in particular, 
the audit risks identified therein
• Reports of the Committee of Public Accounts
• Board and EMT minutes
• Minutes of steering group/working group/implementation 
groups etc.
• External reviews undertaken by the HSE to assist in 
identifying financial control issues and implementing 
revised policies and business processes
• HSE Corporate Risk Register quarterly review process
• Findings arising from the compliance monitoring 
arrangements with Section 38 and Section 39 agencies
• Feedback from the HSE’s Healthcare Audit function.









Annually the HSE requires all relevant senior staff at Grade 
VIII (or equivalent) and above to complete an internal control 
questionnaire (ICQ) which is designed to provide essential 
feedback in respect of key control and risk areas. This allows 
the HSE to monitor the effectiveness of key controls and to 
direct remediation activity where required.
The HSE has engaged an independent audit firm through 
a competitive process who have conducted a review of 
circa 6.5% of ICQ participants to validate the integrity 
of the responses.
The report on the review of the system of internal control 
will be considered by the Audit and Risk Committee, the 
CEO and EMT and by the Board of the HSE.
The results of the review indicate there is evidence that:
• The HSE has adopted a suite of internal policies and 
procedures, which form the basis of the internal control 
framework
• Where high level risks have been identified, mitigating/
compensating controls are generally in place
• Instances of non-compliance which may expose the 
HSE to material risk have been identified during this 
review process. However, there is evidence that in general 
there is a programme of activity or plans in development 
to improve the controls environment
• Awareness of the requirement for internal controls and 
accountability has increased during 2019 with a continued 
increase in the number of staff who completed the ICQ 
survey increasing significantly by a further 9%. Analysis 
indicates that most managers have a very high 
understanding and awareness of their responsibility 
in respect to internal controls. While this analysis 
indicates that most managers are reporting strong 
levels of compliance with internal controls there is still 
evidence of some continued lack of uniform consistency 
of responses in 2019 which indicates that further efforts 
are required in 2020 to improve understanding and 
compliance with internal controls.
• There is a growing awareness and understanding of 
the need for accountability and responsibility by HSE 
managers to ensure a strong system of internal control. 
However there is still evidence of a lack of understanding 
of the relevant core guidelines and policies across the 
organisation. Additional focus such as management 
and staff training sessions will be a key part of control 
improvement plans for 2020.
• Limited and not absolute assurance can be placed on 
the current system of internal control to mitigate and/or 
manage key inherent risks to which financial activities are 
exposed. Instances of non-compliance observed reduce 
the level of assurance that can be provided. Improvements 
in these areas will continue to receive significant focus 
from the HSE in the short to medium term.
The control weaknesses observed in the review are set out 
in section 8 Internal Control Issue’s along with management 
action that is being taken to address these issues.
8.  Internal Control Issues
i.  Integrated Financial Management 
and Procurement System (IFMS)
The HSE does not have a single financial and procurement 
system. The absence of such a system in the HSE presents 
additional challenges to the effective operation of the system 
of internal financial control. Numerous external reviews have 
reiterated the consensus amongst the finance community in the 
HSE that the current financial systems are not fit for purpose.
The absence of a single national system requires that 
significant work is undertaken manually to ensure that the 
local finance systems and the National Finance Reporting 
Solution are synchronised and reconciled. This approach 
is becoming increasingly challenging in the light of changes 
to organisational structure and the ageing of the systems.
A key element of the Finance Reform Programme is the 
implementation of a single national integrated financial 
management and procurement system, or IFMS, based on 
a set of agreed national standard finance and procurement 
processes, a single National Chart of Accounts and National 
Enterprise Structure and a new National Shared Services Model.
A significant enabler of the IFMS project is the development 
of a Financial Management Framework which defines the 
process, governance and controls required to demonstrate 
effective financial management practice across the health 
system. The Framework is a living document which has most 
recently been approved by the Finance Reform Programme 
(FRP) Steering Committee in June 2019. Development of 
the framework and associated strategies will continue as 
the programme progresses.
Following a properly procured public tender process SAP 
was selected as the software platform for IFMS in June 2017.
The procurement process for a System Integrator (SI) to 
support the HSE with the detailed design, build and testing 
of the system within SAP was concluded in September 2019 
and accordingly the Board approved the appointment of the 
SI in December 2019. The detailed design, build and test 
of the national system will be carried out during 2020 with 
deployment across the health system commencing in 2021.
It is anticipated that the IFMS programme will have 
successfully been rolled out to 80% of the public health 
system by the end of quarter 2 2024 with roll-out prioritised 
by areas of significant expenditure.









ii.  Compliance with Procurement Rules
The HSE incurs expenditure of approximately €2.7bn annually 
in relation to goods and services subject to procurement 
regulations that are set out in detail in the HSE’s National 
Financial Regulations and underpinned by EU Directive 
2014/24 and Public Procurement Guidelines for Goods 
and Services. In line with the revised code of practice for 
the governance of state bodies, and the public procurement 
policy framework, the HSE is required to ensure that all 
contracts that are for a value of €25k or above, are secured 
competitively in line with public procurement requirements 
and to report the levels of non-compliance identified.
The findings of the review of the internal control system 
indicates that compliance with procurement regulations 
remains an issue for the HSE, in particular in relation to 
lack of compliance with:
• Requirements to procure and source from valid contracts 
already in place
• Requirements for market testing, tendering and utilising 
competitive processes
• Requirements to report non-compliance as per DPER 
code and circulars.
Furthermore, the review has also identified that there is a lack 
of awareness of various procurement supports such as 
HBSPASS which is the HSE’s procurement contract 
information site which it is expected that all budget holders 
should be aware of and should utilise when procuring goods 
and services on the behalf of the HSE.
These 2019 control issues were identified by the on-going audits 
carried out by the HSE’s own Internal Audit function as well 
as by the results of the ICQ and controls assurance process.
The HSE cannot provide a definitive rate of procurement 
non-compliance. However the HSE expects to be in a 
position to provide this in respect of 2020. The HSE 
procurement team tasked with providing this analysis is 
currently re-deployed to on-going COVID-19 priority work-
streams. Management and Internal Audit’s monitoring of 
non-compliance indicates that compliance with procurement 
regulations remains an issue for the HSE.
The HSE is continuing to progress a programme of reform 
of its procurement function to improve compliance with 
public procurement regulations and to increase the usage 
of contracts awarded by the HSE and the Office of 
Government Procurement (OGP).
In the context of the HSE’s current procurement systems 
and lack of IFMS it is acknowledged that it will take a number 
of years to fully address procurement compliance issues.
The HSE has continued to progress a number of initiatives 
in 2019, organised around three key themes:
Sourcing
Health Business Service (HBS) Procurement have developed 
a rolling 3-year sourcing plan for the HSE which has the 
explicit aim of putting in place contracts for all procurable 
goods and services required by the HSE.
Currently compliant contract coverage of spend under 
management is at €1.2bn which is approximately 44% of the 
level of procurable spend in 2019. HSE Procurement have 
estimated based on the current pipeline of activity that this 
figure is expected to increase to €1.7bn or 63% of procurable 
spend by the end of 2020.
Supporting Infrastructure
• Assignment of responsibility for overseeing and managing 
related IT developments to an Assistant National Director 
in HBS Procurement.
• Enhanced stock control through on going roll-out of the 
National Distribution Centre (NDC) and roll out of Point 
of Use System (POS) stock management system in the 
CHOs and Hospital Groups.
• Continuing development of the Pricing and Assisted 
Sourcing System (PASS) which will continue to assist HSE 
staff by improving access and visibility of current contracts.
Compliance
• Finalisation of a three-year Compliance Improvement Plan 
2017-2020 in Q4 2016, which addresses identified 
non-compliance issues. Currently, a compliance 
improvement programme is being implemented in a 
systematic manner across selected CHOs and Hospital 
Groups working in conjunction with HBS Procurement.
• Development of an online procurement compliance report 
which provides detail of non-compliance to Service areas. 
This report is currently in use but is not yet fully populated 
for the entire HSE area. Once fully developed this report 
will be used to both identify non-compliance and as a 
benchmark monitoring tool as part of the Compliance 
Improvement Plan roll-out.
• Development of a digital Corporate Procurement Planning 
(CPP) toolset which will be available to each CHO and 
Hospital Group. This online tool is expected to provide 
bespoke analysis and information such as procurement 
activity, expenditure which is greater than €25K, 
compliance levels and savings.
Additionally the IFMS project will include state of the art 
procurement functionality. Key procurement business 
processes have been mapped and these will be used to 
assist in the design of improved lean business processes. 
This will result in improved compliance but will take a number 
of years to progress.
iii.  Governance of Grants to Outside Agencies
In 2019, circa €4.7 billion of the HSE’s total expenditure 
related to grants to outside agencies. The legal framework 
under which the HSE provides grant funding to agencies is 
set out in the Health Act 2004. Annually the HSE funds in 
excess of 2,000 agencies, ranging from the large voluntary 
hospitals in receipt of over €300m to small community based 
agencies in receipt of €500.









The HSE’s governance framework is consistent with the 
management and accountability arrangements for grants 
from Exchequer funding as set out in the instruction issued 
by DPER in September 2014, with one sanctioned exception 
in respect of prefunding arrangements.
Due to the specific nature of the funding arrangements with 
the S38 and S39 agencies, the HSE must continue to ensure 
timely funding particularly in respect of contractual pay and 
staffing costs which account for up to 80% of expenditure.
Before entering into any funding arrangement the HSE 
determines the maximum amount of funding that it proposes 
to make available along with the level of service to be provided 
for that funding. For the larger agencies, cash is disbursed by 
the HSE’s Treasury unit based on agreed cash profiles.
The system of internal control operating in individual funded 
agencies is subject to review on a sample basis by Internal 
Audit.
The requirement to submit financial reports and staffing 
returns and to hold monitoring meetings is dependent 
on the size of the agency.
During 2019, there were weaknesses identified by the HSE’s 
annual internal control review, via the Controls Assurance 
Review process, and Internal Audit reports particularly in the 
application of processes relating to monitoring and oversight 
of some agencies. The HSE has two types of contractual 
agreements with these agencies that are, in the main, tailored 
to reflect the level of funding in place.
• Service Arrangement (SA), health agencies in receipt 
of funding in excess of €250,000
• Grant Aid Agreement (GA), health agencies in receipt 
of funding of less than €250,000.
External and internal audits have found that:
• Monitoring meetings may not have been conducted at the 
frequency required in accordance with the HSE guidelines
• There was a lack of evidence of the review of required 
financial performance data, such as management 
accounts and activity data
• Contractual agreements relating to the provision of 
funding include a requirement for grantees to have 
appropriate risk management and governance 
arrangements in place and to comply with public 
procurement guidelines and public sector pay policy. 
Audits and Annual Compliance Statement (ACS) 
submissions indicate some gaps in governance 
arrangements, compliance in some incidents with 
legacy issues regarding public sector pay policy 
and, in particular, procurement remains an issue.
The steps being taken by the HSE in recent years to address 
the weaknesses identified are set out below. These initiatives 
have enabled the HSE, to a reasonable extent, to be satisfied 
that there are appropriate governance structures and 
procedures in place with these agencies.
• At the end of 2019, 91% (2018: 95%) of funding was 
covered by a completed SA/GA. Reports in this regard are 
circulated on a monthly basis to the service areas, CHOs 
and the Hospital Groups for their necessary attention.
• Briefing sessions on the Governance Framework for both 
HSE and agency staff were held in all CHOs in November 
and December 2019. These briefing sessions focused on 
the key fundamentals of the Governance Framework and 
in particular the requirement to have SAs and GAs 
completed by the end of February 2020.
• Annual Compliance Statements are required from all S38 
agencies (circa 74% of total funding) and S39 agencies in 
receipt of over €3 million (circa 14% of total funding). These 
agencies self-certify annually in respect of the governance 
procedures in place at Board and Executive level within 
their own organisation. The ACS process informs the 
HSE of any gaps in compliance which then allows the 
HSE to ensure that required improvements are considered.
• Annual Financial Monitoring Returns (AFMR) and Annual 
Financial Statements (AFS) are required to be received, 
recorded and reviewed by the CHO and HG staff. The 
Service Provider Governance (SPG) online system was 
further developed to enable the recording of the AFMRs 
and AFS reviews. Reports are produced from the SPG 
system and circulated to the CHOs and Hospital Groups. 
This allows for the timely monitoring of the receipt and 
review of the AFS and AFMR.
• The HSE is establishing Contract Management Support 
Units (CMSUs) in each of the nine CHOs. The CMSUs will 
be a key resource within the CHOs in terms of enhancing 
the level of management and oversight in respect of S38 
and S39 agencies funded by the CHOs. Four pilot sites 
are currently being put in place in CHOs 4, 6, 7 and 9. 
In addition CHOs 3, 5 and 8 are in the very early stages 
of design and development of their CMSUs. Currently 
an implementation group is working with representatives 
from these CHOs to develop appropriate CMSU 
processes. Among the key responsibilities for the 
CMSU will be to ensure that:
– AFS and AFMR of the relevant agencies are received 
and reviewed
– Key documentation such as Business plans, 
Chairpersons’ statements, Management accounts, 
evidence of Monitoring Review Meetings along with 
other key activity data are received and reviewed 
as required.
The HSE’s Compliance Unit will continue to act in an advisory 
and support role during the implementation of this initiative.
• In 2016, the HSE commenced an External Review of 
Governance at Board and Executive level in certain S38 
agencies. Currently 28 of these reviews have been 
completed and the remaining two are nearing completion. 
Chairpersons of the Boards of each of these agencies 
have received either a final report or a draft report to 
consider. Each review contains management responses 
with regard to recommendations set out in the reviews 
and a follow up process has been established in this 
regard. The follow up process requires the HSE to 









engage with the Chairpersons of the relevant Boards of 
the agencies to receive an update on progress plans with 
a further quarterly follow up process with the Agencies 
and the senior management staff in the CHOs and 
Hospital Groups.
• A procurement process for a rolling review programme 
has commenced. This rolling review programme is 
expected to include a number of S39 as well as the 
S38 agencies. These reviews would expect to draw from 
and build upon the work being completed in the current 
external review process. A five year cycle is envisaged 
with eight agencies being reviewed annually.
• Some of the larger S38 and S39 agencies have themselves 
used the outputs of the Annual Compliance Statement, 
Annual Financial Monitoring Return and the external 
reviews, to implement their own initiatives to enhance 
their Governance at Board level. Specifically this has 
had some positive impacts in key areas such as:
– Development of internal audit function
– Rotation of Boards
– Board Committee Structure
– Development of Codes of Conduct.
• In relation to the weaknesses identified in the area of 
procurement regarding S38 and S39 agencies, HBS 
continues to work with and provide on-going support to 
these agencies. All agencies receiving annual funding in 
excess of €150k have been provided with online access 
to the HBS Pricing and Assisted Sourcing System (PASS). 
This provides access for these agencies to the HBS/OGP 
contracts and Framework Agreements. A Corporate 
Procurement Plan Guidance for Health Agencies has been 
communicated along with training by HBS Procurement.
• On-going review of audit findings relating to the governance 
of grants to outside agencies is a priority for the HSE and 
there are established processes in place for following up 
on internal audit as well as external audit findings (local 
management and national management letters).
iv.  Information Communication Technology 
(ICT)
The Office of the Chief Information Officer (OoCIO) 
delivers and manages a full range of ICT services 
throughout the HSE and in part of the voluntary acute 
sector. The HSE have a base of over 50,000 users using 
approximately 1,817 applications and over 1,000 networked 
sites. In addition, the OoCIO provide a range of national 
applications to the acute voluntary sector and indirectly 
supports their user base. There are approximately 266 
ICT projects currently being progressed, of which about 
50 are large multi-annual programmes or projects. 
The OoCIO currently has 318 staff, a revenue budget 
of €51.26m and a capital budget of €85m.
Internal audits have identified weaknesses in the area 
of security controls across parts of the domain including 
application password protocols and the management of 
secure access. Weaknesses have been acknowledged in 
some of the areas audited in disaster recovery protocols, 
particularly in relation to older and legacy systems. The OoCIO 
is committed to improving controls in respect of cyber security. 
The OoCIO has a number of programmes underway 
to manage these weaknesses across our large domain. 
These include Windows 7 refresh programme, the single 
sign-on programme, other key infrastructure upgrades, 
and the upgrading of application software which will, 
over time, provide a means for the following:
• Single logon to domains and applications which ensures 
that all staff have unique and safe access to the domains 
and applications
• Single email platform to improve cross regional 
communication and collaboration
• Upgraded infrastructure with modern security features
• Upgraded applications and database technology.
Migration to a single digital identity for staff has commenced 
and will continue to be rolled out during 2020/2021 across 
CHOs, Hospital Groups and HBS, as well as central 
functions.
The OoCIO also has plans to improve resourcing to ensure 
that staff with the right blend of technology skills, are situated 
where needed most.
A formal review of ICT policies was launched in January 2020 
by the CIO, as part of normal operations within OoCIO this 
will be complete during Q3 of 2020. Following this review 
and the likely updating of some policies, OoCIO management 
intends to conduct a compliance exercise to assess and 
baseline the level of compliance with these policies. This 
compliance assessment will inform what further actions 
then need to be taken.
OoCIO management has initiated an Infrastructure Migration 
Programme which will migrate selected disaster recovery 
environments to the cloud. The initial stages of this 
programme will in turn inform a cloud services procurement 
to be commenced later this year. That procurement will 
include provision for disaster recoveries for all systems.
Further, the Internal Audit function in collaboration with 
external specialist ICT audit support will continue to 
conduct targeted audits on a risk management basis.
v.  Risk Management
As detailed in section 3 the HSE recognises the 
importance of a strong Risk Management Framework. 
The recommendations of the Risk Management Review were 
approved by the Board in September 2019. Implementation 
of these recommendations will be progressed during 2020.
The HSE acknowledges that the current and on-going 
COVID-19 pandemic poses a risk that the management 
actions identified in this section could be delayed due to the 
prioritisation of COVID-19 measures. The HSE’s priority at 
this time is to safeguard the people of Ireland that it serves 
and to reduce the spread of COVID-19. However, the HSE 
considers that the system of internal control is also a priority.










The report on the Review of Effectiveness of the System 
of Internal Control in the HSE has been considered by the 
HSE’s Audit and Risk Committee who have provided advice 
on same on behalf of the Board.
The HSE is an organisation undergoing significant change as 
well as facing a significant challenge in terms of its response 
to the current COVID-19 pandemic emergency facing the 
country. The HSE’s control systems still rely on the legacy 
financial systems of the former health bodies it replaced. 
These legacy systems will be replaced on a phased basis 
with a single national integrated financial and procurement 
system as detailed earlier in section 8.
The review of the system of internal control indicates 
that there are limitations and weaknesses observed in the 
HSE’s system of internal controls. However where these 
weaknesses have been observed there is some evidence of 
mitigation and/or management action plans that have been 
undertaken to reduce the risk exposure, sufficient to support 
the adoption of the Annual Financial Statements. However, 
these weaknesses taken in conjunction with the overall 2019 
limited audit opinion issued by the National Director of 
Internal Audit mean that the review can only provide limited 
assurance in respect of the system of internal control.
The HSE acknowledges that there is a requirement to 
improve overall levels of compliance with the system of 
internal control, and this is receiving senior management 
attention, however, it is encouraging to note that the 2019 
review indicates a continued growing awareness of the 
importance of improved accountability and responsibility 
at all levels of HSE staff, and stronger engagement with 
the controls assurance process for 2019.
The Board acknowledges that it has overall responsibility 
for the system of internal control within the HSE and will 
continue to monitor and support further development of 
controls. Progress will be reassessed in the 2020 Review 














Opinion on the financial statements
I have audited the financial statements of the Health Service 
Executive for the year ended 31 December 2019 as required 
under the provisions of Section 36 of the Health Act 2004. 
The financial statements comprise
• the statement of revenue income and expenditure
• the statement of capital income and expenditure
• the statement of financial position
• the statement of changes in reserves
• the statement of cash flows and
• the related notes, including a summary of significant 
accounting policies.
In my opinion, the financial statements
• properly present the state of the Health Service 
Executive’s affairs at 31 December 2019 and its 
income and expenditure for 2019
• have been properly prepared in accordance with 
the accounting standards specified by the Minister 
for Health as set out in the basis of preparation 
section of the accounting policies.
Basis of the opinion
I conducted my audit of the financial statements in accordance 
with the International Standards on Auditing (ISAs) as 
promulgated by the International Organisation of Supreme 
Audit Institutions. My responsibilities under those standards 
are described in the appendix to this report. I am independent 
of the Health Service Executive and have fulfilled my other 
ethical responsibilities in accordance with the standards.
I believe that the audit evidence I have obtained is sufficient 
and appropriate to provide a basis for my opinion.
Report on information other than the financial 
statements, and on other matters
The Health Service Executive has presented certain other 
information together with the financial statements. This 
comprises the annual report including the governance 
statement and Board members’ report, and the statement on 
internal control. My responsibilities to report in relation to such 
information, and on certain other matters upon which I report 
by exception, are described in the appendix to this report.
Procurement non-compliance
The statement on internal control discloses that compliance 
with procurement regulations remains an issue for the Health 
Service Executive, but that it is not yet in a position to 
quantify the value of its expenditure on goods and services 
where the procedures employed did not comply with 
procurement guidelines.
The statement on internal control sets out the steps 
being taken by the Health Service Executive to address 
its non-compliance with procurement rules, but it 
acknowledges that it will take a number of years 
to fully address procurement compliance issues.
Seamus McCarthy 
Comptroller and Auditor General
14 May 2020









Comptroller and Auditor General Report
For presentation to the Houses of the Oireachtas
Appendix to the report
Responsibilities of Board members
The members are responsible for
• the preparation of financial statements in the form prescribed 
under Section 36 of the Health Act 2004 and accounting 
standards specified by the Minister for Health
• ensuring the regularity of transactions
• assessing whether the use of the going concern basis 
of accounting is appropriate, and
• such internal control as they determine is necessary to 
enable the preparation of financial statements that are free 
from material misstatement, whether due to fraud or error.
Responsibilities of the Comptroller 
and Auditor General
I am required under Section 36 of the Health Act 2004 to 
audit the financial statements of the Health Service Executive 
and to report thereon to the Houses of the Oireachtas.
My objective in carrying out the audit is to obtain reasonable 
assurance about whether the financial statements as a whole 
are free from material misstatement due to fraud or error. 
Reasonable assurance is a high level of assurance, but 
is not a guarantee that an audit conducted in accordance 
with the ISAs will always detect a material misstatement 
when it exists. Misstatements can arise from fraud or 
error and are considered material if, individually or in the 
aggregate, they could reasonably be expected to influence 
the economic decisions of users taken on the basis of these 
financial statements.
As part of an audit in accordance with the ISAs, I exercise 
professional judgment and maintain professional scepticism 
throughout the audit. In doing so,
• I identify and assess the risks of material misstatement 
of the financial statements whether due to fraud or error; 
design and perform audit procedures responsive to those 
risks; and obtain audit evidence that is sufficient and 
appropriate to provide a basis for my opinion. The risk 
of not detecting a material misstatement resulting from 
fraud is higher than for one resulting from error, as fraud 
may involve collusion, forgery, intentional omissions, 
misrepresentations, or the override of internal control.
• I obtain an understanding of internal control relevant 
to the audit in order to design audit procedures that 
are appropriate in the circumstances, but not for the 
purpose of expressing an opinion on the effectiveness 
of the internal controls.
• I evaluate the appropriateness of accounting policies 
used and the reasonableness of accounting estimates 
and related disclosures.
• I conclude on the appropriateness of the use of the going 
concern basis of accounting and, based on the audit 
evidence obtained, on whether a material uncertainty 
exists related to events or conditions that may cast 
significant doubt on the Health Service Executive’s ability 
to continue as a going concern. If I conclude that a 
material uncertainty exists, I am required to draw attention 
in my report to the related disclosures in the financial 
statements or, if such disclosures are inadequate, to 
modify my opinion. My conclusions are based on the audit 
evidence obtained up to the date of my report. However, 
future events or conditions may cause the Health Service 
Executive to cease to continue as a going concern.
I communicate with those charged with governance regarding, 
among other matters, the planned scope and timing of the 
audit and significant audit findings, including any significant 
deficiencies in internal control that I identify during my audit.
Information other than the financial 
statements
My opinion on the financial statements does not cover the 
other information presented with those statements, and I 
do not express any form of assurance conclusion thereon.
In connection with my audit of the financial statements, I am 
required under the ISAs to read the other information presented 
and, in doing so, consider whether thwe other information is 
materially inconsistent with the financial statements or with 
knowledge obtained during the audit, or if it otherwise appears 
to be materially misstated. If, based on the work I have 
performed, I conclude that there is a material misstatement 
of this other information, I am required to report that fact.
Reporting on other matters
My audit is conducted by reference to the special considerations 
which attach to State bodies in receipt of substantial funding 
from the State in relation to their management and operation. 
I report if I identify material matters relating to the manner in 
which public business has been conducted.
I seek to obtain evidence about the regularity of financial 
transactions in the course of audit. I report if I identify any 
material instance where public money has not been applied 
for the purposes intended or where transactions did not 
conform to the authorities governing them.
I also report by exception if, in my opinion,
• I have not received all the information and explanations 
I required for my audit, or
• the accounting records were not sufficient to permit the 
financial statements to be readily and properly audited, or
• the financial statements are not in agreement with the 
accounting records.















Department of Health Revenue Grant 3(a) 16,471,023 15,221,624
Deficit on Revenue Income and Expenditure brought forward 3(b) (85,174) (139,871)
16,385,849 15,081,753
Patient Income 4 408,249 406,079




Clinical 6 & 7 3,842,649 3,530,941
Non Clinical 6 & 7 1,268,349 1,230,996
Other Client/Patient Services 6 & 7 895,811 860,838
6,006,809 5,622,775
Non Pay
Clinical 8 1,186,858 1,098,509
Patient Transport and Ambulance Services 8 74,724 69,522
Primary Care and Medical Card Schemes 8 3,285,665 3,176,042
Other Client/Patient Services 8 6,919 6,169
Grants to Outside Agencies 8 4,699,339 4,283,454
Housekeeping 8 269,512 259,042
Office and Administration Expenses 8 618,248 609,943
Other Operating Expenses 8 12,219 12,176
Long Stay Charges Repaid to Patients 9 1 193
Hepatitis C Insurance Scheme 10 641 484
Payments to State Claims Agency 11 390,939 318,690
Nursing Home Support Scheme (Fair Deal) – Private Nursing Home only 12 685,959 649,354
11,231,024 10,483,578
Total Expenditure 17,237,833 16,106,353
Net Operating Surplus/(Deficit) for the Year 60,462 (85,174)
All gains and losses with the exception of depreciation and amortisation have been dealt with through the Statement 
of Revenue Income and Expenditure and the Statement of Capital Income and Expenditure.
The primary financial statements of the HSE comprise the Statement of Revenue Income and Expenditure, Statement of Capital 
Income and Expenditure, Statement of Changes in Reserves, Statement of Financial Position and Statement of Cash Flows.
 
Ciarán Devane Paul Reid 
Chairperson Chief Executive Officer
13 May 2020 13 May 2020









Statement of Revenue Income and Expenditure







Department of Health Capital Grant 3(a) 678,113 500,771
Surplus on Capital Income and Expenditure brought forward 3(b) 16,356 8,322
694,469 509,093
Revenue Funding Applied to Capital Projects 1,665 1,607
Application of Proceeds of Disposals 2,979 4,199
Government Departments and Other Sources 13(c) 3,764 29,514
702,877 544,413
Expenditure
Capital Expenditure on HSE Capital Projects 13(b) 362,682 347,756
Capital Grants to Outside Agencies (Appendix 1) 13(b) 324,967 180,301
687,649 528,057
Net Capital Surplus for the Year 15,228 16,356
All gains and losses with the exception of depreciation and amortisation have been dealt with through the Statement 
of Revenue Income and Expenditure and the Statement of Capital Income and Expenditure.
The primary financial statements of the HSE comprise the Statement of Revenue Income and Expenditure, Statement of Capital 
Income and Expenditure, Statement of Changes in Reserves, Statement of Financial Position and Statement of Cash Flows.
 
Ciarán Devane Paul Reid 
Chairperson Chief Executive Officer
13 May 2020 13 May 2020









Statement of Capital Income and Expenditure







Notes €’000 €’000 €’000 €’000
Balance at 1 January 2018 (1,269,501) (130,072) 4,989,085 3,589,512
Transfer of (Deficit)/Surplus in accordance with 
Section 33(3) of the Health Act 2004, as amended 3(b) 139,871 (8,322) 131,549
Net (Deficit)/Surplus for the year (85,174) 16,356 (68,818)
Proceeds of Disposal Account 
– reserves movement 14 (593) (593)
Additions to Property, Plant and Equipment 
in the year 13(a) 305,257 305,257
State Investment in PPP Service Concession 
Arrangements 15,118 15,118
Less: Net book value of Property, Plant and 
Equipment disposed in year (10,674) (10,674)
Less: Depreciation charge in year 15 (181,774) (181,774)
Balance at 31 December 2018 (1,214,804) (122,631) 5,117,012 3,779,577
Balance at 1 January 2019 (1,214,804) (122,631) 5,117,012 3,779,577
Transfer of Deficit/(Surplus) in accordance with 
Section 33(3) of the Health Act 2004, as amended 3(b) 85,174 (16,356) 68,818
Net Surplus for the year 60,462 15,228 75,690
Proceeds of Disposal Account 
– reserves movement 14 0 0
Additions to Property, Plant and Equipment 
in the year 13(a) 333,735 333,735
State Investment in PPP Service Concession 
Arrangements 5,424 5,424
Less: Net book value of Property, Plant and 
Equipment disposed in year (8,268) (8,268)
Less: Depreciation charge in year 15 (195,572) (195,572)
Balance at 31 December 2019 (1,069,168) (123,759) 5,252,331 4,059,404
The primary financial statements of the HSE comprise the Statement of Revenue Income and Expenditure, Statement of Capital 
Income and Expenditure, Statement of Changes in Reserves, Statement of Financial Position and Statement of Cash Flows.
 
Ciarán Devane Paul Reid 
Chairperson Chief Executive Officer
13 May 2020 13 May 2020









Statement of Changes in Reserves







Property, Plant and Equipment 15 5,404,501 5,274,606
Financial Assets 360 2
Total Fixed Assets 5,404,861 5,274,608
Current Assets
Inventories 16 170,162 164,196
Trade and Other Receivables 17 451,204 410,853
Cash 21 353,605 114,128
Creditors (amounts falling due within one year) 18 (2,096,590) (1,962,936)
Net Current Liabilities (1,121,619) (1,273,759)
Creditors (amounts falling due after more than one year) 19 (174,031) (179,385)
Deferred Income 20 (49,807) (41,887)
Net Assets 4,059,404 3,779,577
Capitalisation Account 5,252,331 5,117,012
Capital Reserves (123,759) (122,631)
Revenue Reserves (1,069,168) (1,214,804)
Capital and Reserves 4,059,404 3,779,577
The primary financial statements of the HSE comprise the Statement of Revenue Income and Expenditure, Statement of Capital 
Income and Expenditure, Statement of Changes in Reserves, Statement of Financial Position and Statement of Cash Flows.
 
Ciarán Devane Paul Reid 
Chairperson Chief Executive Officer
13 May 2020 13 May 2020









Statement of Financial Position






Net Cash Inflow from Operating Activities 21 297,542 76,392
Cash Flow from Investing Activities
Interest paid on finance leases (935) (993)
Donation of Shares (358) 0
Capital expenditure funded from Capital Allocation – capitalised 13(b) (274,331) (261,051)
Capital expenditure funded from Capital Allocation – not capitalised 13(b) (413,317) (267,006)
State Investment in PPP Service Concession Arrangements – Movement 5,424 15,118
Payments from revenue re: acquisition of property, plant and equipment 
(net of trade-ins) 13(a) (59,404) (44,207)
Revenue funding applied to Capital 1,665 1,607
Receipts from sale of property, plant and equipment (excluding trade-ins) 14 2,979 3,607
Net Cash Outflow from Investing Activities (738,277) (552,925)
Cash Flow from Financing Activities
Capital Grant received 678,113 500,771
Capital receipts from other sources 13(c) 3,764 29,514
Payment of capital element of finance lease and loan repayments from 
Revenue funding (1,665) (1,607)
Net Cash Inflow from Financing Activities 680,212 528,678
Increase in cash and cash equivalents in the year 239,477 52,145
Cash and cash equivalents at the beginning of the year 114,128 61,983
Cash and cash equivalents at the end of the year 353,605 114,128
The primary financial statements of the HSE comprise the Statement of Revenue Income and Expenditure, Statement of Capital 
Income and Expenditure, Statement of Changes in Reserves, Statement of Financial Position and Statement of Cash Flows.
 
Ciarán Devane Paul Reid 
Chairperson Chief Executive Officer
13 May 2020 13 May 2020









Statement of Cash Flows
For the year ended 31 December 2019
Note 1 Accounting Policies
Statement of Compliance and 
Basis of Preparation
The financial statements have been prepared on an accruals 
basis, in accordance with the historical cost convention. Under 
Section 36(3) of the Health Act 2004, the Minister specifies the 
accounting standards to be followed by the HSE. The HSE 
has adopted Irish and UK Generally Accepted Accounting 
Principles (GAAP), FRS 102, in accordance with accounting 
standards issued by the Financial Reporting Council subject 
to the following exceptions specified by the Minister:
1. Depreciation is not charged to the Statement of Revenue 
Income and Expenditure, rather it is charged against the 
Capitalisation (Reserve) Account balance. Under GAAP 
depreciation must be charged in the Statement of 
Revenue Income and Expenditure.
2. Capital grants received from the State to fund the 
purchase of property, plant and equipment are recorded 
in the Statement of Capital Income and Expenditure. 
Under GAAP, capital grants are recorded as deferred 
income and amortised over the useful life of related 
property, plant and equipment, in order to match the 
accounting treatment of the grant against the related 
depreciation charge. Capital expenditure in relation to 
assets other than those purchased by way of service 
concession arrangement are recognised in the Statement 
of Capital Income and Expenditure as incurred. Under 
FRS 102, such expenditure is capitalised and charged 
to income and expenditure over the life of the asset.
3. Pensions are accounted for on a ‘pay as-you go’ 
basis. The provisions of FRS 102 ‘Section 28: Employee 
Benefits’ are not applied and the liability for future pension 
benefits accrued in the year has not been recognised in 
the financial statements.
4. Claims under the Clinical Indemnity Scheme which are 
paid by the HSE, and administered by the State Claims 
Agency on the HSE’s behalf, are accounted for on a ‘pay 
as-you go’ basis. This does not comply with FRS 102 
‘Section 21 – Provisions and Contingencies’. Details of 
the amount recognised in the Statement of Revenue 
Income and Expenditure in 2018, together with the 
actuarially estimated future liability attaching to this 
scheme at 31 December 2019, are set out in Note 11.
5. The Consultant Contract (2008) settlement was 
agreed between the State and medical consultants in 
June 2018 and provides for the payment of retrospective 
remuneration in 2019 and 2020 to eligible consultants, 
subject to compliance with the terms of the legal 
agreement. The estimated liability arising from the 
settlement has not been recognised in 2018. This is not 
compliant with FRS 102 Section 21 – Provisions and 
Contingencies, which requires the recognition of the 
liability due at the year-end date. Recognition of this 
remuneration will be matched with future funding allocated 
on a ‘receipts and payments’ basis in 2019 and 2020. 
Further detail on this matter is set out in Note 26.
The HSE financial statements are prepared in Euro and 
rounded to the nearest €’000.
Going Concern
The HSE is working with the Department of Health to 
implement the Sláintecare Plan and the proposed reform 
of the HSE central functions along with the introduction of 
new regional structures for the delivery of health and social 
services in Ireland. These programmes for Government are 
committed to the HSE, in its present form and it is assumed 
that all existing HSE activities will therefore continue. The 
Financial Statements for 2019 continue to be prepared 
on the going concern basis.
Income Recognition
Department of Health Revenue and Capital Grant
Monies to fund the health service are voted to the 
Department of Health (Vote 38). The Department of Health 
provides grants to the HSE in respect of administration, 
capital and non-capital services.
Section 33(1) of Health Act 2004, as amended provides that 
each year the Minister will issue a Letter of Determination to 
the HSE setting out the maximum expenditure it may incur 
in the relevant financial year. The final Letter of Determination 
in relation to 2019 was received on 23 December 2019.
In accordance with the accounting standards prescribed 
by the Minister, the HSE accounts for grants on an accruals 
basis. Accordingly, the amount specified in the Letter of 
Determination for the relevant financial year is recognised 
as income in that year.
Grant income in respect of administration and non-capital 
services is accounted for:
• in the Statement of Revenue Income and Expenditure 
where it is applied to non-capital areas of expenditure;
• in the Statement of Capital Income and Expenditure 
under the heading ‘Revenue Funding Applied to Capital 
Projects’ where non-capital grant monies is used to fund 
capital expenditure.
Grant income in respect of capital services is accounted 
for in the Statement of Capital Income and Expenditure.
Section 33(3) of the Health Act 2004, as amended, requires 
the HSE to manage and deliver services in a manner that is 
in accordance with an approved Service Plan and within the 
determination notified by the Minister. The Act provides for 
any deficits to be charged to income and expenditure in the 
next financial year and, subject to the approval of the Minister 
with the consent of the Department of Public Expenditure 
and Reform, for surpluses to be credited to income and 
expenditure in the next financial year.









Notes to the Financial Statements
Other Income
(i) Patient and service income is recognised at the time 
the service is provided.
(ii) Superannuation contributions from staff are recognised 
when the deduction is made (see pensions accounting 
policy below).
(iii) Income from all other sources is recognised when received.
Grants to Outside Agencies
The HSE funds a number of service providers and bodies 
for the provision of health and personal social services on 
its behalf, in accordance with the provisions of Sections 38 
and 39 of the Health Act 2004. Before entering into such an 
arrangement, the HSE determines the maximum amount of 
funding that it proposes to make available in the financial year 
under the arrangement and the level of service it expects to 
be provided for that funding. This funding is charged, in the 
year of account, to income and expenditure at the maximum 
determined level for the year, although a certain element may 
not actually be disbursed until the following year.
Leases
Operating Leases – Rentals payable under operating leases 
are dealt with in the financial statements as they fall due. 
Lease incentives are recognised over the lease term on 
a straight line basis.
Finance Leases – The HSE is not permitted to enter into 
finance lease obligations under the Department of Public 
Expenditure and Reform’s Public Financial Procedures, 
without prior sanction or approval from the HSE. Where 
assets of predecessor bodies have been acquired under 
finance leases, these leases have been taken over by the 
HSE on establishment. For these leases, the capital element 
of the asset is included in fixed assets and is depreciated 
over its useful life.
Assets purchased by way of finance lease are stated at initial 
recognition at an amount equal to the fair value of the leased 
property or, if lower, the present value of the minimum lease 
payments at inception of the lease. At initial recognition, a 
finance lease liability is also recognised at an amount equal 
to the fair value of the leased property or, if lower, the present 
value of the minimum lease payments.
In addition to the normal GAAP treatment for assets acquired 
under finance leases, the cost of the asset is charged to the 
Statement of Capital Income and Expenditure and the 
Capitalisation (Reserve) Account is credited with an equivalent 
amount. The outstanding capital element of the leasing 
obligation is included in creditors. Interest is calculated 
using the effective interest rate method and charged to 
income and expenditure over the period of the lease.
Capital Grants
Capital grant funding is recorded in the Statement of Capital 
Income and Expenditure. In addition to capital grant funding 
some minor capital expenditure is funded from revenue. 
The amount of this revenue funding expended in the year 
in respect of minor capital is charged in full in the Statement 
of Revenue Income and Expenditure in the year. This 
accounting treatment, which does not comply with generally 
accepted accounting principles, is a consequence of the 
exceptions to generally accepted accounting principles 
specified by the Minister.
Property, Plant and Equipment and 
Capitalisation Account
Valuation – Property, Plant and Equipment comprise Land, 
Buildings, Work in Progress, Equipment and Motor Vehicles.
• The carrying values of assets taken over from predecessor 
bodies by the HSE were included in the opening balance 
sheet on establishment day, 1 January 2005, at their 
original cost/valuation. The related aggregate depreciation 
account balance was also included in the opening 
Statement of Financial Position. On establishment 
of the HSE, land of predecessor bodies was included 
at valuation based on rates per hectare/square metre 
supplied by the Department of Health and Children 
following consultation with the Valuation Office. These 
valuations were last updated in 2002. The HSE continues 
to value land taken over from predecessor bodies using 
these rates. It should be noted that lands owned by the 
HSE are held for the provision of health and personal 
social services.
• Property plant and equipment additions since 1 January 
2005 are stated at historic cost less accumulated 
depreciation.
Capital Expenditure Recognition – In accordance with the 
accounting standards prescribed by the Minister, expenditure 
on property, plant and equipment additions is charged to 
the Statement of Revenue Income and Expenditure or the 
Statement of Capital Income and Expenditure, depending 
on whether the asset is funded by capital or revenue funding.
Capitalisation Policy – Capital funded assets and revenue 
funded assets are capitalised if the cost exceeds certain 
value thresholds: €2,000 for computer equipment and 
€7,000 for all other asset classes. Asset additions below this 
threshold and funded from revenue are written off in the year 
of purchase. Asset additions below this threshold funded 
from capital are included in Note 13(b) under ‘Expenditure on 
HSE projects not resulting in Property, Plant and Equipment 
additions’. A breakdown of asset additions by funding source 
is provided in Note 13(a) to the accounts.
Primary Care Centres acquired under Public Private Partnership 
(PPP) service concession arrangements are capitalised and 
accounted for using the finance lease liability model.









The value of the Primary Care Centre asset and the service 
concession liability is recognised as assets and liabilities in 
the Statement of Financial Position at amounts equal to the 
fair value of the leased property or, if lower, the present value 
of the minimum lease payments, each determined at the 
inception of the lease. Future minimum lease payments are 
calculated from the unitary charge payments set out in the 
contract, to be made directly by the HSE. The property 
elements of the unitary charge plus any reliably measured 
capital element of operational payments are used as the 
basis of the future minimum lease payments.
PPP service concession arrangements are accounted for in 
the HSE's accounts using the Capital Investment Approach. 
This provides for the accumulation of capital value reflecting 
the State’s equity in PPP property assets. Using this 
approach the PPP capital commitment is recognised in the 
Capitalisation (Reserve) Account at an amount equal to the 
related finance lease liability. Over the life of the concession, 
the reduction in the outstanding finance lease liability is 
amortised annually through the Statement of Capital 
Income and Expenditure with the corresponding entry 
to the Capitalisation (Reserve) Account.
Depreciation – In accordance with the accounting standards 
specified by the Minister for Health, depreciation is not charged 
to the Statement of Income and Expenditure over the useful life 
of the asset. Instead, a Statement of Financial Position reserve 
account, the Capitalisation Account, is the reciprocal entry 
to Property, Plant and Equipment. Depreciation is charged 
to the Property, Plant and Equipment and Capitalisation 
Accounts over the useful economic life of the asset.
Assets are not depreciated where they have been acquired 
or are managed under PPP service concession agreements 
which guarantee residual useful lives and operating capacity 
at the end of the concession term that would be equivalent to 
that of the asset when it was first commissioned. Other fixed 
assets, where subject to depreciation, are depreciated for 
a full year in the year of acquisition.
Residual value represents the estimated amount which would 
currently be obtained from disposal of an asset, after deducting 
estimated costs of disposal, if the asset were already of an 
age and in the condition expected at the end of its useful life.
Depreciation on all other property, plant and equipment is 
calculated to write-off the original cost/valuation of each 
asset over its useful economic life on a straight line basis 
at the following rates:
• Land: land is not depreciated.
• Buildings: depreciated at 2.5% per annum.
• Modular buildings (i.e. prefabricated buildings): 
depreciated at 10% per annum.
• Work in progress: no depreciation.
• Equipment – computers and ICT systems: depreciated 
at 33.33% per annum.
• Equipment – other: depreciated at 10% per annum.
• Motor vehicles: depreciated at 20% per annum.
On disposal of fixed assets both the Property Plant and 
Equipment and Capitalisation Accounts are reduced by 
the net book value of the asset disposal. An analysis of 
the movement on the Capitalisation Account is provided 
in the Statement of Changes in Reserves.
The Letter of Sanction for Capital provides for an allowance 
to re-invest proceeds of sale of fixed assets.
Public Private Partnerships Service 
Concession Agreements
The HSE has entered into a public private partnership (PPP) 
or service concession agreement with a private sector entity 
to design, build, finance and maintain infrastructure assets 
for a specified period of time (concession period). This is a 
single PPP contract for the delivery of fourteen Primary Care 
Centres (PCC).
The HSE controls or regulates what services the operator 
must provide using the PCC infrastructure assets, to whom, 
and at what price; and the HSE controls the residual interest 
in the assets at the end of the term of the concession period.
The HSE makes payments over the life of the concession 
for the construction, financing, operating, maintenance and 
renewal of the PCC infrastructure assets and the delivery 
of services that are the subject of the concession.
The contract entered into is on an availability basis and is for a 
25-year service period from the date of service commencement 
for each PCC, it is payable by way of an annual unitary charge. 
The unitary charge is subject to deductions for periods when 
the assets are unavailable for use.
Service charge elements of the unitary charge payments 
are expensed in the Statement of Capital Income and 
Expenditure. Obligations to make payments of an operational 
nature are disclosed in Note 22 to the financial statements.
Pensions
Eligible HSE employees are members of various defined 
benefit superannuation schemes. Pensions are paid to 
former employees by the HSE. The HSE is funded by the 
Department of Health on a pay-as-you-go basis for this 
purpose. Funding from the Department of Health in respect 
of pensions is included in income. Pension payments under 
the schemes are charged to the Statement of Revenue 
Income and Expenditure when paid, as follows:
(i) Superannuation paid to retired HSE employees is 
accounted for within the pay classification (see Note 6);
(ii) Superannuation paid to retirees from the voluntary health 
service providers are accounted for under grants to 
outside agencies within the non-pay classification (see 
Note 8 and Appendix 1).









Contributions from HSE employees who are members of the 
schemes are credited to the Statement of Revenue Income and 
Expenditure when received. Contributions from employees of 
the voluntary health service providers who are members of the 
scheme are retained as income of the health service provider.
No provision has been made in respect of pension benefits 
earned by employees and payable in future years under the 
pension scheme, consistent with the accounting treatment in 
previous years. This continues to be the treatment adopted by 
the HSE following the accounting specifications of the Minister.
The Public Service (Single Scheme and Other Provisions) 
Act 2012 introduced the new Single Public Service Pension 
Scheme (“Single Scheme”) which commenced with effect 
from 1 January 2013. All new staff members to the Health 
Service Executive, who are new entrants to the Public Sector, 
on or after 1 January 2013 are members of the Single 
Scheme. Single Scheme member contributions are paid 
over to the Department of Public Expenditure and Reform.
Additional Superannuation Contribution (ASC)
ASC was introduced and operative from 1 January 
2019 and replaces the Pension Related Deduction (PRD). 
Whereas PRD was a temporary emergency measure, ASC 
is a permanent contribution in respect of pension. Details of 
the amounts collected in respect of the ASC are set out in 
Note 5(a) to the Financial Statements.
Inventories
Inventories are stated at the lower of cost and net realisable 
value. Net realisable value is the estimated proceeds of sale less 
costs to be incurred in the sale of inventory. The HSE historically 
carries a provision against specific vaccine inventories and any 
other write-offs and adjustments for obsolescence are charged 
in the current year against revenue income and expenditure.
Patients’ Private Property
Monies received for safe-keeping by the HSE from or on behalf 
of patients are kept in special accounts separate and apart 
from the HSE’s own accounts. Such accounts are collectively 
called Patients’ Private Property accounts. The HSE is 
responsible for the administration of these accounts. However, 
as this money is not the property of the HSE, these accounts 
are not included on the HSE’s Statement of Financial Position. 
The HSE acts as trustee of the funds. Patients’ Private 
Property accounts are independently audited each year.
Critical Accounting Judgements and Estimates
The preparation of the financial statements requires the HSE 
to make significant judgements and estimates that effect the 
amounts reported for assets and liabilities as at the Statement 
of Financial Position date and the amounts reported for 
revenue and capital income and expenditure during the year. 
However the nature of estimation means that actual outcomes 
could differ from those estimates. The following judgements 
and estimates have had the most significant effect on 
amounts recognised in the financial statements:
Accounting for Bad and Doubtful Debts
Known bad debts are written off in the period in which they 
are identified. Specific provision is made for any amount 
which is considered doubtful. Provision is made for patient 
debts which are outstanding for more than one year.
Accrued Holiday Pay
Salaries, wages and employment related benefits are 
recognised in the period in which the service is received 
from employees. The cost of leave earned but not taken 
by employees at the end of the financial year is recognised 
in the financial statements to the extent that employees 
are permitted to carry forward unpaid annual leave into 
the following year. Due to different payroll systems across 
the HSE it was necessary to make assumptions in order to 
calculate the accrual. The assumptions underlying the holiday 
pay accrual, for which amounts are recognised in the financial 
statements, are determined (including employee profiles and 
the pattern of holidays taken) based on current conditions.
Primary Care Centres: Valuation, Depreciation, 
Residual Values and Future Minimum Lease Payments
Primary Care Centres (PCC) purchased by way of Public 
Private Partnership (PPP) service concession arrangements 
are capitalised and accounted for using the finance lease 
liability model.
The value of the PCC asset and the service concession 
liability is recognised as assets and liabilities in the Statement 
of Financial Position at amounts equal to the present value of 
the minimum lease payments.
Assets acquired under service concession agreements are, 
under specific contractual obligations in those agreements, 
handed back to the HSE at the end of the concession term 
with useful lives equivalent to that of the asset when originally 
commissioned. Performance of the ‘hand back’ provisions 
is guaranteed by significant financial retentions and penalties 
provided for in the concession agreements. As a result of 
these provisions the HSE does not charge depreciation 
on these assets.
Future minimum lease payments are calculated from the unitary 
charge payments set out in the construction contract financial 
model, to be made directly by HSE. The property elements of 
the unitary charge plus any reliably measured capital element 
of operational payments as used at the basis of the future 
minimum lease payments. In line with FRS 102, the effective 
interest rate is used to discount the future construction related 
liabilities arising from concession agreements. The HSE selected 
a discount rate of 3.32% after consultation with the National 
Development Finance Agency (NDFA), on the basis that it 
reflects an appropriate rate for long-term infrastructure assets.
The HSE have reviewed the asset lives and associated 
residual values of the Primary Care Centres and have 
concluded that the asset lives and residual values are 
appropriate.














Net operating surplus for the year is arrived at after charging:
Audit fees 594 540
Remuneration – Director General/CEO* 337 351
*  The CEO (14 May 2019 to 31 December 2019) received total remuneration of €264,314 comprising basic pay €224,359, allowances €30,288 
and benefit in kind (company car) €9,667.
The CEO is not a member of the HSE pension scheme and no employer pension contributions are made by the HSE on the behalf of the 
CEO. As a consequence, the CEO receives an equivalent allowance.






Tony O’Brien (resigned 11 May 2018) 0 3,990
Stephen Mulvany 0 275
Dr. Philip Crowley (resigned 31 January 2018) 0 1,222
John Connaghan (resigned 31 December 2018) 0 4,493
Dean Sullivan 11,041 8,671
Rosarii Mannion 4,555 6,419
Anne O’Connor (appointed 11 June 2018) 526 361
Liam Woods (appointed 01 January 2019, resigned 13 May 2019) 3,903 0
Dr Colm Henry (appointed 16 October 2018) 5,101 7,705
25,126 33,136
*  Directorate members’ expenses are from 1 January to 27 June 2019.
Prior to the establishment of the Board, and in accordance with the Health Service Executive (Governance) Act 2013, the 
governing body of the HSE was the Directorate which comprised of senior executives appointed by the Minister for Health who 
were persons employed as HSE National Directors or no less senior grade. In accordance with Government pay policy, public 
servants that sit on State Boards or who may be nominated to such boards independently of their public service employment 
are not paid remuneration in the form of board fees and their remuneration applies to their HSE executive roles only. No fees 
were paid to members of the Directorate. The Chief Executive Officer was appointed on the 28 June 2019 and had previously 
held the position of Director General of the Directorate since 14 May 2019. His total expenses for 2019 amounted to €3,411.














Ciarán Devane 3,090 0
Professor Deirdre Madden 2,570 0
Fergus Finlay 0 0
Fiona Ross 0 0
Mark Molloy (resigned 7 January 2020) 1,647 0
Dr Yvonne Traynor 278 0
Tim Hynes 0 0
Aogán Ó Fearghaíl 2,136 0
Dr Sarah McLoughlin 986 0
Brendan Lenihan 2,268 0
Professor Fergus O’Kelly 0 0
12,975 0
*  Board members’ expenses for 2019 are shown from the date of appointment.
The Board of the HSE was established on 28 June 2019 as governing body of the HSE in accordance with the Health Service 
Executive (Governance) Act 2019. The Act provides for a Chief Executive Officer who is accountable to the Board but is not a 
Board member. Fees are paid to Board members.









Note 3 Department of Health Revenue and Capital Grant





Net Revenue Funding allocated to HSE 17,149,136 15,722,395
Less: Capital Funding (678,113) (500,771)
Department of Health Revenue Grant 16,471,023 15,221,624





Revenue Grant – Funding allocation from the Department of Health 16,471,023 15,221,624
Less: Remittances from Department of Health between 1 January and 31 December (16,471,894) (15,220,753)
Revenue Grant balance due from Department of Health (up to Approved Allocation) 
carried forward 54,861 53,990
Revenue Grant balance due from Department of Health (up to Approved Allocation) 
as at 31 December 53,990 54,861
Capital Grant – Funding allocation from the Department of Health 678,113 500,771
Less: Remittances from Department of Health between 1 January and 31 December (678,113) (500,771)
Capital Grant balance due from Department of Health (up to Approved Allocation) 
carried forward 46 46
Balance forward utilised during the year 0 0
Capital Grant balance due from Department of Health (up to Approved Allocation) 
as at 31 December 46 46
Total Revenue and Capital Grant due from Department of Health, up to Approved 
Allocation, as at 31 December (Note 17) 54,036 54,907
3(b)  Transfer of (Deficit)/Surplus in accordance with Section 33(3) of the Health Act 2004, 
as amended
As outlined in the accounting policies, Section 33(3) of the Health Act 2004, as amended, requires that deficits arising in the 
preceding year must be charged to the Statement of Income and Expenditure in the current year. Accordingly, the HSE has 
charged the revenue operating deficit of €85.17 million at 31 December 2018 to the Statement of Revenue Income and 
Expenditure in 2019 and credited the capital operating surplus of €16.36 million at 31 December 2018 to the Statement 
of Capital Income and Expenditure in 2019.














Private Charges 276,052 278,246
Inpatient Charges 23,439 22,688
Emergency Department Charges 13,608 12,521
Road Traffic Accident Charges 5,902 6,051
Long Stay Charges 81,269 81,300
EU Income – E111 Claims 7,979 5,273
408,249 406,079






Superannuation Income 158,099 156,379
Additional Superannuation Contributions (ASC) deductions from HSE own staff 139,517 181,164
Additional Superannuation Contributions (ASC) deductions from service providers 76,506 81,959
Other Payroll Deductions 7,775 7,207
Secondment Recoupments of Pay 18,527 17,032
Agency/Services – provided to Local Authorities and other organisations 7,761 7,324
Canteen Receipts 11,930 12,474
Certificates and Registration Income 11,647 11,730
Parking 12,109 11,844
Refunds 12,530 12,268
Rental Income 4,463 4,369
Donations 2,750 2,800
Legal Costs Recovered 701 185
Income from other Agencies (See Note 5(b) analysis below) 25,609 13,403
Miscellaneous Income 14,273 13,209
504,197 533,347














Department of Foreign Affairs & Trade – Irish Aid: programme for overseas development 152 133
Friends of St. Luke’s Rathgar 390 211
Department of Arts, Heritage, Regional and Gaeltacht Affairs – Helicopter Services 183 151
Department of Children and Youth Affairs – Young Peoples Facilities and Services 0 1,113
Clinical Trials Ireland – Clinical Research Trials 1,035 925
EU Income – various projects 2,908 1,676
Genio Trust 4,226 2,038
Education and Training Boards/Solas 1,372 1,455
The Atlantic Philanthropies – Single Assessment Tool for the Elderly 0 64
The Atlantic Philanthropies – National Dementia Strategy 380 2,213
Department of Children & Youth Affairs/TUSLA – 
Galway Teen Parents Support Programme 39 239
Katherine Howard Foundation – Nurture 1,792 1,029
National Treatment Purchase Fund 10,499 1,937
Friends of Wexford General Hospital 44 174
Nursing and Midwifery Board of Ireland 107 37
Department of Justice – Irish Refugee Programme 257 8
Friends of Letterkenny University Hospital – Donation of X-Ray Imaging Machine 1,406 0
Enterprise Ireland 100 0
NEIC Development Grant 719 0
25,609 13,403
*  Only income from agencies in excess of €100,000 in either year are shown. Income from Other Agencies that did not exceed €100,000 in 
either year is shown at Note 5(a) under Miscellaneous Income. Accordingly, the 2018 comparatives above have been re-stated where appropriate.























Health and Social Care Professional 27,861 23,229
203,246 194,325
Non Clinical HSE Staff
Management/Administration 684,370 654,336
General Support Staff 331,607 336,526
Superannuation 181,186 177,077
1,197,163 1,167,939
Non Clinical Agency Staff
Management/Administration 30,010 24,301
General Support Staff 41,176 38,756
71,186 63,057
Other Client/Patient Services HSE Staff
Other Patient and Client Care 714,760 684,421
Superannuation 106,036 103,050
820,796 787,471
Other Client/Patient Services Agency Staff
Other Patient and Client Care 75,015 73,367
75,015 73,367
Total Pay Expenditure 6,006,809 5,622,775
























Basic Pay 2,405,532 874,799 523,543 3,803,874 3,624,693
Allowances 90,096 10,095 24,547 124,738 107,359
Overtime 146,861 13,526 27,365 187,752 179,886
Night duty 56,255 4,836 15,464 76,555 72,856
Weekends 110,499 24,454 55,948 190,901 181,040
On-Call 55,195 2,037 333 57,565 53,850
Arrears* 36,703 1,647 1,080 39,430 (47,121)
Wages and Salaries 2,901,141 931,394 648,280 4,480,815 4,172,563
Employer PRSI 278,008 84,583 66,480 429,071 391,956
Superannuation** 460,254 181,186 106,036 747,476 727,508
Total HSE Pay 3,639,403 1,197,163 820,796 5,657,362 5,292,027
Agency Pay 203,246 71,186 75,015 349,447 330,748
Total Pay 3,842,649 1,268,349 895,811 6,006,809 5,622,775
*  Note that the HSE has reversed a legacy provision of €68m relating to the ongoing consultants liability in its 2018 accounts, see ‘Arrears’. 
This has resulted in a one off benefit in the year which will not be replicated, see Note 26.
  Total Pay Costs above relate to HSE services only. Pay costs for employees in the voluntary sector are accounted for under Non-Pay 
Expenditure (Revenue Grants to Outside Agencies). See Note 8 and Appendix 1.
Superannuation
Eligible staff employed in the HSE are members of a variety of defined benefit superannuation schemes.
Superannuation entitlements (i.e. pensions) of retired staff are paid out of current income and are charged to income and 
expenditure in the year in which they become payable. In accordance with a Directive from the Minister for Health, no provision 
is made in the financial statements in respect of future pension benefits and no charge is made to the Statement of Revenue 
Income and Expenditure in respect of this. Superannuation contributions from employees who are members of these schemes 
are credited to the Statement of Revenue Income and Expenditure when received. No formal actuarial valuations of the HSE’s 
pension liabilities are carried out. The Pension charge to the Statement of Revenue Income and Expenditure for 2019 was 







Ongoing superannuation payments to pensioners 635,560 599,250
Once-off lump sums and gratuity payments 111,916 128,258
747,476 727,508














Termination benefits charged to Statement of Revenue Income and Expenditure 282 461
282 461
The termination benefits above relate to settlements with seven staff during 2019 (2018: five staff).
In addition to the payments outlined above, one staff member was granted added years on termination. The value of enhanced 
pension arrangements was €nil.
Legal costs of €274,759 (2018: €28,380) were also incurred in relation to concluding the termination agreements.
Note 7 Employment
The number of employees at 31 December by Area of Operation was as follows (in whole time equivalents (WTEs)):**
2019 2018*
Acute Services 33,917 33,351
Mental Health 9,513 9,446
Primary Care 9,923 10,250
Disability and Older Persons’ Services 16,428 16,439
Health and Wellbeing 573 576
Ambulance Services 1,933 1,887
Corporate and HBS 4,618 4,421
Total HSE employees 76,905 76,370
Voluntary Sector – Acute Services 26,230 25,228
Voluntary Sector – Non Acute Services 16,682 16,258
Sub-total Section 38 Sector employees*** 42,912 41,486
Total Health Sector Employees (including Home Helps)**** 119,817 117,856
Source: Health Service Personnel Census.
*  2018 figures are restated to reflect current methodology and organisational mappings.
**  All figures are calculated to 2 decimals and expressed as whole-time equivalents (WTE) under a methodology as set out by the Department 
of Health.
***  Health Sector staffing figures relate to direct employment levels as returned through the Health Service Personnel Census (HSPC) for the 
public health sector (HSE & Section 38 Voluntary Hospitals & Agencies).
****  Directly employed home help staff are included in reported WTE w.e.f. 2019 and historical figures have been restated to reflect 
this methodology change. Pre-registration Student Nurses on clinical placement are recorded at 50 percent actual WTE in line 
with WRC agreement.









Additional Analysis – Department of Expenditure and Reform Circular 13/2014 requirement
The number of HSE employees whose total employee benefits (including basic pay, allowances, overtime, night duty, 
weekends, on-call, arrears and excluding employer PRSI, employer pension costs) for the reporting period fell within 
each band of €10,000 from €60,000 upwards are as follows:
2019 2018
Pay Band (Number of Staff)
€60,001 to €70,000 8,613 8,028
€70,001 to €80,000 3,497 3,368
€80,001 to €90,000 2,206 1,839
€90,001 to €100,000 981 1,011
€100,001 to €110,000 581 485
€110,001 to €120,000 428 363
€120,001 to €130,000 162 179
€130,001 to €140,000 138 152
€140,001 to €150,000 129 142
€150,001 to €160,000 166 190
€160,001 to €170,000 171 168
€170,001 to €180,000 131 275
€180,001 to €190,000 124 247
€190,001 to €200,000 103 237
€200,001 to €210,000 78 117
€210,001 to €220,000 85 74
€220,001 to €230,000 87 72
€230,001 to €240,000 88 40
€240,001 to €250,000 128 24
€250,001 to €260,000 101 19
€260,001 to €270,000 136 13
€270,001 to €280,000 78 7
€280,001 to €290,000 65 7
€290,001 to €300,000 48 4
€300,001 to €310,000 38 4
€310,001 to €320,000 24 0
€320,001 to €330,000 20 2
€330,001 to €340,000 18 2
€340,001 to €350,000 1 0
€350,001 to €360,000 7 0
€360,001 to €370,000 3 0
€370,001 to €380,000 8 2
€380,001 to €390,000 1 0
€390,001 to €400,000 4 2
€400,001 to €410,000 1 0
€410,001 to €420,000 1 0
€420,001 to €430,000 1 1
€430,001 to €440,000 0 1
€440,001 to €450,000 1 0
€450,001 to €460,000 5 0
€500,001 to €510,000 1 0
€570,001 to €580,000 1 0
€610,001 to €620,000 0 1
Total HSE employees in excess of €60,001 18,459 17,076
*  The HSE does not have an integrated payroll system and this disclosure which is required by DPER circular 13/2014 has therefore been 
prepared from multiple payroll systems across HSE areas.















Drugs and Medicines (excl. demand led schemes) 326,693 303,458
Less Rebate from Pharmaceutical Manufacturers* (9,190) (10,402)
Net Cost Drugs and Medicines (excl. demand led schemes) 317,503 293,056
Blood/Blood Products 30,687 31,041
Medical Gases 12,420 11,197
Medical/Surgical Supplies 314,053 301,840
Other Medical Equipment 166,202 141,444
X-Ray/Imaging 37,671 34,163
Laboratory 141,806 128,621
Professional Services (e.g. therapy costs, radiology etc.) 104,268 99,131
Education and Training 62,248 58,016
1,186,858 1,098,509
Patient Transport and Ambulance Services
Patient Transport 57,534 53,473
Vehicles Running Costs 17,190 16,049
74,724 69,522
Primary Care and Medical Card Schemes
Pharmaceutical Services 2,406,513 2,329,147
Less Rebate from Pharmaceutical Manufacturers* (182,841) (135,459)
Less Prescription Levy Charges (85,334) (93,550)
Net Cost Pharmaceutical Services 2,138,338 2,100,138
Doctors’ Fees and Allowances 616,772 572,660
Pension Payments to Former District Medical Officers/Dependents 2,081 2,238
Dental Treatment Services Scheme 55,584 58,768
Community Ophthalmic Services Scheme 29,262 29,864
Cash Allowances (Blind Welfare, Mobility, etc.) 30,629 31,311
Capitation Payments:
Treatment Abroad Schemes and Related Expenditure 54,441 47,250
Intellectual/Physical Disabilities, Psychiatry, Therapeutic Services etc. 251,246 225,384
Elderly and Non-Fair Deal Nursing Home Payments 71,099 78,451
Rehabilitative and Vocational Training 21,362 22,461
Respite Beds 14,851 7,517
3,285,665 3,176,042
Other Client/Patient Services
Professional Services e.g. care assistants, childcare contracted services, etc. 5,686 4,989
Education and Training 1,233 1,180
6,919 6,169













Grants to Outside Agencies




Heat, Power and Light 65,770 68,709
Cleaning and Washing 108,225 99,500
Furniture, Crockery and Hardware 15,692 13,921
Bedding and Clothing 14,658 13,546
269,512 259,042
Office and Administration Expenses
Maintenance 120,600 113,910
Finance Costs 3,137 3,122
Prompt Payment Interest and Compensation 420 632
Insurance 6,349 6,138
Audit 594 540
Legal and Professional Fees 73,410 88,083
Bad and Doubtful Debts 29,171 22,448
Education and Training 14,224 22,183
Travel and Subsistence 73,367 68,662
Vehicle Costs 2,357 4,373
Office Expenses 147,549 144,206
Rent and Rates 71,527 68,894




Sundry Expenses 7,720 7,421
Burial Expenses 149 98
Recreation (Residential Units) 1,032 1,042
Materials for Workshops 353 299
Meals on Wheels Subsidisation 1,368 1,286
Ex Gratia Payments to Patients** 62 336
Refunds 642 737
12,219 12,176
*  In respect of 2016 IPHA Agreement and special arrangements for specific drugs and medicines.
**  This relates to CervicalCheck payments.









Note 9 The Health (Repayment Scheme) Act 2006
The Health (Repayment Scheme) Act 2006 provides the legislative basis for the repayment of what has been referred to as ‘long 
stay charges’, which were incorrectly levied on persons with full medical card eligibility prior to 14 July 2005. The scheme allows 
for the repayment of charges to the following people:
• Living people who were wrongly charged at any time since 1976
• The estates of people who were wrongly charged and died on or after 9 December 1998
A special account was set up which is funded by monies provided by the Oireachtas and from which repayments are made. 
An amount of €2m was set aside in 2019 for this purpose. The majority of this funding refers to a provision for payments that 
will arise as a result of follow-on claims and offer acceptances.
The scheme closed to new applicants on 31 December 2007 and nearly 14,000 claims have been received in respect of living 
patients and nearly 27,000 claims in respect of estates. Up to 31 December 2019, 20,300 claims were paid. As at December 
2019, there were no outstanding claims being processed to offer stage under the scheme. €0.5m has been provided in the 
HSE’s 2020 budget to fund repayments for outstanding claims and associated administrative costs.
The cumulative total expenditure of the scheme (including administrative costs) to 31 December 2019 is €485.82m.
In 2019, the following expenditure has been charged to the Statement of Revenue Income and Expenditure in respect 







Repayments to Patients 1 193
Payments to Third Party Scheme Administrator 0 0
1 193
Legal and Professional Fees 0 0
Office Expenses* 37 15
Total Non Pay 38 208
Total 134 326
*  All expenditure in relation to the Health (Repayment Scheme) Act 2006 is included in HSE expenditure.









Note 10 The Hepatitis C Compensation Tribunal (Amendment) Act 2006
The Hepatitis C Compensation Tribunal (Amendment) Act 2006 established a statutory scheme to address insurance difficulties 
experienced by persons infected with Hepatitis C and HIV through the administration within the State of blood and blood 
products. This scheme addresses the problems faced by these persons due to their inability to purchase mortgage protection 
and life assurance policies as a result of contaminated blood products being administered to them. The scheme covers the 
insurance risk for the 1,700 or more people entitled to avail of assurance products, regardless of any other medical conditions 
these people may have, once they pay the standard premium that an uninfected person of the same age and gender would 
pay. The life assurance element of the scheme was launched by the HSE in September 2007. A further element, providing 
for travel insurance cover, was introduced in March 2009.
The overall cost over the lifetime of the scheme was originally estimated at €90m. The cumulative expenditure on the insurance 
scheme to 31 December 2019 was €11m.








Payments of premium loadings 511 462
Payments of benefits underwritten by HSE 130 22
641 484
Office Expenses* 15 3
Total Non Pay 656 487
Total** 745 575
*  All expenditure in relation to the Hepatitis C Compensation Tribunal (Amendment) Act 2006 is included in HSE expenditure.
**  These costs are included in the Hepatitis C Insurance Scheme Special Account. Other Hepatitis C Costs are included in the Hepatitis C 
Special Account and the Hepatitis C Reparation Account.
Note 11 State Claims Agency
Since 1 July 2009, the HSE is funded for claims processed by the State Claims Agency under the terms of the Clinical Indemnity 
Scheme. From 1 January 2010, the National Treasury Management Agency (Delegation of Functions) Order 2009 extended 
the State indemnity to personal injury and third party property damage claims against the HSE. Awards paid to claimants 
under the terms of the scheme are accounted for on a pay-as-you-go basis. The State Claims Agency’s best current estimate 
of the ultimate cost of resolving each claim, includes all foreseeable costs such as settlement amounts, plaintiff legal costs and 
defence costs such as fees payable to counsel, consultants etc. In 2019, the charge to the Statement of Revenue Income and 
Expenditure was €390.94m (2018: €318.69m). Based on actuarial estimates, the charge to the Statement of Revenue Income 
and Expenditure is expected to increase significantly in future years. In accordance with the directions of the Minister for Health, 
no provision has been made for this liability in the financial statements.
The estimated liability is revised on a regular basis in light of any new information received for example past trends in settlement 
amounts and legal costs. At 31 December 2019, the estimated liability incurred to that date under the Clinical Indemnity Scheme 
and State indemnity was €3,302m (2018 €2,792m). Of this €3,302m, approximately €2,722m relates to active claims in respect 
of clinical care, with the balance of the estimated liability relating to non-clinical care claims. Active claims are those that have 
been notified to the State Claims Agency through legal process and that have not yet concluded as at the reporting date.









Note 12  Long-Term Residential Care (incorporating Nursing Homes 
Support Scheme/Fair Deal)
The Nursing Homes Support Scheme (Fair Deal) commenced in 2009 and phases out the former Nursing Homes Subvention 
Scheme and the ‘contract beds’ system for older persons. Under the scheme, people who need long-term residential care 
services have their income and assets assessed, and then contribute up to 80% of assessable income and up to 7.5% per 
annum of the value of the assets they own, subject to a maximum period of three years in respect of their principal private 
residence, towards the cost of their care. The HSE pays the balance, if any, of the costs of their care in both registered public 
and private nursing homes covered under the scheme.





Private Nursing Homes 648,761 610,991
Section 39 Agencies 21,265 18,271
Private Nursing Homes Contract Beds and Subvention Payments 15,933 20,092
Total Payments to Private Nursing Homes including Section 39 Agencies 685,959 649,354
Gross NHSS Cost of Public Nursing Homes* 359,725 354,675
Payments to Section 38 Agencies 26,793 26,082
Nursing Home Fixed and Other Unit Costs 26,567 23,122
Total Long-Term Residential Care 1,099,044 1,053,233
*  Public nursing homes costs are included under the relevant expenditure headings in the Statement of Revenue Income and Expenditure.
Patient contributions
NHSS recipient contributions for those patients in public homes amounted to €63.07m (2018: €61.14m) and are included 
in the HSE Financial Statements – Revenue Income & Expenditure Account.
NHSS recipient contributions for those patients in voluntary centres (S38 Organisations) amounted to €6.86m (2018: €6.67m), 
and is retained by those centres and does not constitute income for the HSE.
Additional Income
Under Section 27 of the Nursing Homes Support Scheme Act 2009, a Schedule of Assets must be submitted to the HSE 
in respect of a deceased person who received financial support under the Scheme. This is checked to identify and calculate 
any overpayment of financial support that is repayable to the HSE pursuant to Section 42 of the Act. The HSE collected 
income of €7.61m during 2019 (2018 : €6.58m) in respect of non-declared income and assets of Fair Deal clients.
Contract beds and Subvention beds
In 2019, payments of €15.9m (2018: €20.1m) were made in relation to contract beds and nursing home subvention. These 
schemes are being phased out having had no new entrants since the Nursing Homes Support Scheme commenced in 2009.
Expenditure within public facilities
Within the public homes in 2019 there was an additional €26.57m (2018: €23.12m) of costs relating to long-term care. 
These costs related to fixed unit costs and other costs incurred which were in excess of the reimbursed ‘money follows 
the patient’ rate paid under the Nursing Homes Support Scheme.
Cost of Public Nursing Homes
In 2019, the cost of public nursing homes amounted to €359.73m (2018 €354.67m), these costs are gross and the 
client contribution element amounted to €63.07m (2018 €61.13m). The contributions are recognised as income in Long 
Stay Charges in Statement of Income and Expenditure.










Ancillary State Support is an optional extra feature of the Nursing Homes Support Scheme for people who own property 
or assets in the State. Instead of a person paying their assessed contribution for care from their own resources, a person 
can choose to apply for a Nursing Home Loan, to cover the portion of their contribution, which is based on property or 
land-based assets within the State. The HSE then pays that portion of the cost of care on top of the State Support payment. 
The loan is paid back to the State following the occurrence of a relevant event e.g. sale of the asset or death of the person. 
Repayment of the loan is made to the Revenue Commissioners. In certain cases, repayment of the loan can be deferred. 
This part of the scheme is designed to protect people from having to sell their home during their lifetime.
The total gross amount of Ancillary State Support advised to Revenue as at 31 December 2019 for recoupment from 
the commencement of the Nursing Homes Support Scheme (where a relevant and non-relevant event has occurred) was 
€160.74m, representing 7,483 client loans. As at 31 December 2019 the Revenue Commissioners are collecting €160.12m, 
representing 7,497 clients. The difference accounts for clients where their Nursing Home loan is not due for repayment such 
as the Further Deferral option, as mentioned above, and also clients who wish to make a voluntary repayment prior to a relevant 
event occurring. The Revenue Commissioners have confirmed that they had received €113.28m of loan repayments paid in full, 
representing 5,699 client loans.
The total amount of Nursing Home Loan payments made under the Nursing Homes Support Scheme that are outstanding 
(i.e. where a repayable amount has not been notified to Revenue for collection – a relevant event has not occurred), as at 31 
December 2019 is €140.01m. This amount does not include an adjustment for CPI as a relevant event has not yet occurred.











Advised by HSE to Revenue for recoupment 160,123 7,497 123,525 6,170
Confirmed by Revenue as being paid* (113,281) (5,699) (86,829) (4,668)
Subtotal 46,842 1,798 36,696 1,502
Not yet advised to Revenue for recoupment 140,014 5,034 115,945 4,518
Total Ancillary State Support outstanding 186,856 6,832 152,641 6,020
*  Amounts confirmed by Revenue does not include part payments and only includes loans fully repaid.
Note 13 Capital Expenditure





Additions to Property, Plant and Equipment (Note 15)  
Land and Buildings – Service Concession* 0 0
Additions to Property, Plant and Equipment (Note 15)  
Land and Buildings – Other 214,377 232,906
Additions to Property, Plant and Equipment (Note 15)  
Other than Land and Buildings 119,358 72,352
333,735 305,258
Funded from Department of Health Capital Grant 274,331 261,051
Funded from Department of Health Revenue Grant 59,404 44,207
Capitalised – Investment in PPP Service Concession Arrangements* 0 0
333,735 305,258














Expenditure on HSE’s own assets (Capitalised) 274,331 261,051
Expenditure on HSE projects not resulting in property, plant and equipment additions** 82,927 71,587
Capitalised Interest – PPP Service Concession Arrangements* 5,424 15,118
Total expenditure on HSE Projects charged to capital*** 362,682 347,756
Capital grants to outside agencies (Appendix 1)** 324,967 180,301
Total Capital Expenditure per Statement of Capital Income and Expenditure 687,649 528,057
*  Relates to Primary Care Centre assets acquired under Public Private Partnership (PPP) service concession arrangements.
**  Total capital expenditure not capitalised amounts to €413.31m (2018: €267.01m).
***  Capital funded assets and Revenue funded assets are capitalised if the cost exceeds certain value thresholds: €2,000 for computer 
equipment and €7,000 for all other asset classes.
(c) Analysis of Capital Income from Other Sources





Sustainable Energy Authority of Ireland (SEAI) – Energy savings in acute hospitals 1,396 408
Waterford Hospice Movement Ltd – Waterford Hospital Palliative Care Unit 400 4,000
Insurance Proceeds – St. Dympna’s Hospital, fire damage 194 807
Ballymote CNU – Donation 116 0
Insurance Proceeds – Letterkenny General Hospital, flood damage 0 10,051
Department of Education – Children’s Hospital School 0 3,100
NUI Galway – Sligo Regional Hospital Medical Academy 0 1,664
University of Limerick – Clinical Education & Research Centre Project Contribution 0 1,347
NUI Galway – Letterkenny General Hospital Medical Education and Training Unit 0 978
Aontacht Phobail Teoranta – due to HSE on liquidation of subsidiary holding 0 718
Letterkenny Hospital Association Ltd – Contribution towards Mental Health Unit. 0 760
Irish Hospice Foundation – Design and Dignity grant 0 580
Friends of Mid West Regional Hospital – Nenagh Ward Upgrade 0 300
Charitable Contribution towards Community Nursing Unit, Tuam, Co. Galway 0 250
Friends of Bandon Community Hospital – Day Room Extension to the Hospital 0 230
University College Cork – CUH Paediatric Projects 0 59
Other Miscellaneous Income 1,658 4,262
Total Capital Income from Other Sources 3,764 29,514














Gross Proceeds of all Disposals in year 2,992 3,721
Less: Net Expenses Incurred on Disposals (13) (114)
Net Proceeds of Disposal 2,979 3,607
Less Application of Proceeds (2,979) (4,200)
Movement in the year (0) (593)
At 1 January 38 631
Balance at 31 December 38 38
The Multi-Annual Delegated Capital sanction 2019-2022 was issued in December 2019 by the Department of Public 
Expenditure and Reform.












€’000 €’000 €’000 €’000 €’000 €’000 €’000
Cost/Valuation
At 1 January 2019 1,677,679 4,470,891 322,727 91,970 1,486,070 5,898 8,055,235
Additions 1,623 41,899 170,855 5,401 94,850 19,107 333,735
Transfers from Work 
in Progress 0 88,673 (88,673) 4,433 1,776 (6,209) 0
Disposals (2,149) (1,240) (3,259) (7,274) (26,195) (3) (40,120)




1 January 2019 0 1,417,176 0 68,392 1,295,061 0 2,780,629
Charge for the Year 0 108,731 0 11,127 75,714 0 195,572
Disposals 0 (516) 0 (7,030) (24,306) 0 (31,852)
At 31 December 2019 0 1,525,390 0 72,489 1,346,470 0 2,944,349
Net Book Values
At 1 January 2019 1,677,679 3,053,715 322,727 23,578 191,009 5,898 5,274,606
At 31 December 2019 1,677,153 3,074,833 401,650 22,041 210,031 18,793 5,404,501
The current carrying value of land amounting to €1.67bn held by the HSE at 31 December 2019 is based on the 2002 Department of Health 
Valuation rates.






























Cost 45,824 45,824 165,217 165,217 211,041 211,041
Accumulated Depreciation 
at 1 January (23,485) (21,623) 0 0 (23,485) (21,623)
Depreciation charged 
for the year (1,862) (1,862) 0 0 (1,862) (1,862)
Net Book Values 
at 31 December 20,477 22,339 165,217 165,217 185,694 187,556
*/**  Relates to Primary Care Centre (PCC) assets acquired under Public Private Partnership (PPP) service concession arrangements. 
The ten PCC sites included within Work in Progress (Land and Buildings) at a value of €137m in 2017 were transferred to Buildings 
during 2018. All fourteen PCC sites have reached service commencement.
PCC Assets are not depreciated where they have been acquired or are managed under service concession agreements which guarantee 
residual useful lives and operating capacity at the end of the concession term that would be equivalent to that of the asset when it was 
first commissioned.
During 2019 the National Paediatric Hospital Development Board completed the building of an outpatient and urgent care centre 






Medical, Dental and Surgical Supplies 41,020 37,398
Laboratory Supplies 6,645 6,345
Pharmacy Supplies 25,398 22,366
High Tech Pharmacy Inventories 48,893 56,867
Pharmacy Dispensing Inventories 541 589
Blood and Blood Products 1,262 1,133
Vaccine Inventories 33,639 30,066
Household Services 7,436 6,569
Stationery and Office Supplies 2,195 1,874
Sundries 3,133 989
170,162 164,196














Receivables: Patient Debtors – Private Facilities in Public Hospitals* 95,357 97,759
Receivables: Patient Debtors – Public Inpatient Charges 6,234 6,174
Receivables: Patient Debtors – Long Stay Charges 10,280 10,745
Prepayments and Accrued Income 31,657 31,443
Department of Health (DoH) 54,036 54,907
Pharmaceutical Manufacturers 100,441 61,789
Payroll Technical Adjustment 16,494 18,592
Additional Superannuation Contributions (ASC) Deductions from Staff 7,745 8,670
Statutory Redundancy Claim 0 2,200
Local Authorities 664 519
Payroll Advances 626 844
Voluntary Hospitals – National Medical Device Service Contracts 41 2,085
Voluntary Hospitals – Grant Funding Advances 75,648 73,558
Sundry Receivables 51,981 41,568
451,204 410,853
*  Private Healthcare Insurance Income.
  In line with the HSE's accounting policy the HSE recognises patient income due from private health insurance companies at the time the 
service is provided. During 2017 some insurance companies commenced deductions from claims made by the HSE relating to the time 
period between the date of admission and the date the Private Insurance Patient form was signed by the patient. The HSE has disputed 
these deductions through a legal process and it is expected that this dispute will be heard by the Courts sometime at the end of 2020 
present COVID-19 environment allowing. In line with the HSE's accounting policy a bad and doubtful debt provision is created in relation 
to debts outstanding for more than one year.





Finance Leases 2,734 2,675
Service Concession Liability 3,874 5,667
Payables – Revenue 165,967 140,702
Payables – Capital 12,472 8,520
Accruals Non Pay – Revenue 761,386 731,113
Accruals Non Pay – Capital 7,861 5,436
Accruals – Grants to Voluntary Hospitals and Outside Agencies 402,740 397,073
Accruals Pay 557,545 501,974
Taxes and Social Welfare 157,144 148,489
Department of Public Expenditure and Reform – Single Public Service Pension Scheme 3,579 2,916
Lottery Grants Payable* 815 1,390
Sundry Payables 20,473 16,981
2,096,590 1,962,936
*  The HSE administers the disbursement of National Lottery grants for local programmes under the National Lottery’s Health and Welfare 
Funded Schemes. The balance represents funding approved but not yet disbursed to grant recipients at year end.














Finance Leases 25,735 27,458
Service Concession Liability 148,296 151,927
Total Finance Lease obligations 174,031 179,385
Note 20 Deferred Income





Donations and bequests* 17,215 15,616
Grant Funding from the State and other bodies 27,711 21,895
Funding from specific capital projects 92 154
General 4,789 4,222
Balance at 31 December 49,807 41,887
*  Unspent income arising from donations and bequests where the purposes to which money may be applied has been specified but the related 
expenditure has not been incurred.





Surplus/(Deficit) for the current year 60,462 (85,174)
Capital element of lease payments charged to revenue 1,665 1,607
Purchase of equipment charged to Statement of Revenue Income and Expenditure 59,404 44,207
Finance Costs charged to Statement of Revenue Income and Expenditure 935 993
Decrease in Inventories (5,966) (6,568)
(Increase) in Trade and Other Receivables (40,352) (57,678)
Increase in Creditors (falling due within one year) 133,654 55,596
Revenue Reserves – transfer of Deficit in accordance with Section 33(3) of the Health 
Act, 2004, as amended 85,174 139,871
(Decrease) in Creditors (falling due in more than one year) (5,354) (5,292)
Increase/(Decrease) in Deferred Income 7,920 (11,170)
Net Cash Inflow from Operating Activities 297,542 76,392















Future Property, Plant and Equipment purchase commitments:
Within one year 814,776 690,401
After one but within five years 1,451,120 1,496,800
After five years 0 0
2,265,896 2,187,201
Contracted for, but not provided for, in the financial statements 1,333,877 1,398,339
Included in the Capital Plan but not contracted for 932,019 788,862
2,265,896 2,187,201
The HSE has a multi-annual Capital Investment Plan which prioritises expenditure on capital projects in line with goals in the 
Corporate Plan and the Annual Service Plan. The commitments identified above are in respect of the total cost of projects for 
which specific funding budgets have been approved at year end. These commitments may involve costs in years after 2019 






Operating lease rentals (charged to the Statement of Revenue Income and Expenditure)
Land and Buildings 54,166 50,450
Motor Vehicles 374 146
Equipment 716 801
55,256 51,397
The HSE has the following total amounts payable under non-cancellable operating leases split between amounts due:
Land and









Within one year 50,282 489 50,771 44,999
In the second to fifth years inclusive 182,631 452 183,083 163,679
In over five years 499,183 3 499,186 483,275
732,096 944 733,040 691,953















Service Concession Arrangement – Primary Care Centres (14 sites bundle) 196,231 201,551
These commitments incorporate facilities management services, operational, and lifecycle costs, for the remaining life of the 
agreement. They are not discounted to present value.
Finance Lease Commitments

















Not later than one year 3,600 3,600 8,891 10,832
Later than one year but not later than five years 11,520 10,960 44,620 35,139
Later than five years 18,630 21,790 167,267 185,397
Total Gross Payments 33,750 36,350 220,778 231,368
Less: Finance Charges (5,281) (6,217) (68,608) (73,774)
Carrying Amount of Liability 28,469 30,133 152,170 157,594
Classified as:
– Creditors (amounts falling due within one year) 2,734 2,675 3,874 5,667
– Creditors (amounts falling due after more than one year) 25,735 27,458 148,296 151,927
*  The value of the PCC asset and the service concession liability is recognised as assets and liabilities in the Statement of Financial Position 
at an amount of €165.2m which is equal to the present value of the minimum lease payments. In line with FRS 102, the effective interest 
rate is used to discount the future construction related liabilities arising from concession agreements. The carrying amount of the liability 
at 31 December 2019 is €152.2m.
















Title to the properties can be analysed as follows:
Freehold 1,587 1,583
Leasehold 938 916
Total Properties 2,525 2,499
Primary utilisation of the properties can be analysed as follows:
Delivery of health and personal social services 2,438 2,420
Health Business Services and Support (including medical card processing etc.) 87 79
Total Properties 2,525 2,499
The 2018 figure has been revised as two properties had been classified as additional properties in error. These were two new 
buildings completed in 2018 on existing HSE properties. 
During the year there were 57 property additions to the healthcare estate and 31 properties were removed through both 
disposals and lease terminations. The net result is an increase of 26 healthcare properties during 2019. The total number of 
properties in the HSE healthcare estate at the end of 2019 has been impacted by a combination of routine estate management 
activities as well as the requirements of specific key healthcare strategies to deliver ongoing rollout of primary care centres and 
relocation of disability services to community settings.
Note 24 Taxation
The HSE carried out a significant self-review of tax compliance in respect of 2018 with external specialist tax assistance which 
was completed in 2019. The self-review was conducted on an agreed risk based assessment across all tax heads for which 
the HSE needs to account. The liability to taxes identified in the course of the self-review for 2018 was set out by means 
of a Self-Correction disclosure and payment (including interest) of €3,128,034 was made to the Revenue Commissioners in 
September 2019. The amount represents 0.18% of the overall tax paid by the HSE for that year. The HSE has a dedicated 
in house tax team resourced by tax professionals developing a strong relationship with Revenue and with access to external 
advisors where necessary. The HSE remains committed to exemplary tax compliance.
Note 25 Contingent Liabilities
General
The HSE is involved in a number of claims involving legal proceedings which may generate liabilities, depending on the outcome 
of the litigation. The HSE has insurance cover for professional indemnity, fire and specific all risk claims. In most cases, such 
insurance would be sufficient to cover all costs, but this cannot be certain due to indemnity limits and certain policy conditions. 
The financial effects of any uninsured contingencies have not been provided in the financial statements.
Patient Private Property Retained Interest
Prior to 2005, interest income earned on patients’ private funds was retained by the former Health Boards and used to partially 
defray the costs incurred in administering approximately 19,000 Patients’ Private Property Accounts. This action was based 
on previous legal advice. Subsequent legal advice taken by the HSE indicated that the Patients’ Private Property Accounts 
operated under an implied trustee relationship with the patients and, as such, the HSE was obliged to remit interest earned 
to those patients.
The lack of available historic private patient property records limits the ability of the HSE to estimate the full potential liability 
and therefore a partial liability only has been provided for in the HSE's financial statements. The HSE has set up a Steering 
Group to actively manage this issue to a satisfactory resolution.
Clinical Indemnity Scheme
Details of the contingent liability in respect of the Clinical Indemnity Scheme are set out in Note 11.









Note 26 Consultants’ Settlement
In June 2018, a settlement was agreed between the State and Medical Consultants arising from an alleged breach of contract 
in relation to the non-implementation of the 2008 Consultants contract. The settlement specifies that 40% of the retrospective 
remuneration should be paid in 2019 and the balance in 2020. The HSE’s estimate of the liability at 31 December 2018 was 
€198 million. The total cost of the legal settlement is now estimated at €186m at 31 December 2019. The amount paid in 2019 
was €85m (Clinical Pay). The estimated remaining liability due is 2020 is €101m.
Note 27 Post Balance Sheet Events
The unprecedented outbreak of the COVID-19 Pandemic presents significant global challenges and uncertainties in all sectors, 
but in particular on the Health Sector. The HSE is tasked with the provision of health and personal social services for the citizens 
of Ireland and is therefore significantly impacted by the COVID-19 outbreak.
The HSE and its staff are playing a major role in the response to the COVID-19 outbreak and is actively taking steps to limit 
the spread of the outbreak and to ensure resources are available such that appropriate Hospital and Community services 
are in place to look after those whose health has become impacted by the virus.
There are increased pressures on services and resourcing which have resulted in the requirement for additional funding in 2020 
to continue to react and manage the current outbreak. The HSE has received contingency funding from the Department 
of Health as reflected in “Ireland’s National Action Plan Response to COVID-19” issued March 2020. This commitment 
to additional funding means that the HSE considers that it is still appropriate to apply the going concern concept. 
There is no impact on the financial statements of the HSE for 2019.
HSE management are fully aware of the potential additional risks due to the disruption of the normal activities of the HSE. 
While it is not possible to determine all the likely impacts financial or otherwise due to the evolving nature of the pandemic, 
the HSE continues to monitor the situation and plan accordingly.
Note 28 Related Party Transactions
In the normal course of business, the Health Service Executive may approve grants and may also enter into other contractual 
arrangements with undertakings in which Health Service Directorate members are employed or otherwise interested. The 
Health Service Executive adopts procedures in accordance with the Department of Public Expenditure and Reform’s Code 
of Practice for the Governance of State Bodies, the Ethics in Public Office Act 1995 and the Standards in Public Office Act 
2001, in relation to the disclosure of interests of Health Service Directorate members. These procedures have been adhered 
to by the Directorate members and the HSE during the year. During 2019, a member of staff on secondment to the HSE from 
a funded body served as a member of the Directorate. No other member of the Directorate held an interest with any related 
parties.
From June 28 2019, a number of interests were noted by board members. It was deemed that none of the interests disclosed 
have a material commercial and/or financial impact on the HSE. It was also noted that no investments in unlisted companies, 
partnerships and other forms of business, major shareholdings and beneficial interests were disclosed. No board members 
disclosed gifts or hospitality offered by external bodies in the last twelve months. No board members noted any contractual 
relationship with the HSE and no board members noted any other conflicts not covered elsewhere.
Key Management Personnel
All Board members, in addition to the HSE’s Executive Management Team including the Chief Executive Officer, are 
considered to be key management of the HSE. Overall remuneration in relation to serving key management personnel, 
including those that were appointed and resigned during the year, is €1.7m (2018: €1.1m). The Board members are in receipt 
of fees and other than as disclosed in Note 2 all other key management’s remuneration comprise of basic pay only. With the 
exception of the CEO, the other appointed members of the Executive Management Team are members of the HSE pension 
scheme (and the Voluntary Hospital Superannuation Scheme in the case of the seconded member), and their pension 
entitlements do not extend beyond the standard entitlements of the public sector model scheme.
Note 29 Approval of Financial Statements
The financial statements were approved by the Board on the 13 May 2020.



























Total Grants under €100,000 (1,623 Grants) 34,334 0 34,334 32,647
Grants €100,000 or more each
A Ghra Homecare Services Ltd 1,364 1,364 1,721
Ability West Ltd 27,579 27,579 26,557
Abode Hostel and Day Centre 1,027 1,027 1,026
ACCORD 17 17 108
ACET Ireland 463 463 320
Acquired Brain Injury Ireland (formerly Peter Bradley Foundation) 11,500 11,500 11,114
Active Connections CLG 136 136 0
Active Retirement Ireland 335 335 356
Addiction Response Crumlin (ARC) 922 922 920
Aftercare Recovery Group 105 105 121
AGC Healthcare 380 380 171
Age Action Ireland 454 454 441
Age and Opportunity 545 545 595
AIDS Help West 256 256 261
Aiseanna Tacaíochta 2,103 2,103 1,699
Aiséirí 721 721 475
Aislinn Centre, Kilkenny 1,130 1,130 1,226
Alcohol Action Ireland 220 220 212
All About Healthcare T/A The Care Team 1,199 1,199 1,060
All in Care 7,690 7,690 8,713
All Ireland Institute of Hospice & Palliative Care (AIIHPC) 59 59 204
Alliance 295 295 227
ALONE 729 729 709
Alpha One Foundation 120 120 320
Alzheimer Society of Ireland 11,020 11,020 10,846
An Saol Foundation 500 500 500
Ana Liffey Drug Project 1,236 1,236 1,427
Anchor Treatment Centre 196 196 336
ANEW Support Service 353 353 462
Ann’s Home Care 1,315 1,315 0




























Anne Sullivan Foundation for Deaf/Blind 750 750 109
Applewood Homecare Ltd 2,020 2,020 1,786
Arabella Counselling, t/a Here2Help 188 188 191
Áras Mhuire Day Care Centre 
(North Tipperary Community Services) 309 309 297
ARC Cancer Support Centre 184 184 187
Ard Aoibhinn Centre 4,604 4,604 4,340
Ardee Day Care Centre 291 291 288
Arklow South Wicklow Home Help Service 59 59 103
Arlington Novas Ireland 3,456 3,456 3,369
Arthritis Ireland 228 228 200
Asperger Syndrome Association of Ireland (ASPIRE) 273 273 278
Associated Charities Trust 110 110 187
Association for the Healing of Institutional Abuse (AHIA) (Previously 
known as the Aislinn Centre, Dublin) 230 230 228
Association of Parents and Friends  
of The Mentally Handicapped 1,409 1,409 1,367
Asthma Society of Ireland 33 33 212
Athlone Community Services Council Ltd 275 275 265
Autism Initiatives Group 4,981 4,981 5,309
Aware 481 481 484
Ballinasloe Social Services 112 112 154
Ballincollig Senior Citizens Club Ltd 446 446 361
Ballyfermot Advanced Project Ltd 398 398 398
Ballyfermot Chapelizod Partnership 93 93 133
Ballyfermot Local Drug and Alcohol Task Force CLG 125 125 145
Ballyfermot Star Ltd 370 370 370
Ballymun Local Drugs Task Force 286 286 295
Ballymun Regional Youth Resource (BYRY) 146 146 243
Ballymun Youth Action Project (YAP) 678 678 646
Ballyphehane and Togher Community Resource Centre 340 340 290
Barnardos 972 972 946
Barretstown Camp 151 151 151
Barrow Valley Enterprises for Adult Members 
with Special Needs Ltd (BEAM) 1,825 1,825 1,078
Be Independent Home Care 3,712 3,712 3,121


























Beaufort Day Care Centre 234 234 230
Beaumont Hospital 359,314 4,243 363,557 334,833
Behaviour Detectives Ltd, Kilkenny 223 223 169
Belong to Youth Services Ltd 241 241 233
Bergerie Trust 345 345 290
Best Home Care Services 538 538 134
Blakestown and Mountview Youth Initiative (BMYI) 481 481 484
Blanchardstown and Inner City Home Helps 2,425 2,425 3,253
Blanchardstown Local Drugs Task Force 545 545 567
Blanchardstown Youth Service 162 162 221
Bloomfield Health Services 151 151 384
Bluebird Care 29,459 29,459 24,975
Bodywhys The Eating Disorder Association of Ireland 445 445 325
Bon Secours Sisters 272 272 471
Bray Community Addiction Team 693 693 706
Bray Home Help/Care Service Company Limited by Guarantee 1,036 1,036 1,040
Bray Lakers Social and Recreational Club Ltd 200 200 137
Bray Travellers Group 113 113 133
Brindley Healthcare 1,542 1,542 71
Brothers of Charity Services Ireland 217,871 386 218,257 204,171
Cabra Resource Centre 220 220 217
Cairde 610 610 624
Cairdeas Centre Carlow 533 533 521
Camphill Communities of Ireland 9,495 9,495 1,753
Cancer Care West 600 600 600
Cancer Trials Ireland 100 100 0
Cappagh National Orthopaedic Hospital 39,506 702 40,208 37,822
Care About You 2,265 2,265 1,693
Care at Home Services Ltd 2,026 2,026 1,864
Care For Me Ltd 1,742 1,742 1,737
Care of the Aged, West Kerry 110 110 110
CareBright 4,562 4,562 4,658
Caredoc GP Co-operative 9,915 9,915 9,084
Caremark Ireland 9,992 9,992 10,217
Careworld 720 720 717


























Caring and Sharing Association (CASA) 0 0 102
Caritas Convalescent Centre 1,837 1,837 1,841
Carlow Day Care Centre (Askea Community Services) 97 97 102
Carlow Social Services 220 220 271
Carlow/Kilkenny Home Care Team 218 218 218
Carnew Community Care Centre 152 152 143
Carriglea Cairde Services Ltd (formerly Sisters of the Bon Sauveur) 11,790 11,790 11,291
Carrigoran Nursing Home – Day Care Centre 130 130 102
Casadh 180 180 215
Casla Home Care Ltd 680 680 634
Castle Homecare 1,235 1,235 1,423
Catholic Institute for Deaf People (CIDP) 4,619 4,619 4,174
CDA Trust Ltd (Cavan Drug Awareness) 214 214 221
Central Remedial Clinic 17,718 118 17,836 18,348
Centres for Independent Living (CIL) 12,525 12,525 11,409
Charleville Care Project Ltd 214 214 170
Cheeverstown House Ltd 28,145 28,145 26,706
Cheshire Ireland 29,574 29,574 26,689
Children’s Health Ireland 358,777 3,125 361,902 277,778
Childrens Sunshine Home 4,036 4,036 3,830
ChildVision (St Joseph’s School For The Visually Impaired) 4,440 4,440 4,331
Chime 4,505 4,505 4,572
Chrysalis Community Drug Project 438 438 275
Cill Dara Ar Aghaid 268 268 215
Circle of Friends Cancer Support Centre 0 150 150 0
Clann Mór 1,871 1,871 1,597
Clannad Care 1,143 1,143 1,429
Clarecare Ltd Incorporating Clare Social Service Council 7,367 7,367 6,838
Clarecastle Daycare Centre 394 394 394
Claregalway and District Day Care Centre 0 0 375
Clareville Court Day Centre 176 176 166
Clondalkin Addiction Support Programme (CASP) 852 852 862
Clondalkin Drugs Task Force 223 223 233
Clondalkin Tus Nua Ltd 501 501 440
Clonmany Mental Health Association 340 340 322


























Clontarf Home Help 3,172 3,172 3,835
Cluain Training & Enterprise Ctr 750 750 385
CLUB 91 (Formerly Chez Nous Service), Sligo 0 0 125
Co-Action West Cork 8,716 8,716 7,813
Cobh General Hospital 399 399 406
Comfort Keepers Ltd 21,847 21,847 23,424
Communicare Healthcare Ltd 5,439 5,439 4,354
Community Creations Ltd 1,127 1,127 321
Community Games 2 2 100
Community Response, Dublin 397 397 340
Community Substance Misuse Team Limerick 417 417 417
CONNECT – The National Adult Counselling Service 
(NOVA HELPLINE) 361 361 361
Contact Care 1,663 1,663 1,705
Coolmine Therapeutic Community Ltd 1,999 1,999 1,696
Coombe Women’s Hospital 70,979 1,574 72,553 64,677
COPE Foundation 58,871 58,871 56,266
COPE Galway 1,762 1,762 1,718
Cork Association for Autism 7,754 7,754 6,108
Cork Foyer Project 294 294 302
Cork Mental Health Association 150 150 150
Cork Social and Health Education Project (CSHEP) 794 794 798
Cork University Dental School and Hospital 2,798 2,798 2,117
County Sligo Leader Partnership Company 248 248 159
County Wexford Community Workshop, Enniscorthy/New Ross Ltd 6,951 6,951 5,479
CPL Healthcare 1,667 1,667 1,983
Crescent Homecare Ltd 200 200 14
CROI (West of Ireland Cardiology Foundation) 468 468 486
Crosscare 2,826 2,826 2,701
Crumlin Home Care Service Limited 3,306 3,306 3,530
Cuan Mhuire 2,028 2,028 2,399
Cumann na Daoine 103 103 107
Curam Clainne Ltd 93 93 103
Cystic Fibrosis Registry of Ireland 140 140 140
Daisyhouse Housing Association 237 237 192


























Dara Residential Services 1,931 1,931 1,933
Darndale Belcamp Drug Awareness 243 243 250
Daughters of Charity 121,675 19 121,694 118,467
Dawn Court Day Care Centre Ltd 118 118 93
Delta Centre Carlow 4,005 4,005 3,834
Depaul Ireland 1,941 1,941 1,793
Diabetes Federation of Ireland 268 268 426
Dignity 4 Patients 100 100 100
Disability & Home Support Services Wexford 146 146 0
Disability Federation of Ireland (DFI) 1,239 1,239 1,520
Dóchas 102 102 105
Dolmen Clubhouse Ltd 123 123 124
Donegal Homecare Limited 610 610 0
Donnycarney and Beaumont Home Help Services Ltd 1,454 1,454 1,526
Donnycarney Youth Project Ltd 410 410 410
Donnycarney/Beaumont Local Care 115 115 96
Donore Community Development 178 178 178
Down Syndrome Ireland 163 163 179
Drogheda Community Services 119 119 116
Drogheda Homeless Aid Association 167 167 104
Dromcollogher and District Respite Care Centre 525 525 548
Drumcondra Home Help 1,240 1,240 1,271
Drumkeerin Care Of The Elderly 228 228 175
Drumlin House 174 174 164
Dublin 12 Local Drug and Alcohol Task Force CLG 132 132 126
Dublin AIDS Alliance (DAA) Ltd 477 477 548
Dublin Dental Hospital 7,694 160 7,854 6,226
Dublin North East Drugs Task Force 506 506 317
Dublin Region Homeless Executive 579 579 430
Dublin West Homehelp 4,688 4,688 5,166
Dun Laoghaire Home Help 972 972 1,032
Dun Laoghaire Rathdown Community Addiction Team 417 417 417
Dun Laoghaire Rathdown Local Drugs Task Force 109 109 124
Dun Laoghaire Rathdown Outreach Project 252 252 255
Dundalk Outcomers 123 123 83


























Edward Worth Library 165 165 165
Empowerment Plus 172 172 70
Enable Ireland 44,710 1,000 45,710 42,049
Engaging Dementia 116 116 0
Environmental Protection Agency 104 104 65
Epilepsy Ireland 763 763 774
Errigal Truagh Special Needs Parents and Friends Ltd 312 312 244
Extern Ireland 1,085 1,085 649
Familibase 296 296 296
Family Carers Ireland 8,565 8,565 8,982
Fatima Groups United 116 116 116
Ferns Diocesan Youth Services (FDYS) 447 447 346
Festina Lente Foundation 539 539 459
Fettercairn Drug Rehabilitation Project 109 109 95
Fighting Blindness Ireland 111 111 113
Fingal Home Care 4,605 4,605 4,724
Finglas Addiction Support Team 556 556 521
Finglas Cabra Local Drugs and Alcohol Task Force 170 170 177
Finglas Home Help/Care Organisation 2,972 2,972 3,030
First Employment Services 116 116 0
First Fortnight Ltd 155 155 155
Focus Ireland 1,792 1,792 1,716
Fold Ireland 3,861 3,861 3,813
Foróige 266 266 320
Forum The North West Connemara Rural Project 395 395 243
Fusion CPL Ltd 111 111 111
Gaelic Athletic Association 150 150 140
Galway Hospice Foundation 5,401 5,401 4,975
Gateway Community Care 1,401 1,401 3
Gay Health Network 378 378 319
Genio Trust 702 702 3,586
Gheel Autism Services Ltd 6,217 6,217 7,499
Good Morning Inishowen 51 51 129
Good Shepherd Sisters 1,202 1,202 1,132
Graiguenamanagh Elderly Association 200 200 225


























Grantstown Daycare Centre 106 106 104
Greystones Home Help Service Company Limited by Guarantee 1,644 1,644 1,941
GROW 1,305 1,305 1,247
Guardian Ad Litem and Rehabilitation Office (GALRO) 4,956 4,956 4,493
HADD Family Support Group 233 233 163
Hail Housing Association for Integrated Living 464 464 645
Hands On Peer Education (HOPE) 149 149 145
Headway the National Association for Acquired Brain Injury 2,787 2,787 2,599
Health Research Board Ireland (HRB) 303 303 0
Heritage Homecare Ltd 2,443 2,443 1,633
Hesed House 241 241 241
Holy Angels Carlow, Special Needs Day Care Centre 677 677 616
Holy Family School 111 111 111
Holy Ghost Hospital 350 350 1,130
Home and Away Care 563 563 32
Home Care Plus 1,706 1,706 1,016
Home Instead Senior Care 55,451 55,451 49,058
Homecare & Health Services (Ireland) Limited 103 103 0
Homecare Independent Living Ltd 3,797 3,797 3,766
Homecare Solutions Ltd 863 863 1,002
Hope House 285 285 269
IADP Inter-Agency Drugs Project UISCE 150 150 120
Immigrant Counselling and Psychotherapy (ICAP) 254 254 262
Inchicore Community Drugs Team 529 529 549
Inclusion Ireland 633 633 774
Incorporated Orthopaedic Hospital of Ireland 12,213 12,213 10,979
Inis Care 773 773 93
Inspire Ireland Foundation Ltd 0 0 119
Inspire Wellbeing 177 177 545
International Organisation for Migration Screening 300 300 0
Íontas Arts & Community Resource Centre, Castleblanyey 167 167 188
Irish Advocacy Network 794 794 781
Irish Association for Spina Bifida and Hydrocephalus (IASBH) 928 928 904
Irish Cancer Society 753 753 672
Irish College of General Practitioners 477 477 379


























Irish College of Opthalmogists 0 0 206
Irish Family Planning Association (IFPA) 1,315 1,315 1,210
Irish Guide Dogs for the Blind 830 830 822
Irish Haemophilia Society (IHS) 623 623 575
Irish Heart Foundation 293 293 311
Irish Hospice Foundation 329 329 249
Irish Kidney Association (IKA) 454 454 362
Irish Motor Neurone Disease Association 218 218 264
Irish Prison Service 256 256 256
Irish Society for Autism 4 4 3,082
Irish Society for the Prevention of Cruelty to Children (ISPCC) 343 343 351
Irish Wheelchair Association (IWA) 42,832 42,832 40,101
Jack and Jill Childrens Foundation 1,129 1,129 1,038
Jigsaw (also known as Headstrong) 10,749 10,749 8,046
Jobstown Assisting Drug Dependency Project (JAAD Project) 348 348 278
K Doc (GP Out of Hours Service) 2,334 2,334 1,969
KARE Plan Ltd 7,525 7,525 6,895
Kare Plus Ireland 847 847 17
KARE Social Services, Raheny 0 0 125
KARE, Newbridge 20,786 20,786 19,906
Kerry Parents and Friends Association 11,800 11,800 10,746
Kilbarrack Coast Community Programme Ltd (KCCP) 458 458 456
Kildare and West Wicklow Community Addiction Team Ltd 300 300 368
Kildare Youth Services (KYS) 386 386 371
Killinarden (KARP) 150 150 150
Kilmaley Voluntary Housing Association 267 267 270
Kiltoghert Womens Group 284 284 0
Kingsriver Community 642 642 338
L’Arche Ireland 3,775 3,775 3,511
Leap Ireland 100 100 100
Leitrim Association of People with Disabilities (LAPWD) 550 550 522
Leitrim Development Company 432 432 413
Leopardstown Park Hospital 14,019 948 14,967 14,156
Letterkenny Women’s Centre 195 195 203
Liberties and Rialto Home Help 1,372 1,372 1,526


























Lifetime Care 517 517 731
Lifford Clonleigh Resource Centre 200 200 90
Limerick Social Services Council 294 294 322
Limerick Youth Service Community Training Centre 205 205 245
LINC 126 126 147
Link (Galway) Ltd 160 160 168
Liscarne Court Senior Citizens 115 115 115
Little Angels Hostel Letterkenny 365 365 415
Lochrann Ireland Ltd 133 133 133
Longford Community Resources Ltd 216 216 207
Longford Social Services Committee 155 155 144
Lorcan O’ Toole Day Care Centre 118 118 98
Lotamore Family Centre 48 48 136
Lourdes Day Care Centre 226 226 254
Macroom Senior Citizens Housing Development Sullane Haven Ltd 127 127 124
Mahon Community Creche 178 178 173
Marian Court Welfare Home Clonmel 128 128 128
Mater Misericordiae University Hospital Ltd 327,210 2,841 330,051 288,923
Matt Talbot Adolescent Services 1,275 1,275 1,173
McGann Family Home Care Services 109 109 187
Meath County Council 175 175 175
Meath Partnership 481 481 472
Mental Health Associations (MHAs) 1,122 1,122 414
Mental Health Ireland 2,233 2,233 2,207
Mental Health Reform 362 362 339
Merchant’s Quay Ireland (MQI) 3,727 3,727 3,454
Mercy University Hospital, Cork 100,417 1,233 101,650 89,005
Mid-West Regional Drugs Task Force 473 473 472
MIDOC 1,081 1,081 1,070
Migraine Association of Ireland 132 132 140
Milford Care Centre 11,861 11,861 11,727
MOJO 58 58 137
Moorehaven Centre Tipperary Ltd 2,451 2,451 1,701
Mount Cara House 346 346 347
Mount Carmel Home, Callan, Co Kilkenny 99 99 395


























Mounttown Neighbourhood Youth Project 133 133 133
Mowlam Healthcare 1,467 1,467 323
MS Ireland – Multiple Sclerosis Society of Ireland 2,621 2,621 2,695
Muintir na Tire Ltd 86 86 128
Mulhuddart/Corduff Community Drugs Team 324 324 324
Multiple Sclerosis North West Therapy Centre Ltd 233 233 223
Muscular Dystrophy Ireland 1,180 1,180 1,172
Mymind Ltd 258 258 171
Nasc (The Irish Immigrant Support Centre) 90 90 115
National Association of Housing for the Visually Impaired Ltd 1,037 30 1,067 820
National Childhood Network (NCN) 125 125 145
National Council for the Blind of Ireland (NCBI) 6,553 6,553 6,374
National Federation of Voluntary Bodies in Ireland 240 240 351
National Maternity Hospital 67,831 400 68,231 60,002
National Nutrition Surveillance Centre UCD 93 93 192
National Paediatric Hospital 0 201,423 201,423 107,856
National Rehabilitation Hospital 33,394 56,342 89,736 69,967
National Suicide Research Foundation (NSRF) 1,127 1,127 998
National Youth Council of Ireland 151 151 179
Nazareth House, Mallow 1,812 1,812 1,745
Nazareth House, Sligo 2,572 2,572 2,309
Neart Le Cheile 488 488 488
Newport Social Services, Day Care Centre 265 265 270
No Name Youth Club Ltd 130 130 135
North Doc Medical Services 3,938 3,938 356
North Dublin Inner City Homecare and Home Help Services 1,890 1,890 1,026
North Tipperary Disability Support Services Ltd 747 747 684
North Tipperary Leader Partnership 222 222 222
North West Alcohol Forum 408 408 572
North West Parents and Friends Association 2,454 2,454 2,401
North West Regional Drugs Task Force 122 122 39
Northside Community Health Initiative (NICHE) 626 626 653
Northside Homecare Services Ltd 4,474 4,474 4,035
Northside Partnership 162 162 169
Northstar Family Support Project 160 160 175


























Northwest Hospice 1,174 1,174 1,166
Nua Healthcare Services 4,417 4,417 3,601
Nurse on Call – Homecare Package 3,955 3,955 4,113
O’Connell Court Residential and Day Care 293 293 273
Offaly Local Development Company 128 128 114
Offaly Travellers Movement 280 280 232
One Family 405 405 405
One In Four 678 678 595
Open Door Day Centre 376 376 379
Order of Malta 518 518 500
Ossory Youth Services 76 76 101
Our Lady’s Hospice & Care Services (Sisters of Charity) 31,455 31,455 31,325
Outhouse Ltd 187 187 195
Patient Focus 0 0 108
Pavee Point Traveller and Roma Centre 1,449 1,449 1,419
Peacehaven Trust 861 861 810
Peamount Hospital 30,600 8,594 39,194 35,609
Peter McVerry Trust (previously known as The Arrupe Society) 2,300 2,300 1,782
PHC Care Management Ltd 3,649 3,649 3,475
Pieta House 2,158 2,158 2,007
Pioneer Homecare Ltd 2,384 2,384 236
Positive Futures 3,184 3,184 357
Post Polio Support Group (PPSG) 363 363 363
Prague House 151 151 315
Praxis Care Group 5,475 5,475 5,905
Prosper Group 12,162 12,162 11,363
Purple House Cancer Support 176 176 127
R K Respite Services Ltd 414 414 0
RADE (Recovery through Art Drama and Education) 119 119 106
Radius Housing Association 158 158 0
RAH Home Care Ltd T/a Right At Home 3,250 3,250 2,596
Regional and Local Drugs Task Forces 3,882 3,882 4,376
Rehab Group 65,408 176 65,584 55,459
Resilience Ireland (Resilience Healthcare Ltd) 5,848 5,848 3,716
Respond! Housing Association 765 765 738


























Rialto Community Development 122 122 121
Rialto Community Drugs Team 422 422 422
Rialto Partnership Company 749 749 693
Right of Place Second Chance Group 200 200 160
Ringsend and District Response to Drugs 403 403 397
Roscommon Home Services Co-op 3,859 3,859 4,200
Roscommon Partnership Company Ltd 182 182 134
Roscommon Support Group Ltd 1,662 1,662 1,581
Rosedale Residential Home 96 96 410
Rotunda Hospital 67,906 1,224 69,130 62,416
Royal College of Physicians 2,235 2,235 1,659
Royal College of Surgeons in Ireland 4,218 4,218 2,992
Royal Hospital Donnybrook 20,745 42 20,787 19,595
Royal Victoria Eye and Ear Hospital 30,890 431 31,321 28,777
Ruhama Women’s Project 220 220 230
Rutland Centre 142 142 0
S H A R E 208 208 208
Safeguarding Ireland 246 246 200
Safetynet Primary Care 779 779 584
Sage Advocacy 1,641 1,641 1,358
Salesian Youth Enterprises Ltd 477 477 457
Salvation Army 1,650 1,650 1,650
Samaritans 688 688 661
Sandra Cooneys Homecare 2,552 2,552 2,206
Sandymount Home Help 323 323 359
Sankalpa 251 251 237
Saoirse Addiction Treatment Center 130 130 124
SAOL Project 361 361 340
Schizophrenia Ireland Lucia Foundation 91 91 128
SCJMS/Muiriosa Foundation 62,221 62,221 57,535
SDC South Dublin County Partnership 
(formerly Dodder Valley Partnership) 872 872 688
Servisource Recruitment 6,683 6,683 5,185
Shalamar Finiskilin Housing Association 255 255 243
Shankhill Old Folks Association 151 151 132


























Shannondoc Ltd (GP Out Of Hours Service) 5,030 5,030 4,784
SHINE 1,768 1,768 1,715
Simon Communities of Ireland 9,610 9,610 9,005
Simplicitas Ltd 186 186 72
Sisters of Charity 4,764 452 5,216 6,602
Sisters of Charity St Mary’s Centre 
for the Blind and Visually Impaired 3,183 3,183 3,175
Sisters of Mercy 293 293 402
Skibereen Community and Family Resource Centre 89 89 135
Slí Eile Support Services Ltd 346 346 805
Sligo Family Centre 143 143 128
Sligo Social Services Council Ltd 323 323 419
Snug Community Counselling 149 149 168
Society of St Vincent De Paul (SVDP) 4,103 4,103 4,177
Sophia Housing Association 846 846 908
Sora Healthcare T/A Irish Homecare 11,723 11,723 11,747
SOS (Kilkenny) Ltd Special Occupation Scheme 12,386 12,386 171
South Doc GP Co-operative 8,302 8,302 8,480
South Infirmary Victoria University Hospital 63,933 814 64,747 57,394
South West Mayo Development Company 282 282 262
Southern Gay Health Project 117 117 101
Southside Partnership 122 122 120
Spinal Injuries Ireland 312 86 398 379
Spiritan Asylum Services Initiative (SPIRASI) 403 403 385
St Aengus Community Action Group 141 141 143
St Aidan’s Services 5,410 5,410 4,869
St Andrew’s Resource Centre 602 602 575
St Bridget’s Day Care Centre 117 117 117
St Carthage’s House Lismore 182 182 505
St Catherine’s Association Ltd 5,969 5,969 7,181
St Christopher’s Services, Longford 10,247 10,247 9,516
St Colman’s Care Centre 185 185 155
St Cronan’s Association 1,282 1,282 1,155
St Dominic’s Community Response Project 399 399 536
St Fiacc’s House, Graiguecullen 326 326 401


























St Francis Hospice 12,442 12,442 11,024
St Gabriel’s School and Centre 2,228 2,228 1,900
St Hilda’s Services For The Mentally Handicapped, Athlone 5,684 5,684 5,313
St James’ Hospital 411,596 4,401 415,997 386,220
St James’ Hospital, Jonathan Swift Hostels 4,933 4,933 4,927
St John Bosco Youth Centre 0 0 104
St John of God Hospitaller Services 166,316 166,316 157,305
St John’s Hospital 23,989 263 24,252 21,997
St Joseph’s Foundation 20,383 20,383 18,970
St Joseph’s Home For The Elderly 414 414 472
St Joseph’s Home, Kilmoganny, Co Kilkenny 162 162 313
St Kevin’s Home Help Service 368 368 375
St Laurence O’ Toole SSC 887 887 1,061
St Lazarians House, Bagenalstown 231 231 337
St Luke’s Home 1,306 1,306 1,046
St Michael’s Day Care Centre 188 188 175
St Michael’s Hospital, Dun Laoghaire 31,365 50 31,415 29,184
St Michael’s House 94,271 94,271 90,494
St Monica’s Community Development Committee 401 401 391
St Monica’s Nursing Home 199 199 124
St Nicholas Special School 0 0 110
St Patrick’s Centre, Kilkenny (Sisters of Charity) 18,245 18,245 16,923
St Patrick’s Hospital/Marymount 483 483 336
St Patrick’s Special School 182 182 174
St Patrick’s Wellington Road 10,478 10,478 9,147
St Vincent’s Hospital Fairview 15,654 15,654 15,145
St Vincent’s University Hospital, Elm Park 292,631 21,985 314,616 265,031
St Margaret’s Donnybrook (IRL-IASD) 1,705 1,705 0
St Paul’s Child and Family Care Centre 2,469 2,469 3,093
Star Project Ballymun Ltd 331 331 306
Stella Maris Facility 147 147 147
Stewart’s Care Ltd 53,806 53,806 53,380
Stillorgan Home Help 507 507 542
Suicide or Survive (SOS) 323 323 273
Sunbeam House Services 28,702 28,702 27,232


























Support 4 U Ltd 671 671 575
Tabor House, Navan 158 158 158
Tabor Lodge 944 944 799
Talbot Group 611 611 690
Talbot Grove Treatment Centre 86 86 167
Tallaght Home Help 1,974 1,974 1,915
Tallaght Rehabilitation Project 208 208 201
Tallaght Travellers Youth Service 131 131 124
Tallaght University Hospital 249,838 11,755 261,593 253,875
Tearmann Eanna Teo 407 407 365
Tee Care Home Help Services Limited 194 194 0
Teen Challenge Ireland Ltd 277 277 277
Templemore Day Care Centre 173 173 159
Terenure Home Care Service Ltd 1,450 1,450 1,468
The Arklow Home Help Service Company Limited by Guarantee 2,336 2,336 2,262
The Avalon Centre, Sligo 320 320 261
The Beeches Residential Home 130 130 131
The Birches Alzheimer Day Centre 327 327 308
The Collective Sensory Group 125 125 0
The College of Anaesthetists of Ireland 80 80 123
The Eating Disorder Centre Cork 126 126 136
The Irish Forum for Global Health (IFGH) 110 110 110
The Irish Men’s Sheds Association (IMSA) 324 324 327
The Killarney Asylum Seekers Initiative (KASI) 102 102 89
The Mens Development Network 143 143 161
The Nightingale Placement Agency (TNPA) 1,210 1,210 628
The North Inner City Drugs and Alcohol Task Force 266 266 0
The Oasis Centre 164 164 164
The Office of Public Works (OPW) 3,055 3,055 0
The Paddy McGrath Housing Project (formerly Aids Fund Housing) 364 364 364
The Sexual Health Centre 293 293 314
The Sunflower Clinic 400 400 0
The TCP Group 1,365 1,365 1,412
Thurles Community Social Services 207 207 210
Thurles Lions Trust Housing Association Ltd 79 79 122


























Tiglin Challenge Limited 103 103 84
Tinteán Housing Association Ltd 200 200 184
Tipperary Association for Special Needs 130 130 130
Tipperary Hospice Movement 220 220 220
Tolka River Project 281 281 283
Tralee International Resource Centre 75 75 108
Tralee Womens Forum 120 120 146
Transfusion Positive 143 143 81
Transgender Equality Network Ireland 311 311 294
Traveller Groups and Organisations 4,191 4,191 4,764
Traveller Support Group Galway 678 678 0
Travellers Education & Development Association, Tuam 210 210 0
Treoir 382 382 374
Tribli Limited, t/a Exchange House National Travellers Service 909 909 905
Trinity College Dublin 232 232 230
Trinity Community Care 3,537 3,537 3,774
TTM Healthcare Ltd 191 191 422
Tullow Day Care Centre 166 166 164
Turas Counselling Services Ltd 389 389 359
Turn2Me 364 364 165
Turners Cross Social Services Ltd 157 157 202
TUSLA Child & Family Agency 78 78 148
University College Cork 0 0 102
University College Dublin 308 308 32
University of Limerick 901 901 920
Valentia Community Hospital 219 219 304
Victoria Healthcare Organisation Ltd 936 936 740
Village Counselling Service 135 135 135
Walkinstown Association For Handicapped People Ltd 4,222 4,222 4,067
Walkinstown Greenhills Resource Centre 241 241 233
Waterford and South Tipperary Community Youth Service 525 525 1,365
Waterford Association for the Mentally Handicapped 4,029 4,029 3,465
Waterford Community Childcare 188 188 183
Waterford Hospice Movement 276 276 169
Well Woman Clinics 665 665 547


























West Cork Carers Support Group Ltd 148 148 156
West Limerick Resources Ltd 172 172 153
West Of Ireland Alzheimer Foundation 2,034 2,034 1,891
Westcare Homecare Ltd 475 475 137
Westdoc (GP Out Of Hours Service) 2,757 2,757 2,418
Western Care Association 37,628 37,628 36,040
Western Region Drugs Task Force 255 255 280
Western Traveller and Intercultural Development Association 0 0 208
Westgate Foundation 95 95 103
Westmeath Community Development Ltd 227 227 252
Wexford Homecare Service 202 202 202
Wexford Local Development 132 132 125
White Oaks Addiction Treatment Centre 149 149 0
White Oaks Housing Association Ltd 255 255 379
Wicklow Community Services Company Limited by Guarantee 1,744 1,744 1,816
Wicklow Hospice Foundation 0 0 1,250
Willow Health Care Ltd 869 869 26
Windmill Therapeutic Training Unit 884 884 701
Young Social Innovators Ltd 100 100 100
Youth For Peace Ltd 139 139 139
Youth Work Ireland 226 226 242
Total Grants to Outside Agencies 
(see Note 8 for Revenue; see Note 13 for Capital) 4,699,339 324,967 5,024,306 4,463,755
*  Additional payments, not shown above, may have been made to some agencies related to services provided.
**  Agencies with grants exceeding €100,000 in either year are shown. All other grants are included at “Total Grants under €100,000”. 
Accordingly, the 2018 comparatives above have been re–stated where appropriate.
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